id	sid	tid	token	lemma	pos
bjos-8641360	1	1	oral	oral	ADJ
bjos-8641360	1	2	sciences	sciences	PROPN
bjos-8641360	1	3	n3	n3	PROPN
bjos-8641360	1	4	braz	braz	PROPN
bjos-8641360	1	5	j	j	PROPN
bjos-8641360	1	6	oral	oral	PROPN
bjos-8641360	1	7	sci	sci	PROPN
bjos-8641360	1	8	.	.	PUNCT
bjos-8641360	2	1	11(3):352	11(3):352	NUM
bjos-8641360	2	2	-	-	SYM
bjos-8641360	2	3	356	356	NUM
bjos-8641360	2	4	diagnosis	diagnosis	NOUN
bjos-8641360	2	5	of	of	ADP
bjos-8641360	2	6	oral	oral	ADJ
bjos-8641360	2	7	manifestations	manifestation	NOUN
bjos-8641360	2	8	in	in	ADP
bjos-8641360	2	9	hiv	hiv	PROPN
bjos-8641360	2	10	/	/	SYM
bjos-8641360	2	11	aids	aids	PROPN
bjos-8641360	2	12	patients	patient	NOUN
bjos-8641360	2	13	who	who	PRON
bjos-8641360	2	14	used	use	VERB
bjos-8641360	2	15	haart	haart	PROPN
bjos-8641360	2	16	and	and	CCONJ
bjos-8641360	2	17	developed	developed	ADJ
bjos-8641360	2	18	diabetes	diabetes	NOUN
bjos-8641360	2	19	mellitus	mellitus	NOUN
bjos-8641360	2	20	adam	adam	PROPN
bjos-8641360	2	21	de	de	PROPN
bjos-8641360	2	22	mello	mello	PROPN
bjos-8641360	2	23	silva1	silva1	PROPN
bjos-8641360	2	24	,	,	PUNCT
bjos-8641360	2	25	camila	camila	PROPN
bjos-8641360	2	26	correia	correia	PROPN
bjos-8641360	2	27	dos	dos	PROPN
bjos-8641360	2	28	santos1	santos1	PROPN
bjos-8641360	2	29	,	,	PUNCT
bjos-8641360	2	30	elcio	elcio	PROPN
bjos-8641360	2	31	magdalena	magdalena	PROPN
bjos-8641360	2	32	giovani2	giovani2	VERB
bjos-8641360	3	1	1dds	1dd	NOUN
bjos-8641360	3	2	,	,	PUNCT
bjos-8641360	3	3	msc	msc	PROPN
bjos-8641360	3	4	,	,	PUNCT
bjos-8641360	3	5	paulista	paulista	PROPN
bjos-8641360	3	6	university	university	PROPN
bjos-8641360	3	7	(	(	PUNCT
bjos-8641360	3	8	unip	unip	ADJ
bjos-8641360	3	9	)	)	PUNCT
bjos-8641360	3	10	ceape	ceape	NOUN
bjos-8641360	3	11	(	(	PUNCT
bjos-8641360	3	12	center	center	NOUN
bjos-8641360	3	13	of	of	ADP
bjos-8641360	3	14	study	study	NOUN
bjos-8641360	3	15	and	and	CCONJ
bjos-8641360	3	16	care	care	NOUN
bjos-8641360	3	17	of	of	ADP
bjos-8641360	3	18	patients	patient	NOUN
bjos-8641360	3	19	with	with	ADP
bjos-8641360	3	20	special	special	ADJ
bjos-8641360	3	21	needs	need	NOUN
bjos-8641360	3	22	)	)	PUNCT
bjos-8641360	3	23	oral	oral	ADJ
bjos-8641360	3	24	diagnosis	diagnosis	NOUN
bjos-8641360	3	25	,	,	PUNCT
bjos-8641360	3	26	sp	sp	NOUN
bjos-8641360	3	27	,	,	PUNCT
bjos-8641360	3	28	brazil	brazil	PROPN
bjos-8641360	3	29	2dds	2dds	PROPN
bjos-8641360	3	30	,	,	PUNCT
bjos-8641360	3	31	msc	msc	PROPN
bjos-8641360	3	32	phd	phd	PROPN
bjos-8641360	3	33	,	,	PUNCT
bjos-8641360	3	34	professor	professor	NOUN
bjos-8641360	3	35	at	at	ADP
bjos-8641360	3	36	the	the	DET
bjos-8641360	3	37	integrated	integrate	VERB
bjos-8641360	3	38	and	and	CCONJ
bjos-8641360	3	39	special	special	ADJ
bjos-8641360	3	40	needs	need	NOUN
bjos-8641360	3	41	patients	patient	NOUN
bjos-8641360	3	42	clinic	clinic	NOUN
bjos-8641360	3	43	and	and	CCONJ
bjos-8641360	3	44	professor	professor	NOUN
bjos-8641360	3	45	at	at	ADP
bjos-8641360	3	46	the	the	DET
bjos-8641360	3	47	master	master	NOUN
bjos-8641360	3	48	’s	’s	PART
bjos-8641360	3	49	graduate	graduate	PROPN
bjos-8641360	3	50	program	program	NOUN
bjos-8641360	3	51	,	,	PUNCT
bjos-8641360	3	52	paulista	paulista	PROPN
bjos-8641360	3	53	university	university	PROPN
bjos-8641360	3	54	(	(	PUNCT
bjos-8641360	3	55	unip	unip	PROPN
bjos-8641360	3	56	)	)	PUNCT
bjos-8641360	3	57	,	,	PUNCT
bjos-8641360	3	58	sp	sp	NOUN
bjos-8641360	3	59	,	,	PUNCT
bjos-8641360	3	60	brazil	brazil	PROPN
bjos-8641360	3	61	correspondence	correspondence	NOUN
bjos-8641360	3	62	to	to	ADP
bjos-8641360	3	63	:	:	PUNCT
bjos-8641360	3	64	adam	adam	PROPN
bjos-8641360	3	65	de	de	PROPN
bjos-8641360	3	66	melo	melo	PROPN
bjos-8641360	3	67	silva	silva	PROPN
bjos-8641360	3	68	avenida	avenida	PROPN
bjos-8641360	3	69	itamarati	itamarati	PROPN
bjos-8641360	3	70	1855	1855	PROPN
bjos-8641360	3	71	,	,	PUNCT
bjos-8641360	3	72	curuça	curuça	PROPN
bjos-8641360	3	73	,	,	PUNCT
bjos-8641360	3	74	santo	santo	PROPN
bjos-8641360	3	75	andré	andré	PROPN
bjos-8641360	3	76	sp	sp	ADP
bjos-8641360	3	77	brasil	brasil	PROPN
bjos-8641360	3	78	phone	phone	NOUN
bjos-8641360	3	79	:	:	PUNCT
bjos-8641360	3	80	+55	+55	PROPN
bjos-8641360	3	81	11	11	NUM
bjos-8641360	3	82	86179286	86179286	NUM
bjos-8641360	3	83	e	e	NOUN
bjos-8641360	3	84	-	-	NOUN
bjos-8641360	3	85	mail	mail	NOUN
bjos-8641360	3	86	:	:	PUNCT
bjos-8641360	3	87	businesska@hotmail.com	businesska@hotmail.com	X
bjos-8641360	4	1	abstract	abstract	ADJ
bjos-8641360	4	2	aim	aim	VERB
bjos-8641360	4	3	:	:	PUNCT
bjos-8641360	4	4	to	to	PART
bjos-8641360	4	5	assess	assess	VERB
bjos-8641360	4	6	the	the	DET
bjos-8641360	4	7	prevalence	prevalence	NOUN
bjos-8641360	4	8	of	of	ADP
bjos-8641360	4	9	oral	oral	ADJ
bjos-8641360	4	10	manifestations	manifestation	NOUN
bjos-8641360	4	11	in	in	ADP
bjos-8641360	4	12	hiv	hiv	PROPN
bjos-8641360	4	13	/	/	SYM
bjos-8641360	4	14	aids	aids	PROPN
bjos-8641360	4	15	patients	patient	NOUN
bjos-8641360	4	16	and	and	CCONJ
bjos-8641360	4	17	a	a	DET
bjos-8641360	4	18	possible	possible	ADJ
bjos-8641360	4	19	correlation	correlation	NOUN
bjos-8641360	4	20	of	of	ADP
bjos-8641360	4	21	the	the	DET
bjos-8641360	4	22	development	development	NOUN
bjos-8641360	4	23	of	of	ADP
bjos-8641360	4	24	diabetes	diabetes	NOUN
bjos-8641360	4	25	mellitus	mellitus	NOUN
bjos-8641360	4	26	due	due	ADP
bjos-8641360	4	27	to	to	ADP
bjos-8641360	4	28	highly	highly	ADV
bjos-8641360	4	29	active	active	ADJ
bjos-8641360	4	30	antiretroviral	antiretroviral	ADJ
bjos-8641360	4	31	therapy	therapy	NOUN
bjos-8641360	4	32	(	(	PUNCT
bjos-8641360	4	33	haart	haart	PROPN
bjos-8641360	4	34	)	)	PUNCT
bjos-8641360	4	35	.	.	PUNCT
bjos-8641360	5	1	methods	method	NOUN
bjos-8641360	5	2	:	:	PUNCT
bjos-8641360	5	3	56	56	NUM
bjos-8641360	5	4	patients	patient	NOUN
bjos-8641360	5	5	were	be	AUX
bjos-8641360	5	6	examined	examine	VERB
bjos-8641360	5	7	,	,	PUNCT
bjos-8641360	5	8	divided	divide	VERB
bjos-8641360	5	9	into	into	ADP
bjos-8641360	5	10	two	two	NUM
bjos-8641360	5	11	groups	group	NOUN
bjos-8641360	5	12	,	,	PUNCT
bjos-8641360	5	13	group	group	NOUN
bjos-8641360	5	14	1	1	NUM
bjos-8641360	5	15	,	,	PUNCT
bjos-8641360	5	16	the	the	DET
bjos-8641360	5	17	hiv	hiv	PROPN
bjos-8641360	5	18	group	group	NOUN
bjos-8641360	5	19	,	,	PUNCT
bjos-8641360	5	20	with	with	ADP
bjos-8641360	5	21	28	28	NUM
bjos-8641360	5	22	patients	patient	NOUN
bjos-8641360	5	23	known	know	VERB
bjos-8641360	5	24	to	to	PART
bjos-8641360	5	25	be	be	AUX
bjos-8641360	5	26	hiv+	hiv+	NOUN
bjos-8641360	5	27	,	,	PUNCT
bjos-8641360	5	28	who	who	PRON
bjos-8641360	5	29	developed	develop	VERB
bjos-8641360	5	30	diabetes	diabetes	NOUN
bjos-8641360	5	31	mellitus	mellitus	NOUN
bjos-8641360	5	32	due	due	ADP
bjos-8641360	5	33	to	to	ADP
bjos-8641360	5	34	haart	haart	PROPN
bjos-8641360	5	35	,	,	PUNCT
bjos-8641360	5	36	and	and	CCONJ
bjos-8641360	5	37	group	group	NOUN
bjos-8641360	5	38	2	2	NUM
bjos-8641360	5	39	,	,	PUNCT
bjos-8641360	5	40	the	the	DET
bjos-8641360	5	41	control	control	NOUN
bjos-8641360	5	42	group	group	NOUN
bjos-8641360	5	43	,	,	PUNCT
bjos-8641360	5	44	with	with	ADP
bjos-8641360	5	45	28	28	NUM
bjos-8641360	5	46	patients	patient	NOUN
bjos-8641360	5	47	with	with	ADP
bjos-8641360	5	48	hivdiagnosed	hivdiagnose	VERB
bjos-8641360	5	49	with	with	ADP
bjos-8641360	5	50	diabetes	diabetes	NOUN
bjos-8641360	5	51	mellitus	mellitus	NOUN
bjos-8641360	5	52	.	.	PUNCT
bjos-8641360	6	1	results	result	NOUN
bjos-8641360	6	2	:	:	PUNCT
bjos-8641360	6	3	in	in	ADP
bjos-8641360	6	4	group	group	NOUN
bjos-8641360	6	5	1	1	NUM
bjos-8641360	6	6	,	,	PUNCT
bjos-8641360	6	7	normal	normal	ADJ
bjos-8641360	6	8	salivary	salivary	ADJ
bjos-8641360	6	9	flow	flow	NOUN
bjos-8641360	6	10	rate	rate	NOUN
bjos-8641360	6	11	and	and	CCONJ
bjos-8641360	6	12	buffering	buffering	NOUN
bjos-8641360	6	13	capacity	capacity	NOUN
bjos-8641360	6	14	were	be	AUX
bjos-8641360	6	15	observed	observe	VERB
bjos-8641360	6	16	in	in	ADP
bjos-8641360	6	17	18	18	NUM
bjos-8641360	6	18	(	(	PUNCT
bjos-8641360	6	19	64.3	64.3	NUM
bjos-8641360	6	20	%	%	NOUN
bjos-8641360	6	21	)	)	PUNCT
bjos-8641360	6	22	patients	patient	NOUN
bjos-8641360	6	23	,	,	PUNCT
bjos-8641360	6	24	but	but	CCONJ
bjos-8641360	6	25	the	the	DET
bjos-8641360	6	26	bleeding	bleed	VERB
bjos-8641360	6	27	index	index	NOUN
bjos-8641360	6	28	high	high	ADJ
bjos-8641360	6	29	(	(	PUNCT
bjos-8641360	6	30	46.53	46.53	NUM
bjos-8641360	6	31	%	%	NOUN
bjos-8641360	6	32	)	)	PUNCT
bjos-8641360	6	33	and	and	CCONJ
bjos-8641360	6	34	higher	high	ADJ
bjos-8641360	6	35	incidence	incidence	NOUN
bjos-8641360	6	36	of	of	ADP
bjos-8641360	6	37	periodontal	periodontal	ADJ
bjos-8641360	6	38	disease	disease	NOUN
bjos-8641360	6	39	was	be	AUX
bjos-8641360	6	40	found	find	VERB
bjos-8641360	6	41	in	in	ADP
bjos-8641360	6	42	this	this	DET
bjos-8641360	6	43	group	group	NOUN
bjos-8641360	6	44	.	.	PUNCT
bjos-8641360	7	1	in	in	ADP
bjos-8641360	7	2	group	group	NOUN
bjos-8641360	7	3	2	2	NUM
bjos-8641360	7	4	,	,	PUNCT
bjos-8641360	7	5	11	11	NUM
bjos-8641360	7	6	(	(	PUNCT
bjos-8641360	7	7	39.2	39.2	NUM
bjos-8641360	7	8	%	%	NOUN
bjos-8641360	7	9	)	)	PUNCT
bjos-8641360	7	10	and	and	CCONJ
bjos-8641360	7	11	15	15	NUM
bjos-8641360	7	12	(	(	PUNCT
bjos-8641360	7	13	53.5	53.5	NUM
bjos-8641360	7	14	%	%	NOUN
bjos-8641360	7	15	)	)	PUNCT
bjos-8641360	7	16	patients	patient	NOUN
bjos-8641360	7	17	had	have	VERB
bjos-8641360	7	18	low	low	ADJ
bjos-8641360	7	19	and	and	CCONJ
bjos-8641360	7	20	normal	normal	ADJ
bjos-8641360	7	21	salivary	salivary	ADJ
bjos-8641360	7	22	flow	flow	NOUN
bjos-8641360	7	23	rate	rate	NOUN
bjos-8641360	7	24	,	,	PUNCT
bjos-8641360	7	25	respectively	respectively	ADV
bjos-8641360	7	26	.	.	PUNCT
bjos-8641360	8	1	high	high	PROPN
bjos-8641360	8	2	t	t	PROPN
bjos-8641360	8	3	-	-	PUNCT
bjos-8641360	8	4	cd4	cd4	PROPN
bjos-8641360	8	5	indices	index	NOUN
bjos-8641360	8	6	with	with	ADP
bjos-8641360	8	7	mean	mean	ADJ
bjos-8641360	8	8	value	value	NOUN
bjos-8641360	8	9	of	of	ADP
bjos-8641360	8	10	22.46	22.46	NUM
bjos-8641360	8	11	for	for	ADP
bjos-8641360	8	12	each	each	DET
bjos-8641360	8	13	patient	patient	NOUN
bjos-8641360	8	14	,	,	PUNCT
bjos-8641360	8	15	showing	show	VERB
bjos-8641360	8	16	xerostomia	xerostomia	NOUN
bjos-8641360	8	17	in	in	ADP
bjos-8641360	8	18	9	9	NUM
bjos-8641360	8	19	(	(	PUNCT
bjos-8641360	8	20	32.1	32.1	NUM
bjos-8641360	8	21	%	%	NOUN
bjos-8641360	8	22	)	)	PUNCT
bjos-8641360	8	23	patients	patient	NOUN
bjos-8641360	8	24	and	and	CCONJ
bjos-8641360	8	25	dental	dental	ADJ
bjos-8641360	8	26	caries	carie	NOUN
bjos-8641360	8	27	in	in	ADP
bjos-8641360	8	28	11	11	NUM
bjos-8641360	8	29	(	(	PUNCT
bjos-8641360	8	30	39.3	39.3	NUM
bjos-8641360	8	31	%	%	NOUN
bjos-8641360	8	32	)	)	PUNCT
bjos-8641360	8	33	.	.	PUNCT
bjos-8641360	9	1	conclusions	conclusion	NOUN
bjos-8641360	9	2	:	:	PUNCT
bjos-8641360	9	3	regarding	regard	VERB
bjos-8641360	9	4	the	the	DET
bjos-8641360	9	5	oral	oral	ADJ
bjos-8641360	9	6	and	and	CCONJ
bjos-8641360	9	7	general	general	ADJ
bjos-8641360	9	8	manifestations	manifestation	NOUN
bjos-8641360	9	9	,	,	PUNCT
bjos-8641360	9	10	the	the	DET
bjos-8641360	9	11	hiv	hiv	PROPN
bjos-8641360	9	12	group	group	NOUN
bjos-8641360	9	13	showed	show	VERB
bjos-8641360	9	14	higher	high	ADJ
bjos-8641360	9	15	rates	rate	NOUN
bjos-8641360	9	16	of	of	ADP
bjos-8641360	9	17	pathologies	pathology	NOUN
bjos-8641360	9	18	when	when	SCONJ
bjos-8641360	9	19	compared	compare	VERB
bjos-8641360	9	20	with	with	ADP
bjos-8641360	9	21	the	the	DET
bjos-8641360	9	22	control	control	NOUN
bjos-8641360	9	23	group	group	NOUN
bjos-8641360	9	24	.	.	PUNCT
bjos-8641360	10	1	the	the	DET
bjos-8641360	10	2	hiv	hiv	PROPN
bjos-8641360	10	3	group	group	NOUN
bjos-8641360	10	4	and	and	CCONJ
bjos-8641360	10	5	the	the	DET
bjos-8641360	10	6	control	control	NOUN
bjos-8641360	10	7	group	group	NOUN
bjos-8641360	10	8	were	be	AUX
bjos-8641360	10	9	diagnosed	diagnose	VERB
bjos-8641360	10	10	with	with	ADP
bjos-8641360	10	11	diabetes	diabetes	NOUN
bjos-8641360	10	12	,	,	PUNCT
bjos-8641360	10	13	but	but	CCONJ
bjos-8641360	10	14	this	this	DET
bjos-8641360	10	15	condition	condition	NOUN
bjos-8641360	10	16	in	in	ADP
bjos-8641360	10	17	the	the	DET
bjos-8641360	10	18	hiv	hiv	PROPN
bjos-8641360	10	19	group	group	NOUN
bjos-8641360	10	20	presented	present	VERB
bjos-8641360	10	21	earlier	early	ADV
bjos-8641360	10	22	than	than	ADP
bjos-8641360	10	23	in	in	ADP
bjos-8641360	10	24	the	the	DET
bjos-8641360	10	25	control	control	NOUN
bjos-8641360	10	26	group	group	NOUN
bjos-8641360	10	27	,	,	PUNCT
bjos-8641360	10	28	suggesting	suggest	VERB
bjos-8641360	10	29	a	a	DET
bjos-8641360	10	30	possible	possible	ADJ
bjos-8641360	10	31	association	association	NOUN
bjos-8641360	10	32	with	with	ADP
bjos-8641360	10	33	haart	haart	PROPN
bjos-8641360	10	34	.	.	PUNCT
bjos-8641360	11	1	keywords	keyword	NOUN
bjos-8641360	11	2	:	:	PUNCT
bjos-8641360	11	3	aids	aids	PROPN
bjos-8641360	11	4	,	,	PUNCT
bjos-8641360	11	5	hiv	hiv	PROPN
bjos-8641360	11	6	,	,	PUNCT
bjos-8641360	11	7	diabetes	diabete	VERB
bjos-8641360	11	8	mellitus	mellitus	NOUN
bjos-8641360	11	9	.	.	PUNCT
bjos-8641360	12	1	introduction	introduction	NOUN
bjos-8641360	12	2	acquired	acquire	VERB
bjos-8641360	12	3	immunodeficiency	immunodeficiency	NOUN
bjos-8641360	12	4	syndrome	syndrome	NOUN
bjos-8641360	12	5	(	(	PUNCT
bjos-8641360	12	6	aids	aids	PROPN
bjos-8641360	12	7	)	)	PUNCT
bjos-8641360	12	8	was	be	AUX
bjos-8641360	12	9	first	first	ADV
bjos-8641360	12	10	described	describe	VERB
bjos-8641360	12	11	in	in	ADP
bjos-8641360	12	12	1981	1981	NUM
bjos-8641360	12	13	in	in	ADP
bjos-8641360	12	14	the	the	DET
bjos-8641360	12	15	united	united	PROPN
bjos-8641360	12	16	states	states	PROPN
bjos-8641360	12	17	,	,	PUNCT
bjos-8641360	12	18	and	and	CCONJ
bjos-8641360	12	19	its	its	PRON
bjos-8641360	12	20	causative	causative	ADJ
bjos-8641360	12	21	agent	agent	NOUN
bjos-8641360	12	22	is	be	AUX
bjos-8641360	12	23	the	the	DET
bjos-8641360	12	24	human	human	ADJ
bjos-8641360	12	25	immunodeficiency	immunodeficiency	NOUN
bjos-8641360	12	26	virus	virus	NOUN
bjos-8641360	12	27	(	(	PUNCT
bjos-8641360	12	28	hiv	hiv	PROPN
bjos-8641360	12	29	)	)	PUNCT
bjos-8641360	12	30	.	.	PUNCT
bjos-8641360	13	1	since	since	SCONJ
bjos-8641360	13	2	1996	1996	NUM
bjos-8641360	13	3	,	,	PUNCT
bjos-8641360	13	4	with	with	ADP
bjos-8641360	13	5	the	the	DET
bjos-8641360	13	6	advent	advent	NOUN
bjos-8641360	13	7	and	and	CCONJ
bjos-8641360	13	8	introduction	introduction	NOUN
bjos-8641360	13	9	of	of	ADP
bjos-8641360	13	10	highly	highly	ADV
bjos-8641360	13	11	active	active	ADJ
bjos-8641360	13	12	antiretroviral	antiretroviral	ADJ
bjos-8641360	13	13	therapy	therapy	NOUN
bjos-8641360	13	14	(	(	PUNCT
bjos-8641360	13	15	haart	haart	PROPN
bjos-8641360	13	16	)	)	PUNCT
bjos-8641360	13	17	,	,	PUNCT
bjos-8641360	13	18	a	a	DET
bjos-8641360	13	19	profound	profound	ADJ
bjos-8641360	13	20	impact	impact	NOUN
bjos-8641360	13	21	on	on	ADP
bjos-8641360	13	22	the	the	DET
bjos-8641360	13	23	natural	natural	ADJ
bjos-8641360	13	24	history	history	NOUN
bjos-8641360	13	25	of	of	ADP
bjos-8641360	13	26	hiv	hiv	PROPN
bjos-8641360	13	27	infection	infection	NOUN
bjos-8641360	13	28	was	be	AUX
bjos-8641360	13	29	observed	observe	VERB
bjos-8641360	13	30	,	,	PUNCT
bjos-8641360	13	31	with	with	ADP
bjos-8641360	13	32	a	a	DET
bjos-8641360	13	33	remarkable	remarkable	ADJ
bjos-8641360	13	34	increase	increase	NOUN
bjos-8641360	13	35	in	in	ADP
bjos-8641360	13	36	the	the	DET
bjos-8641360	13	37	survival	survival	NOUN
bjos-8641360	13	38	of	of	ADP
bjos-8641360	13	39	hiv	hiv	PROPN
bjos-8641360	13	40	-	-	PUNCT
bjos-8641360	13	41	infected	infect	VERB
bjos-8641360	13	42	individuals	individual	NOUN
bjos-8641360	13	43	,	,	PUNCT
bjos-8641360	13	44	transforming	transform	VERB
bjos-8641360	13	45	the	the	DET
bjos-8641360	13	46	panorama	panorama	NOUN
bjos-8641360	13	47	of	of	ADP
bjos-8641360	13	48	the	the	DET
bjos-8641360	13	49	disease	disease	NOUN
bjos-8641360	13	50	.	.	PUNCT
bjos-8641360	14	1	today	today	NOUN
bjos-8641360	14	2	,	,	PUNCT
bjos-8641360	14	3	the	the	DET
bjos-8641360	14	4	morbidity	morbidity	NOUN
bjos-8641360	14	5	and	and	CCONJ
bjos-8641360	14	6	mortality	mortality	NOUN
bjos-8641360	14	7	ratios	ratio	NOUN
bjos-8641360	14	8	become	become	VERB
bjos-8641360	14	9	significantly	significantly	ADV
bjos-8641360	14	10	smaller	small	ADJ
bjos-8641360	14	11	in	in	ADP
bjos-8641360	14	12	those	those	PRON
bjos-8641360	14	13	adhering	adhere	VERB
bjos-8641360	14	14	to	to	ADP
bjos-8641360	14	15	the	the	DET
bjos-8641360	14	16	treatment	treatment	NOUN
bjos-8641360	14	17	.	.	PUNCT
bjos-8641360	15	1	however	however	ADV
bjos-8641360	15	2	,	,	PUNCT
bjos-8641360	15	3	although	although	SCONJ
bjos-8641360	15	4	the	the	DET
bjos-8641360	15	5	substantial	substantial	ADJ
bjos-8641360	15	6	benefits	benefit	NOUN
bjos-8641360	15	7	of	of	ADP
bjos-8641360	15	8	haart	haart	PROPN
bjos-8641360	15	9	far	far	ADV
bjos-8641360	15	10	outweigh	outweigh	VERB
bjos-8641360	15	11	its	its	PRON
bjos-8641360	15	12	potential	potential	ADJ
bjos-8641360	15	13	risks	risk	NOUN
bjos-8641360	15	14	,	,	PUNCT
bjos-8641360	15	15	it	it	PRON
bjos-8641360	15	16	is	be	AUX
bjos-8641360	15	17	known	know	VERB
bjos-8641360	15	18	that	that	SCONJ
bjos-8641360	15	19	prolonged	prolong	VERB
bjos-8641360	15	20	treatment	treatment	NOUN
bjos-8641360	15	21	may	may	AUX
bjos-8641360	15	22	result	result	VERB
bjos-8641360	15	23	in	in	ADP
bjos-8641360	15	24	a	a	DET
bjos-8641360	15	25	variety	variety	NOUN
bjos-8641360	15	26	of	of	ADP
bjos-8641360	15	27	disorders	disorder	NOUN
bjos-8641360	15	28	related	relate	VERB
bjos-8641360	15	29	to	to	ADP
bjos-8641360	15	30	compliance	compliance	NOUN
bjos-8641360	15	31	and	and	CCONJ
bjos-8641360	15	32	toxicity	toxicity	NOUN
bjos-8641360	15	33	.	.	PUNCT
bjos-8641360	16	1	long	long	ADJ
bjos-8641360	16	2	-	-	PUNCT
bjos-8641360	16	3	term	term	NOUN
bjos-8641360	16	4	haart	haart	PROPN
bjos-8641360	16	5	is	be	AUX
bjos-8641360	16	6	accompanied	accompany	VERB
bjos-8641360	16	7	by	by	ADP
bjos-8641360	16	8	undesirable	undesirable	ADJ
bjos-8641360	16	9	adverse	adverse	ADJ
bjos-8641360	16	10	side	side	NOUN
bjos-8641360	16	11	effects	effect	NOUN
bjos-8641360	16	12	such	such	ADJ
bjos-8641360	16	13	as	as	ADP
bjos-8641360	16	14	cardiovascular	cardiovascular	ADJ
bjos-8641360	16	15	and	and	CCONJ
bjos-8641360	16	16	metabolic	metabolic	NOUN
bjos-8641360	16	17	alterations	alteration	NOUN
bjos-8641360	16	18	that	that	PRON
bjos-8641360	16	19	are	be	AUX
bjos-8641360	16	20	risk	risk	NOUN
bjos-8641360	16	21	factors	factor	NOUN
bjos-8641360	16	22	for	for	ADP
bjos-8641360	16	23	cardiovascular	cardiovascular	ADJ
bjos-8641360	16	24	disease	disease	NOUN
bjos-8641360	16	25	and	and	CCONJ
bjos-8641360	16	26	diabetes	diabetes	NOUN
bjos-8641360	16	27	mellitus	mellitus	NOUN
bjos-8641360	16	28	(	(	PUNCT
bjos-8641360	16	29	dm	dm	PROPN
bjos-8641360	16	30	)	)	PUNCT
bjos-8641360	16	31	.	.	PUNCT
bjos-8641360	17	1	metabolic	metabolic	NOUN
bjos-8641360	17	2	alterations	alteration	NOUN
bjos-8641360	17	3	include	include	VERB
bjos-8641360	17	4	dyslipidemia	dyslipidemia	NOUN
bjos-8641360	17	5	,	,	PUNCT
bjos-8641360	17	6	diabetes	diabetes	NOUN
bjos-8641360	17	7	mellitus	mellitus	NOUN
bjos-8641360	17	8	type	type	NOUN
bjos-8641360	17	9	2	2	NUM
bjos-8641360	17	10	(	(	PUNCT
bjos-8641360	17	11	dm2	dm2	PROPN
bjos-8641360	17	12	)	)	PUNCT
bjos-8641360	17	13	,	,	PUNCT
bjos-8641360	17	14	insulin	insulin	NOUN
bjos-8641360	17	15	resistance	resistance	NOUN
bjos-8641360	17	16	,	,	PUNCT
bjos-8641360	17	17	hyperlactatemia	hyperlactatemia	ADV
bjos-8641360	17	18	,	,	PUNCT
bjos-8641360	17	19	hyperlipidemia	hyperlipidemia	NOUN
bjos-8641360	17	20	.	.	PUNCT
bjos-8641360	18	1	a	a	DET
bjos-8641360	18	2	morphological	morphological	ADJ
bjos-8641360	18	3	,	,	PUNCT
bjos-8641360	18	4	anatomical	anatomical	ADJ
bjos-8641360	18	5	,	,	PUNCT
bjos-8641360	18	6	metabolic	metabolic	NOUN
bjos-8641360	18	7	change	change	NOUN
bjos-8641360	18	8	in	in	ADP
bjos-8641360	18	9	body	body	NOUN
bjos-8641360	18	10	fat	fat	NOUN
bjos-8641360	18	11	and	and	CCONJ
bjos-8641360	18	12	bone	bone	NOUN
bjos-8641360	18	13	metabolism	metabolism	NOUN
bjos-8641360	18	14	is	be	AUX
bjos-8641360	18	15	the	the	DET
bjos-8641360	18	16	set	set	NOUN
bjos-8641360	18	17	of	of	ADP
bjos-8641360	18	18	changes	change	NOUN
bjos-8641360	18	19	known	know	VERB
bjos-8641360	18	20	as	as	ADP
bjos-8641360	18	21	lipodystrophy	lipodystrophy	NOUN
bjos-8641360	18	22	syndrome1	syndrome1	NOUN
bjos-8641360	18	23	-	-	SYM
bjos-8641360	18	24	8	8	NUM
bjos-8641360	18	25	.	.	PUNCT
bjos-8641360	19	1	original	original	ADJ
bjos-8641360	19	2	article	article	NOUN
bjos-8641360	19	3	braz	braz	PROPN
bjos-8641360	19	4	j	j	PROPN
bjos-8641360	19	5	oral	oral	PROPN
bjos-8641360	19	6	sci	sci	PROPN
bjos-8641360	19	7	.	.	PUNCT
bjos-8641360	20	1	july	july	PROPN
bjos-8641360	20	2	|	|	ADV
bjos-8641360	20	3	september	september	PROPN
bjos-8641360	20	4	2012	2012	NUM
bjos-8641360	20	5	volume	volume	NOUN
bjos-8641360	20	6	11	11	NUM
bjos-8641360	20	7	,	,	PUNCT
bjos-8641360	20	8	number	number	NOUN
bjos-8641360	20	9	3	3	NUM
bjos-8641360	20	10	received	receive	VERB
bjos-8641360	20	11	for	for	ADP
bjos-8641360	20	12	publication	publication	NOUN
bjos-8641360	20	13	:	:	PUNCT
bjos-8641360	20	14	october	october	PROPN
bjos-8641360	20	15	18	18	NUM
bjos-8641360	20	16	,	,	PUNCT
bjos-8641360	20	17	2011	2011	NUM
bjos-8641360	20	18	accepted	accept	VERB
bjos-8641360	20	19	:	:	PUNCT
bjos-8641360	20	20	february	february	PROPN
bjos-8641360	20	21	18	18	NUM
bjos-8641360	20	22	,	,	PUNCT
bjos-8641360	20	23	2012	2012	NUM
bjos-8641360	20	24	braz	braz	PROPN
bjos-8641360	20	25	j	j	PROPN
bjos-8641360	20	26	oral	oral	PROPN
bjos-8641360	20	27	sci	sci	PROPN
bjos-8641360	20	28	.	.	PUNCT
bjos-8641360	21	1	11(3):352	11(3):352	NUM
bjos-8641360	21	2	-	-	SYM
bjos-8641360	21	3	356	356	NUM
bjos-8641360	21	4	the	the	DET
bjos-8641360	21	5	anatomical	anatomical	ADJ
bjos-8641360	21	6	changes	change	NOUN
bjos-8641360	21	7	include	include	VERB
bjos-8641360	21	8	lipoatrophy	lipoatrophy	NOUN
bjos-8641360	21	9	in	in	ADP
bjos-8641360	21	10	the	the	DET
bjos-8641360	21	11	region	region	NOUN
bjos-8641360	21	12	of	of	ADP
bjos-8641360	21	13	the	the	DET
bjos-8641360	21	14	face	face	NOUN
bjos-8641360	21	15	(	(	PUNCT
bjos-8641360	21	16	facial	facial	ADJ
bjos-8641360	21	17	fat	fat	ADJ
bjos-8641360	21	18	loss	loss	NOUN
bjos-8641360	21	19	)	)	PUNCT
bjos-8641360	21	20	,	,	PUNCT
bjos-8641360	21	21	loss	loss	NOUN
bjos-8641360	21	22	of	of	ADP
bjos-8641360	21	23	limb	limb	NOUN
bjos-8641360	21	24	fat	fat	ADJ
bjos-8641360	21	25	(	(	PUNCT
bjos-8641360	21	26	upper	upper	ADJ
bjos-8641360	21	27	and	and	CCONJ
bjos-8641360	21	28	lower	low	ADJ
bjos-8641360	21	29	)	)	PUNCT
bjos-8641360	21	30	,	,	PUNCT
bjos-8641360	21	31	especially	especially	ADV
bjos-8641360	21	32	of	of	ADP
bjos-8641360	21	33	the	the	DET
bjos-8641360	21	34	superficial	superficial	ADJ
bjos-8641360	21	35	veins	vein	NOUN
bjos-8641360	21	36	,	,	PUNCT
bjos-8641360	21	37	loss	loss	NOUN
bjos-8641360	21	38	of	of	ADP
bjos-8641360	21	39	fat	fat	NOUN
bjos-8641360	21	40	from	from	ADP
bjos-8641360	21	41	the	the	DET
bjos-8641360	21	42	buttocks	buttock	NOUN
bjos-8641360	21	43	associated	associate	VERB
bjos-8641360	21	44	or	or	CCONJ
bjos-8641360	21	45	not	not	PART
bjos-8641360	21	46	with	with	ADP
bjos-8641360	21	47	the	the	DET
bjos-8641360	21	48	accumulation	accumulation	NOUN
bjos-8641360	21	49	of	of	ADP
bjos-8641360	21	50	fat	fat	NOUN
bjos-8641360	21	51	in	in	ADP
bjos-8641360	21	52	the	the	DET
bjos-8641360	21	53	abdomen	abdomen	NOUN
bjos-8641360	21	54	mainly	mainly	ADV
bjos-8641360	21	55	due	due	ADP
bjos-8641360	21	56	to	to	ADP
bjos-8641360	21	57	fat	fat	ADJ
bjos-8641360	21	58	deposition	deposition	NOUN
bjos-8641360	21	59	,	,	PUNCT
bjos-8641360	21	60	visceral	visceral	ADJ
bjos-8641360	21	61	fat	fat	ADJ
bjos-8641360	21	62	accumulation	accumulation	NOUN
bjos-8641360	21	63	in	in	ADP
bjos-8641360	21	64	the	the	DET
bjos-8641360	21	65	posterior	posterior	ADJ
bjos-8641360	21	66	cervical	cervical	ADJ
bjos-8641360	21	67	region	region	NOUN
bjos-8641360	21	68	(	(	PUNCT
bjos-8641360	21	69	giba	giba	NOUN
bjos-8641360	21	70	)	)	PUNCT
bjos-8641360	21	71	,	,	PUNCT
bjos-8641360	21	72	accumulation	accumulation	NOUN
bjos-8641360	21	73	of	of	ADP
bjos-8641360	21	74	fat	fat	NOUN
bjos-8641360	21	75	in	in	ADP
bjos-8641360	21	76	the	the	DET
bjos-8641360	21	77	breasts	breast	NOUN
bjos-8641360	21	78	that	that	PRON
bjos-8641360	21	79	can	can	AUX
bjos-8641360	21	80	occur	occur	VERB
bjos-8641360	21	81	in	in	ADP
bjos-8641360	21	82	both	both	DET
bjos-8641360	21	83	women	woman	NOUN
bjos-8641360	21	84	and	and	CCONJ
bjos-8641360	21	85	men	man	NOUN
bjos-8641360	21	86	.	.	PUNCT
bjos-8641360	22	1	metabolic	metabolic	NOUN
bjos-8641360	22	2	changes	change	NOUN
bjos-8641360	22	3	include	include	VERB
bjos-8641360	22	4	the	the	DET
bjos-8641360	22	5	increase	increase	NOUN
bjos-8641360	22	6	of	of	ADP
bjos-8641360	22	7	serum	serum	NOUN
bjos-8641360	22	8	lipids	lipid	NOUN
bjos-8641360	22	9	and	and	CCONJ
bjos-8641360	22	10	peripheral	peripheral	ADJ
bjos-8641360	22	11	insulin	insulin	NOUN
bjos-8641360	22	12	resistance	resistance	NOUN
bjos-8641360	22	13	resulting	result	VERB
bjos-8641360	22	14	in	in	ADP
bjos-8641360	22	15	dm9	dm9	NOUN
bjos-8641360	22	16	-	-	PUNCT
bjos-8641360	22	17	12	12	NUM
bjos-8641360	22	18	.	.	PUNCT
bjos-8641360	23	1	insulin	insulin	NOUN
bjos-8641360	23	2	resistance	resistance	NOUN
bjos-8641360	23	3	(	(	PUNCT
bjos-8641360	23	4	ir	ir	NOUN
bjos-8641360	23	5	)	)	PUNCT
bjos-8641360	23	6	is	be	AUX
bjos-8641360	23	7	common	common	ADJ
bjos-8641360	23	8	in	in	ADP
bjos-8641360	23	9	hiv	hiv	PROPN
bjos-8641360	23	10	-	-	PUNCT
bjos-8641360	23	11	seropositive	seropositive	ADJ
bjos-8641360	23	12	patients	patient	NOUN
bjos-8641360	23	13	,	,	PUNCT
bjos-8641360	23	14	particularly	particularly	ADV
bjos-8641360	23	15	among	among	ADP
bjos-8641360	23	16	those	those	PRON
bjos-8641360	23	17	receiving	receive	VERB
bjos-8641360	23	18	protease	protease	NOUN
bjos-8641360	23	19	inhibitor	inhibitor	NOUN
bjos-8641360	23	20	(	(	PUNCT
bjos-8641360	23	21	pi	pi	NOUN
bjos-8641360	23	22	)	)	PUNCT
bjos-8641360	23	23	and	and	CCONJ
bjos-8641360	23	24	is	be	AUX
bjos-8641360	23	25	more	more	ADV
bjos-8641360	23	26	prevalent	prevalent	ADJ
bjos-8641360	23	27	among	among	ADP
bjos-8641360	23	28	those	those	PRON
bjos-8641360	23	29	with	with	ADP
bjos-8641360	23	30	lipoatrophy	lipoatrophy	NOUN
bjos-8641360	23	31	or	or	CCONJ
bjos-8641360	23	32	fat	fat	ADJ
bjos-8641360	23	33	accumulation	accumulation	NOUN
bjos-8641360	23	34	in	in	ADP
bjos-8641360	23	35	the	the	DET
bjos-8641360	23	36	visceral	visceral	ADJ
bjos-8641360	23	37	region	region	NOUN
bjos-8641360	23	38	.	.	PUNCT
bjos-8641360	24	1	the	the	DET
bjos-8641360	24	2	prevalence	prevalence	NOUN
bjos-8641360	24	3	of	of	ADP
bjos-8641360	24	4	hyperglycemia	hyperglycemia	NOUN
bjos-8641360	24	5	and	and	CCONJ
bjos-8641360	24	6	diabetes	diabetes	NOUN
bjos-8641360	24	7	is	be	AUX
bjos-8641360	24	8	significantly	significantly	ADV
bjos-8641360	24	9	higher	high	ADJ
bjos-8641360	24	10	in	in	ADP
bjos-8641360	24	11	those	those	PRON
bjos-8641360	24	12	receiving	receive	VERB
bjos-8641360	24	13	haart	haart	NOUN
bjos-8641360	24	14	,	,	PUNCT
bjos-8641360	24	15	compared	compare	VERB
bjos-8641360	24	16	to	to	ADP
bjos-8641360	24	17	the	the	DET
bjos-8641360	24	18	general	general	ADJ
bjos-8641360	24	19	population	population	NOUN
bjos-8641360	24	20	.	.	PUNCT
bjos-8641360	25	1	the	the	DET
bjos-8641360	25	2	occurrence	occurrence	NOUN
bjos-8641360	25	3	of	of	ADP
bjos-8641360	25	4	diabetes	diabetes	NOUN
bjos-8641360	25	5	is	be	AUX
bjos-8641360	25	6	four	four	NUM
bjos-8641360	25	7	times	time	NOUN
bjos-8641360	25	8	greater	great	ADJ
bjos-8641360	25	9	in	in	ADP
bjos-8641360	25	10	hivseropositive	hivseropositive	ADJ
bjos-8641360	25	11	patients	patient	NOUN
bjos-8641360	25	12	than	than	ADP
bjos-8641360	25	13	in	in	ADP
bjos-8641360	25	14	hiv	hiv	PROPN
bjos-8641360	25	15	-	-	PUNCT
bjos-8641360	25	16	seronegative	seronegative	ADJ
bjos-8641360	25	17	patients	patient	NOUN
bjos-8641360	25	18	matched	match	VERB
bjos-8641360	25	19	by	by	ADP
bjos-8641360	25	20	age	age	NOUN
bjos-8641360	25	21	and	and	CCONJ
bjos-8641360	25	22	body	body	NOUN
bjos-8641360	25	23	mass10,13	mass10,13	NOUN
bjos-8641360	25	24	-	-	PUNCT
bjos-8641360	25	25	16	16	NUM
bjos-8641360	25	26	.	.	PUNCT
bjos-8641360	26	1	according	accord	VERB
bjos-8641360	26	2	to	to	ADP
bjos-8641360	26	3	the	the	DET
bjos-8641360	26	4	american	american	ADJ
bjos-8641360	26	5	diabetes	diabetes	NOUN
bjos-8641360	26	6	association17	association17	NOUN
bjos-8641360	26	7	,	,	PUNCT
bjos-8641360	26	8	dm	dm	PROPN
bjos-8641360	26	9	is	be	AUX
bjos-8641360	26	10	a	a	DET
bjos-8641360	26	11	disease	disease	NOUN
bjos-8641360	26	12	in	in	ADP
bjos-8641360	26	13	which	which	PRON
bjos-8641360	26	14	the	the	DET
bjos-8641360	26	15	body	body	NOUN
bjos-8641360	26	16	does	do	AUX
bjos-8641360	26	17	not	not	PART
bjos-8641360	26	18	produce	produce	VERB
bjos-8641360	26	19	insulin	insulin	NOUN
bjos-8641360	26	20	or	or	CCONJ
bjos-8641360	26	21	does	do	AUX
bjos-8641360	26	22	not	not	PART
bjos-8641360	26	23	produce	produce	VERB
bjos-8641360	26	24	it	it	PRON
bjos-8641360	26	25	correctly	correctly	ADV
bjos-8641360	26	26	.	.	PUNCT
bjos-8641360	27	1	diabetes	diabetes	NOUN
bjos-8641360	27	2	is	be	AUX
bjos-8641360	27	3	latent	latent	ADJ
bjos-8641360	27	4	when	when	SCONJ
bjos-8641360	27	5	a	a	DET
bjos-8641360	27	6	blood	blood	NOUN
bjos-8641360	27	7	glucose	glucose	NOUN
bjos-8641360	27	8	level	level	NOUN
bjos-8641360	27	9	of	of	ADP
bjos-8641360	27	10	100	100	NUM
bjos-8641360	27	11	-	-	SYM
bjos-8641360	27	12	126	126	NUM
bjos-8641360	27	13	mg	mg	PROPN
bjos-8641360	27	14	/	/	SYM
bjos-8641360	27	15	dl	dl	PROPN
bjos-8641360	27	16	is	be	AUX
bjos-8641360	27	17	detected	detect	VERB
bjos-8641360	27	18	on	on	ADP
bjos-8641360	27	19	fasting	fast	VERB
bjos-8641360	27	20	.	.	PUNCT
bjos-8641360	28	1	diabetes	diabetes	NOUN
bjos-8641360	28	2	is	be	AUX
bjos-8641360	28	3	relatively	relatively	ADV
bjos-8641360	28	4	similar	similar	ADJ
bjos-8641360	28	5	in	in	ADP
bjos-8641360	28	6	hiv	hiv	PROPN
bjos-8641360	28	7	-	-	PUNCT
bjos-8641360	28	8	positive	positive	ADJ
bjos-8641360	28	9	and	and	CCONJ
bjos-8641360	28	10	negative	negative	ADJ
bjos-8641360	28	11	individuals	individual	NOUN
bjos-8641360	28	12	.	.	PUNCT
bjos-8641360	29	1	however	however	ADV
bjos-8641360	29	2	,	,	PUNCT
bjos-8641360	29	3	the	the	DET
bjos-8641360	29	4	association	association	NOUN
bjos-8641360	29	5	with	with	ADP
bjos-8641360	29	6	haart	haart	PROPN
bjos-8641360	29	7	has	have	AUX
bjos-8641360	29	8	shown	show	VERB
bjos-8641360	29	9	an	an	DET
bjos-8641360	29	10	increased	increase	VERB
bjos-8641360	29	11	risk	risk	NOUN
bjos-8641360	29	12	for	for	ADP
bjos-8641360	29	13	developing	develop	VERB
bjos-8641360	29	14	dm	dm	NOUN
bjos-8641360	29	15	,	,	PUNCT
bjos-8641360	29	16	cardiovascular	cardiovascular	ADJ
bjos-8641360	29	17	disease	disease	NOUN
bjos-8641360	29	18	and	and	CCONJ
bjos-8641360	29	19	metabolic	metabolic	NOUN
bjos-8641360	29	20	syndrome	syndrome	NOUN
bjos-8641360	29	21	.	.	PUNCT
bjos-8641360	30	1	there	there	PRON
bjos-8641360	30	2	is	be	VERB
bjos-8641360	30	3	a	a	DET
bjos-8641360	30	4	relationship	relationship	NOUN
bjos-8641360	30	5	between	between	ADP
bjos-8641360	30	6	diabetes	diabetes	NOUN
bjos-8641360	30	7	and	and	CCONJ
bjos-8641360	30	8	re	re	NOUN
bjos-8641360	30	9	-	-	NOUN
bjos-8641360	30	10	exposure	exposure	NOUN
bjos-8641360	30	11	to	to	ADP
bjos-8641360	30	12	haart	haart	PROPN
bjos-8641360	30	13	,	,	PUNCT
bjos-8641360	30	14	especially	especially	ADV
bjos-8641360	30	15	among	among	ADP
bjos-8641360	30	16	individuals	individual	NOUN
bjos-8641360	30	17	under	under	ADP
bjos-8641360	30	18	therapy	therapy	NOUN
bjos-8641360	30	19	with	with	ADP
bjos-8641360	30	20	stavudine	stavudine	ADJ
bjos-8641360	30	21	,	,	PUNCT
bjos-8641360	30	22	zidovudine	zidovudine	NOUN
bjos-8641360	30	23	,	,	PUNCT
bjos-8641360	30	24	didanosine	didanosine	PROPN
bjos-8641360	30	25	,	,	PUNCT
bjos-8641360	30	26	and	and	CCONJ
bjos-8641360	30	27	indinavir	indinavir	NOUN
bjos-8641360	30	28	,	,	PUNCT
bjos-8641360	30	29	while	while	SCONJ
bjos-8641360	30	30	the	the	DET
bjos-8641360	30	31	risk	risk	NOUN
bjos-8641360	30	32	is	be	AUX
bjos-8641360	30	33	reduced	reduce	VERB
bjos-8641360	30	34	in	in	ADP
bjos-8641360	30	35	case	case	NOUN
bjos-8641360	30	36	of	of	ADP
bjos-8641360	30	37	exposure	exposure	NOUN
bjos-8641360	30	38	to	to	ADP
bjos-8641360	30	39	ritonavir	ritonavir	PROPN
bjos-8641360	30	40	and	and	CCONJ
bjos-8641360	30	41	nevirapine	nevirapine	ADJ
bjos-8641360	30	42	.	.	PUNCT
bjos-8641360	31	1	there	there	PRON
bjos-8641360	31	2	is	be	VERB
bjos-8641360	31	3	a	a	DET
bjos-8641360	31	4	clear	clear	ADJ
bjos-8641360	31	5	cumulative	cumulative	ADJ
bjos-8641360	31	6	effect	effect	NOUN
bjos-8641360	31	7	of	of	ADP
bjos-8641360	31	8	exposure	exposure	NOUN
bjos-8641360	31	9	to	to	ADP
bjos-8641360	31	10	different	different	ADJ
bjos-8641360	31	11	classes	class	NOUN
bjos-8641360	31	12	of	of	ADP
bjos-8641360	31	13	drugs	drug	NOUN
bjos-8641360	31	14	on	on	ADP
bjos-8641360	31	15	the	the	DET
bjos-8641360	31	16	incidence	incidence	NOUN
bjos-8641360	31	17	of	of	ADP
bjos-8641360	31	18	diabetes	diabetes	NOUN
bjos-8641360	31	19	,	,	PUNCT
bjos-8641360	31	20	exposure	exposure	NOUN
bjos-8641360	31	21	to	to	ADP
bjos-8641360	31	22	nrti	nrti	PROPN
bjos-8641360	31	23	(	(	PUNCT
bjos-8641360	31	24	nucleoside	nucleoside	ADV
bjos-8641360	31	25	reverse	reverse	ADJ
bjos-8641360	31	26	transcriptase	transcriptase	NOUN
bjos-8641360	31	27	inhibitors	inhibitor	NOUN
bjos-8641360	31	28	)	)	PUNCT
bjos-8641360	31	29	,	,	PUNCT
bjos-8641360	31	30	a	a	DET
bjos-8641360	31	31	combination	combination	NOUN
bjos-8641360	31	32	of	of	ADP
bjos-8641360	31	33	nrti	nrti	NOUN
bjos-8641360	31	34	with	with	ADP
bjos-8641360	31	35	pi	pi	NOUN
bjos-8641360	31	36	,	,	PUNCT
bjos-8641360	31	37	or	or	CCONJ
bjos-8641360	31	38	combination	combination	NOUN
bjos-8641360	31	39	with	with	ADP
bjos-8641360	31	40	nrti	nrti	NOUN
bjos-8641360	31	41	,	,	PUNCT
bjos-8641360	31	42	pi	pi	PROPN
bjos-8641360	31	43	,	,	PUNCT
bjos-8641360	31	44	nnrti	nnrti	NOUN
bjos-8641360	31	45	increasing	increase	VERB
bjos-8641360	31	46	the	the	DET
bjos-8641360	31	47	risk	risk	NOUN
bjos-8641360	31	48	of	of	ADP
bjos-8641360	31	49	developing	develop	VERB
bjos-8641360	31	50	dm	dm	PROPN
bjos-8641360	31	51	6,18	6,18	NUM
bjos-8641360	31	52	-	-	SYM
bjos-8641360	31	53	21	21	NUM
bjos-8641360	31	54	.	.	PUNCT
bjos-8641360	32	1	the	the	DET
bjos-8641360	32	2	most	most	ADV
bjos-8641360	32	3	common	common	ADJ
bjos-8641360	32	4	oral	oral	ADJ
bjos-8641360	32	5	manifestations	manifestation	NOUN
bjos-8641360	32	6	associated	associate	VERB
bjos-8641360	32	7	with	with	ADP
bjos-8641360	32	8	hiv	hiv	PROPN
bjos-8641360	32	9	are	be	AUX
bjos-8641360	32	10	candidiasis	candidiasis	NOUN
bjos-8641360	32	11	,	,	PUNCT
bjos-8641360	32	12	gun	gun	NOUN
bjos-8641360	32	13	(	(	PUNCT
bjos-8641360	32	14	necrotizing	necrotize	VERB
bjos-8641360	32	15	ulcerative	ulcerative	ADJ
bjos-8641360	32	16	gingivitis	gingivitis	NOUN
bjos-8641360	32	17	)	)	PUNCT
bjos-8641360	32	18	,	,	PUNCT
bjos-8641360	32	19	pun	pun	VERB
bjos-8641360	32	20	(	(	PUNCT
bjos-8641360	32	21	necrotizing	necrotize	VERB
bjos-8641360	32	22	ulcerative	ulcerative	ADJ
bjos-8641360	32	23	periodontitis	periodontitis	NOUN
bjos-8641360	32	24	)	)	PUNCT
bjos-8641360	32	25	,	,	PUNCT
bjos-8641360	32	26	hairy	hairy	ADJ
bjos-8641360	32	27	leukoplakia	leukoplakia	NOUN
bjos-8641360	32	28	,	,	PUNCT
bjos-8641360	32	29	herpes	herpe	NOUN
bjos-8641360	32	30	simplex	simplex	NOUN
bjos-8641360	32	31	,	,	PUNCT
bjos-8641360	32	32	hpv	hpv	X
bjos-8641360	32	33	(	(	PUNCT
bjos-8641360	32	34	human	human	ADJ
bjos-8641360	32	35	papillomavirus	papillomavirus	NOUN
bjos-8641360	32	36	)	)	PUNCT
bjos-8641360	32	37	and	and	CCONJ
bjos-8641360	32	38	kaposi	kaposi	PROPN
bjos-8641360	32	39	’s	’s	PART
bjos-8641360	32	40	sarcoma22	sarcoma22	PROPN
bjos-8641360	32	41	-	-	PUNCT
bjos-8641360	32	42	25	25	NUM
bjos-8641360	32	43	,	,	PUNCT
bjos-8641360	32	44	but	but	CCONJ
bjos-8641360	32	45	haart	haart	PROPN
bjos-8641360	32	46	is	be	AUX
bjos-8641360	32	47	a	a	DET
bjos-8641360	32	48	associated	associate	VERB
bjos-8641360	32	49	with	with	ADP
bjos-8641360	32	50	a	a	DET
bjos-8641360	32	51	significant	significant	ADJ
bjos-8641360	32	52	reduction	reduction	NOUN
bjos-8641360	32	53	in	in	ADP
bjos-8641360	32	54	the	the	DET
bjos-8641360	32	55	occurrence	occurrence	NOUN
bjos-8641360	32	56	of	of	ADP
bjos-8641360	32	57	oral	oral	ADJ
bjos-8641360	32	58	manifestations	manifestation	NOUN
bjos-8641360	32	59	.	.	PUNCT
bjos-8641360	33	1	currently	currently	ADV
bjos-8641360	33	2	,	,	PUNCT
bjos-8641360	33	3	the	the	DET
bjos-8641360	33	4	oral	oral	ADJ
bjos-8641360	33	5	manifestations	manifestation	NOUN
bjos-8641360	33	6	of	of	ADP
bjos-8641360	33	7	candidiasis	candidiasis	NOUN
bjos-8641360	33	8	,	,	PUNCT
bjos-8641360	33	9	severe	severe	ADJ
bjos-8641360	33	10	and	and	CCONJ
bjos-8641360	33	11	rapid	rapid	ADJ
bjos-8641360	33	12	progression	progression	NOUN
bjos-8641360	33	13	periodontal	periodontal	ADJ
bjos-8641360	33	14	disease	disease	NOUN
bjos-8641360	33	15	,	,	PUNCT
bjos-8641360	33	16	hairy	hairy	ADJ
bjos-8641360	33	17	leukoplakia	leukoplakia	NOUN
bjos-8641360	33	18	are	be	AUX
bjos-8641360	33	19	important	important	ADJ
bjos-8641360	33	20	indicators	indicator	NOUN
bjos-8641360	33	21	,	,	PUNCT
bjos-8641360	33	22	highlighting	highlight	VERB
bjos-8641360	33	23	the	the	DET
bjos-8641360	33	24	increase	increase	NOUN
bjos-8641360	33	25	of	of	ADP
bjos-8641360	33	26	immunosuppression	immunosuppression	NOUN
bjos-8641360	33	27	and/or	and/or	CCONJ
bjos-8641360	33	28	the	the	DET
bjos-8641360	33	29	failure	failure	NOUN
bjos-8641360	33	30	of	of	ADP
bjos-8641360	33	31	haart	haart	PROPN
bjos-8641360	33	32	.	.	PUNCT
bjos-8641360	34	1	however	however	ADV
bjos-8641360	34	2	,	,	PUNCT
bjos-8641360	34	3	these	these	DET
bjos-8641360	34	4	manifestations	manifestation	NOUN
bjos-8641360	34	5	are	be	AUX
bjos-8641360	34	6	more	more	ADV
bjos-8641360	34	7	evident	evident	ADJ
bjos-8641360	34	8	and	and	CCONJ
bjos-8641360	34	9	exuberant	exuberant	ADJ
bjos-8641360	34	10	with	with	ADP
bjos-8641360	34	11	the	the	DET
bjos-8641360	34	12	development	development	NOUN
bjos-8641360	34	13	of	of	ADP
bjos-8641360	34	14	dm	dm	PROPN
bjos-8641360	34	15	as	as	ADP
bjos-8641360	34	16	a	a	DET
bjos-8641360	34	17	result	result	NOUN
bjos-8641360	34	18	of	of	ADP
bjos-8641360	34	19	the	the	DET
bjos-8641360	34	20	adverse	adverse	ADJ
bjos-8641360	34	21	effects	effect	NOUN
bjos-8641360	34	22	of	of	ADP
bjos-8641360	34	23	haart26	haart26	NOUN
bjos-8641360	34	24	-	-	PUNCT
bjos-8641360	34	25	29	29	NUM
bjos-8641360	34	26	.	.	PUNCT
bjos-8641360	35	1	the	the	DET
bjos-8641360	35	2	aim	aim	NOUN
bjos-8641360	35	3	of	of	ADP
bjos-8641360	35	4	this	this	DET
bjos-8641360	35	5	study	study	NOUN
bjos-8641360	35	6	was	be	AUX
bjos-8641360	35	7	to	to	PART
bjos-8641360	35	8	determine	determine	VERB
bjos-8641360	35	9	the	the	DET
bjos-8641360	35	10	prevalence	prevalence	NOUN
bjos-8641360	35	11	of	of	ADP
bjos-8641360	35	12	oral	oral	ADJ
bjos-8641360	35	13	manifestations	manifestation	NOUN
bjos-8641360	35	14	in	in	ADP
bjos-8641360	35	15	hiv	hiv	PROPN
bjos-8641360	35	16	/	/	SYM
bjos-8641360	35	17	aids	aids	PROPN
bjos-8641360	35	18	patients	patient	NOUN
bjos-8641360	35	19	and	and	CCONJ
bjos-8641360	35	20	a	a	DET
bjos-8641360	35	21	possible	possible	ADJ
bjos-8641360	35	22	correlation	correlation	NOUN
bjos-8641360	35	23	of	of	ADP
bjos-8641360	35	24	the	the	DET
bjos-8641360	35	25	development	development	NOUN
bjos-8641360	35	26	of	of	ADP
bjos-8641360	35	27	dm	dm	NUM
bjos-8641360	35	28	due	due	ADP
bjos-8641360	35	29	to	to	ADP
bjos-8641360	35	30	haart	haart	PROPN
bjos-8641360	35	31	.	.	PUNCT
bjos-8641360	36	1	material	material	NOUN
bjos-8641360	36	2	and	and	CCONJ
bjos-8641360	36	3	methods	method	NOUN
bjos-8641360	36	4	the	the	DET
bjos-8641360	36	5	research	research	NOUN
bjos-8641360	36	6	protocol	protocol	NOUN
bjos-8641360	36	7	was	be	AUX
bjos-8641360	36	8	approved	approve	VERB
bjos-8641360	36	9	by	by	ADP
bjos-8641360	36	10	the	the	DET
bjos-8641360	36	11	institutional	institutional	ADJ
bjos-8641360	36	12	ethics	ethic	NOUN
bjos-8641360	36	13	committee	committee	PROPN
bjos-8641360	36	14	(	(	PUNCT
bjos-8641360	36	15	process	process	NOUN
bjos-8641360	36	16	#	#	NOUN
bjos-8641360	36	17	015/09	015/09	NUM
bjos-8641360	36	18	cep	cep	NOUN
bjos-8641360	36	19	/	/	SYM
bjos-8641360	36	20	ics	ics	PROPN
bjos-8641360	36	21	/	/	SYM
bjos-8641360	36	22	unip	unip	NOUN
bjos-8641360	36	23	)	)	PUNCT
bjos-8641360	36	24	and	and	CCONJ
bjos-8641360	36	25	all	all	DET
bjos-8641360	36	26	patients	patient	NOUN
bjos-8641360	36	27	that	that	PRON
bjos-8641360	36	28	agreed	agree	VERB
bjos-8641360	36	29	to	to	PART
bjos-8641360	36	30	participate	participate	VERB
bjos-8641360	36	31	in	in	ADP
bjos-8641360	36	32	the	the	DET
bjos-8641360	36	33	study	study	NOUN
bjos-8641360	36	34	signed	sign	VERB
bjos-8641360	36	35	an	an	DET
bjos-8641360	36	36	informed	informed	ADJ
bjos-8641360	36	37	consent	consent	NOUN
bjos-8641360	36	38	form	form	NOUN
bjos-8641360	36	39	.	.	PUNCT
bjos-8641360	37	1	individuals	individual	NOUN
bjos-8641360	37	2	of	of	ADP
bjos-8641360	37	3	both	both	DET
bjos-8641360	37	4	genders	gender	NOUN
bjos-8641360	37	5	aged	age	VERB
bjos-8641360	37	6	27	27	NUM
bjos-8641360	37	7	to	to	PART
bjos-8641360	37	8	75	75	NUM
bjos-8641360	37	9	years	year	NOUN
bjos-8641360	37	10	were	be	AUX
bjos-8641360	37	11	tested	test	VERB
bjos-8641360	37	12	for	for	ADP
bjos-8641360	37	13	hiv	hiv	PROPN
bjos-8641360	37	14	/	/	SYM
bjos-8641360	37	15	aids	aid	NOUN
bjos-8641360	37	16	and	and	CCONJ
bjos-8641360	37	17	distributed	distribute	VERB
bjos-8641360	37	18	into	into	ADP
bjos-8641360	37	19	two	two	NUM
bjos-8641360	37	20	groups	group	NOUN
bjos-8641360	37	21	:	:	PUNCT
bjos-8641360	37	22	group	group	NOUN
bjos-8641360	37	23	i	i	PRON
bjos-8641360	37	24	–	–	PUNCT
bjos-8641360	37	25	hiv	hiv	NOUN
bjos-8641360	37	26	-	-	PUNCT
bjos-8641360	37	27	positive	positive	ADJ
bjos-8641360	37	28	patients	patient	NOUN
bjos-8641360	37	29	referred	refer	VERB
bjos-8641360	37	30	to	to	ADP
bjos-8641360	37	31	the	the	DET
bjos-8641360	37	32	ceape	ceape	NOUN
bjos-8641360	37	33	(	(	PUNCT
bjos-8641360	37	34	center	center	NOUN
bjos-8641360	37	35	of	of	ADP
bjos-8641360	37	36	study	study	NOUN
bjos-8641360	37	37	and	and	CCONJ
bjos-8641360	37	38	care	care	NOUN
bjos-8641360	37	39	of	of	ADP
bjos-8641360	37	40	patients	patient	NOUN
bjos-8641360	37	41	with	with	ADP
bjos-8641360	37	42	special	special	ADJ
bjos-8641360	37	43	needs	need	NOUN
bjos-8641360	37	44	)	)	PUNCT
bjos-8641360	37	45	who	who	PRON
bjos-8641360	37	46	were	be	AUX
bjos-8641360	37	47	under	under	ADP
bjos-8641360	37	48	haart	haart	PROPN
bjos-8641360	37	49	and	and	CCONJ
bjos-8641360	37	50	had	have	AUX
bjos-8641360	37	51	developed	develop	VERB
bjos-8641360	37	52	dm	dm	PROPN
bjos-8641360	37	53	as	as	ADP
bjos-8641360	37	54	an	an	DET
bjos-8641360	37	55	adverse	adverse	ADJ
bjos-8641360	37	56	effect	effect	NOUN
bjos-8641360	37	57	of	of	ADP
bjos-8641360	37	58	the	the	DET
bjos-8641360	37	59	antiretroviral	antiretroviral	ADJ
bjos-8641360	37	60	therapy	therapy	NOUN
bjos-8641360	37	61	and/or	and/or	CCONJ
bjos-8641360	37	62	their	their	PRON
bjos-8641360	37	63	own	own	ADJ
bjos-8641360	37	64	immunosuppression	immunosuppression	NOUN
bjos-8641360	37	65	;	;	PUNCT
bjos-8641360	37	66	group	group	NOUN
bjos-8641360	37	67	ii	ii	PROPN
bjos-8641360	37	68	(	(	PUNCT
bjos-8641360	37	69	control	control	PROPN
bjos-8641360	37	70	)	)	PUNCT
bjos-8641360	37	71	hiv	hiv	PROPN
bjos-8641360	37	72	-	-	PUNCT
bjos-8641360	37	73	negative	negative	ADJ
bjos-8641360	37	74	patients	patient	NOUN
bjos-8641360	37	75	with	with	ADP
bjos-8641360	37	76	dm	dm	PROPN
bjos-8641360	37	77	referred	refer	VERB
bjos-8641360	37	78	to	to	ADP
bjos-8641360	37	79	the	the	DET
bjos-8641360	37	80	ceape	ceape	NOUN
bjos-8641360	37	81	.	.	PUNCT
bjos-8641360	38	1	the	the	DET
bjos-8641360	38	2	tests	test	NOUN
bjos-8641360	38	3	to	to	PART
bjos-8641360	38	4	confirm	confirm	VERB
bjos-8641360	38	5	dm	dm	PROPN
bjos-8641360	38	6	control	control	NOUN
bjos-8641360	38	7	of	of	ADP
bjos-8641360	38	8	glycosylated	glycosylated	ADJ
bjos-8641360	38	9	hemoglobin	hemoglobin	NOUN
bjos-8641360	38	10	or	or	CCONJ
bjos-8641360	38	11	glucose	glucose	NOUN
bjos-8641360	38	12	were	be	AUX
bjos-8641360	38	13	performed	perform	VERB
bjos-8641360	38	14	by	by	ADP
bjos-8641360	38	15	the	the	DET
bjos-8641360	38	16	physician	physician	NOUN
bjos-8641360	38	17	who	who	PRON
bjos-8641360	38	18	referred	refer	VERB
bjos-8641360	38	19	the	the	DET
bjos-8641360	38	20	patient	patient	NOUN
bjos-8641360	38	21	and	and	CCONJ
bjos-8641360	38	22	not	not	PART
bjos-8641360	38	23	by	by	ADP
bjos-8641360	38	24	ceape	ceape	NOUN
bjos-8641360	38	25	,	,	PUNCT
bjos-8641360	38	26	so	so	SCONJ
bjos-8641360	38	27	some	some	DET
bjos-8641360	38	28	patients	patient	NOUN
bjos-8641360	38	29	could	could	AUX
bjos-8641360	38	30	not	not	PART
bjos-8641360	38	31	inform	inform	VERB
bjos-8641360	38	32	how	how	SCONJ
bjos-8641360	38	33	long	long	ADV
bjos-8641360	38	34	they	they	PRON
bjos-8641360	38	35	had	have	VERB
bjos-8641360	38	36	the	the	DET
bjos-8641360	38	37	disease	disease	NOUN
bjos-8641360	38	38	.	.	PUNCT
bjos-8641360	39	1	for	for	ADP
bjos-8641360	39	2	both	both	DET
bjos-8641360	39	3	groups	group	NOUN
bjos-8641360	39	4	,	,	PUNCT
bjos-8641360	39	5	relevant	relevant	ADJ
bjos-8641360	39	6	information	information	NOUN
bjos-8641360	39	7	on	on	ADP
bjos-8641360	39	8	age	age	NOUN
bjos-8641360	39	9	,	,	PUNCT
bjos-8641360	39	10	race	race	NOUN
bjos-8641360	39	11	,	,	PUNCT
bjos-8641360	39	12	education	education	NOUN
bjos-8641360	39	13	,	,	PUNCT
bjos-8641360	39	14	general	general	ADJ
bjos-8641360	39	15	and	and	CCONJ
bjos-8641360	39	16	oral	oral	ADJ
bjos-8641360	39	17	manifestations	manifestation	NOUN
bjos-8641360	39	18	,	,	PUNCT
bjos-8641360	39	19	and	and	CCONJ
bjos-8641360	39	20	habits	habit	NOUN
bjos-8641360	39	21	was	be	AUX
bjos-8641360	39	22	collected	collect	VERB
bjos-8641360	39	23	.	.	PUNCT
bjos-8641360	40	1	for	for	ADP
bjos-8641360	40	2	group	group	NOUN
bjos-8641360	40	3	i	i	PROPN
bjos-8641360	40	4	,	,	PUNCT
bjos-8641360	40	5	information	information	NOUN
bjos-8641360	40	6	was	be	AUX
bjos-8641360	40	7	collected	collect	VERB
bjos-8641360	40	8	on	on	ADP
bjos-8641360	40	9	the	the	DET
bjos-8641360	40	10	probable	probable	ADJ
bjos-8641360	40	11	means	mean	NOUN
bjos-8641360	40	12	of	of	ADP
bjos-8641360	40	13	contamination	contamination	NOUN
bjos-8641360	40	14	by	by	ADP
bjos-8641360	40	15	hiv	hiv	PROPN
bjos-8641360	40	16	,	,	PUNCT
bjos-8641360	40	17	the	the	DET
bjos-8641360	40	18	t	t	PROPN
bjos-8641360	40	19	lymphocytecd4	lymphocytecd4	PROPN
bjos-8641360	40	20	count	count	NOUN
bjos-8641360	40	21	,	,	PUNCT
bjos-8641360	40	22	viral	viral	ADJ
bjos-8641360	40	23	load	load	NOUN
bjos-8641360	40	24	,	,	PUNCT
bjos-8641360	40	25	and	and	CCONJ
bjos-8641360	40	26	haart	haart	VERB
bjos-8641360	40	27	in	in	ADP
bjos-8641360	40	28	use	use	NOUN
bjos-8641360	40	29	.	.	PUNCT
bjos-8641360	41	1	for	for	ADP
bjos-8641360	41	2	both	both	DET
bjos-8641360	41	3	groups	group	NOUN
bjos-8641360	41	4	,	,	PUNCT
bjos-8641360	41	5	the	the	DET
bjos-8641360	41	6	following	follow	VERB
bjos-8641360	41	7	tests	test	NOUN
bjos-8641360	41	8	and	and	CCONJ
bjos-8641360	41	9	examinations	examination	NOUN
bjos-8641360	41	10	were	be	AUX
bjos-8641360	41	11	performed	perform	VERB
bjos-8641360	41	12	:	:	PUNCT
bjos-8641360	41	13	salivary	salivary	ADJ
bjos-8641360	41	14	flow	flow	NOUN
bjos-8641360	41	15	rate	rate	NOUN
bjos-8641360	41	16	,	,	PUNCT
bjos-8641360	41	17	bacterial	bacterial	ADJ
bjos-8641360	41	18	plaque	plaque	NOUN
bjos-8641360	41	19	index	index	NOUN
bjos-8641360	41	20	,	,	PUNCT
bjos-8641360	41	21	gingival	gingival	NOUN
bjos-8641360	41	22	bleeding	bleeding	NOUN
bjos-8641360	41	23	,	,	PUNCT
bjos-8641360	41	24	periodontal	periodontal	ADJ
bjos-8641360	41	25	pockets	pocket	NOUN
bjos-8641360	41	26	and	and	CCONJ
bjos-8641360	41	27	dmft	dmft	VERB
bjos-8641360	41	28	(	(	PUNCT
bjos-8641360	41	29	decayed	decay	VERB
bjos-8641360	41	30	missing	miss	VERB
bjos-8641360	41	31	and	and	CCONJ
bjos-8641360	41	32	filled	fill	VERB
bjos-8641360	41	33	tooth	tooth	NOUN
bjos-8641360	41	34	)	)	PUNCT
bjos-8641360	41	35	index	index	NOUN
bjos-8641360	41	36	.	.	PUNCT
bjos-8641360	42	1	stimulated	stimulate	VERB
bjos-8641360	42	2	saliva	saliva	NOUN
bjos-8641360	42	3	of	of	ADP
bjos-8641360	42	4	all	all	DET
bjos-8641360	42	5	patients	patient	NOUN
bjos-8641360	42	6	was	be	AUX
bjos-8641360	42	7	collected	collect	VERB
bjos-8641360	42	8	for	for	ADP
bjos-8641360	42	9	5	5	NUM
bjos-8641360	42	10	min	min	NOUN
bjos-8641360	42	11	and	and	CCONJ
bjos-8641360	42	12	a	a	DET
bjos-8641360	42	13	saliva	saliva	NOUN
bjos-8641360	42	14	test	test	NOUN
bjos-8641360	42	15	method	method	NOUN
bjos-8641360	42	16	(	(	PUNCT
bjos-8641360	42	17	dentobuff	dentobuff	PROPN
bjos-8641360	42	18	kit	kit	PROPN
bjos-8641360	42	19	®	®	PROPN
bjos-8641360	42	20	;	;	PUNCT
bjos-8641360	42	21	inodon	inodon	NOUN
bjos-8641360	42	22	,	,	PUNCT
bjos-8641360	42	23	porto	porto	PROPN
bjos-8641360	42	24	alegre	alegre	PROPN
bjos-8641360	42	25	,	,	PUNCT
bjos-8641360	42	26	brazil	brazil	PROPN
bjos-8641360	42	27	)	)	PUNCT
bjos-8641360	42	28	was	be	AUX
bjos-8641360	42	29	used	use	VERB
bjos-8641360	42	30	to	to	PART
bjos-8641360	42	31	assess	assess	VERB
bjos-8641360	42	32	salivary	salivary	ADJ
bjos-8641360	42	33	flow	flow	NOUN
bjos-8641360	42	34	,	,	PUNCT
bjos-8641360	42	35	daily	daily	ADJ
bjos-8641360	42	36	secretion	secretion	NOUN
bjos-8641360	42	37	of	of	ADP
bjos-8641360	42	38	saliva	saliva	NOUN
bjos-8641360	42	39	,	,	PUNCT
bjos-8641360	42	40	buffering	buffering	NOUN
bjos-8641360	42	41	capacity	capacity	NOUN
bjos-8641360	42	42	,	,	PUNCT
bjos-8641360	42	43	salivary	salivary	ADJ
bjos-8641360	42	44	ph	ph	VERB
bjos-8641360	42	45	.	.	PROPN
bjos-8641360	42	46	normal	normal	ADJ
bjos-8641360	42	47	salivary	salivary	ADJ
bjos-8641360	42	48	flow	flow	NOUN
bjos-8641360	42	49	:	:	PUNCT
bjos-8641360	42	50	1.6	1.6	NUM
bjos-8641360	42	51	to	to	PART
bjos-8641360	42	52	2.3	2.3	NUM
bjos-8641360	42	53	ml/	ml/	NOUN
bjos-8641360	42	54	min	min	PROPN
bjos-8641360	42	55	,	,	PUNCT
bjos-8641360	42	56	intermediate	intermediate	ADJ
bjos-8641360	42	57	:	:	PUNCT
bjos-8641360	42	58	between	between	ADP
bjos-8641360	42	59	1.0	1.0	NUM
bjos-8641360	42	60	and	and	CCONJ
bjos-8641360	42	61	1.5	1.5	NUM
bjos-8641360	42	62	ml	ml	NOUN
bjos-8641360	42	63	/	/	SYM
bjos-8641360	42	64	min	min	NOUN
bjos-8641360	42	65	and	and	CCONJ
bjos-8641360	42	66	low	low	ADJ
bjos-8641360	42	67	:	:	PUNCT
bjos-8641360	42	68	less	less	ADJ
bjos-8641360	42	69	than	than	ADP
bjos-8641360	42	70	1.0	1.0	NUM
bjos-8641360	42	71	ml	ml	NOUN
bjos-8641360	42	72	/	/	SYM
bjos-8641360	42	73	min	min	NOUN
bjos-8641360	42	74	.	.	NOUN
bjos-8641360	42	75	normal	normal	ADJ
bjos-8641360	42	76	buffering	buffering	NOUN
bjos-8641360	42	77	capacity	capacity	NOUN
bjos-8641360	42	78	,	,	PUNCT
bjos-8641360	42	79	ph	ph	NOUN
bjos-8641360	42	80	greater	great	ADJ
bjos-8641360	42	81	than	than	ADP
bjos-8641360	42	82	5.5	5.5	NUM
bjos-8641360	42	83	,	,	PUNCT
bjos-8641360	42	84	intermediate	intermediate	ADJ
bjos-8641360	42	85	:	:	PUNCT
bjos-8641360	42	86	between	between	ADP
bjos-8641360	42	87	4.5	4.5	NUM
bjos-8641360	42	88	and	and	CCONJ
bjos-8641360	42	89	5.5	5.5	NUM
bjos-8641360	42	90	and	and	CCONJ
bjos-8641360	42	91	low	low	ADJ
bjos-8641360	42	92	:	:	PUNCT
bjos-8641360	42	93	less	less	ADJ
bjos-8641360	42	94	than	than	ADP
bjos-8641360	42	95	4.5	4.5	NUM
bjos-8641360	42	96	.	.	PUNCT
bjos-8641360	43	1	a	a	DET
bjos-8641360	43	2	plaque	plaque	NOUN
bjos-8641360	43	3	disclosing	disclose	VERB
bjos-8641360	43	4	agent	agent	NOUN
bjos-8641360	43	5	(	(	PUNCT
bjos-8641360	43	6	erythrosine	erythrosine	ADJ
bjos-8641360	43	7	tablet	tablet	NOUN
bjos-8641360	43	8	)	)	PUNCT
bjos-8641360	43	9	was	be	AUX
bjos-8641360	43	10	used	use	VERB
bjos-8641360	43	11	to	to	PART
bjos-8641360	43	12	obtain	obtain	VERB
bjos-8641360	43	13	bacterial	bacterial	ADJ
bjos-8641360	43	14	plaque	plaque	NOUN
bjos-8641360	43	15	index	index	NOUN
bjos-8641360	43	16	.	.	PUNCT
bjos-8641360	44	1	the	the	DET
bjos-8641360	44	2	result	result	NOUN
bjos-8641360	44	3	was	be	AUX
bjos-8641360	44	4	evaluated	evaluate	VERB
bjos-8641360	44	5	using	use	VERB
bjos-8641360	44	6	the	the	DET
bjos-8641360	44	7	ainamo	ainamo	NOUN
bjos-8641360	44	8	and	and	CCONJ
bjos-8641360	44	9	bay	bay	NOUN
bjos-8641360	44	10	test	test	NOUN
bjos-8641360	44	11	(	(	PUNCT
bjos-8641360	44	12	1975)30	1975)30	NUM
bjos-8641360	44	13	to	to	PART
bjos-8641360	44	14	determine	determine	VERB
bjos-8641360	44	15	the	the	DET
bjos-8641360	44	16	presence	presence	NOUN
bjos-8641360	44	17	or	or	CCONJ
bjos-8641360	44	18	absence	absence	NOUN
bjos-8641360	44	19	of	of	ADP
bjos-8641360	44	20	plaque	plaque	NOUN
bjos-8641360	44	21	in	in	ADP
bjos-8641360	44	22	a	a	DET
bjos-8641360	44	23	standard	standard	ADJ
bjos-8641360	44	24	binomial	binomial	NOUN
bjos-8641360	44	25	(	(	PUNCT
bjos-8641360	44	26	dichotomous	dichotomous	ADJ
bjos-8641360	44	27	score	score	NOUN
bjos-8641360	44	28	)	)	PUNCT
bjos-8641360	44	29	.	.	PUNCT
bjos-8641360	45	1	the	the	DET
bjos-8641360	45	2	visible	visible	ADJ
bjos-8641360	45	3	plaque	plaque	NOUN
bjos-8641360	45	4	received	receive	VERB
bjos-8641360	45	5	a	a	DET
bjos-8641360	45	6	visible	visible	ADJ
bjos-8641360	45	7	marking	marking	NOUN
bjos-8641360	45	8	“	"	PUNCT
bjos-8641360	45	9	1	1	NUM
bjos-8641360	45	10	”	"	PUNCT
bjos-8641360	45	11	while	while	SCONJ
bjos-8641360	45	12	the	the	DET
bjos-8641360	45	13	non	non	ADJ
bjos-8641360	45	14	-	-	ADJ
bjos-8641360	45	15	visible	visible	ADJ
bjos-8641360	45	16	plaque	plaque	NOUN
bjos-8641360	45	17	received	receive	VERB
bjos-8641360	45	18	marking	mark	VERB
bjos-8641360	45	19	“	"	PUNCT
bjos-8641360	45	20	0	0	NUM
bjos-8641360	45	21	”	"	PUNCT
bjos-8641360	45	22	for	for	ADP
bjos-8641360	45	23	the	the	DET
bjos-8641360	45	24	analysis	analysis	NOUN
bjos-8641360	45	25	of	of	ADP
bjos-8641360	45	26	the	the	DET
bjos-8641360	45	27	dmft	dmft	ADJ
bjos-8641360	45	28	index	index	NOUN
bjos-8641360	45	29	.	.	PUNCT
bjos-8641360	46	1	after	after	ADP
bjos-8641360	46	2	pumice	pumice	NOUN
bjos-8641360	46	3	prophylaxis	prophylaxis	ADJ
bjos-8641360	46	4	,	,	PUNCT
bjos-8641360	46	5	clinical	clinical	ADJ
bjos-8641360	46	6	examination	examination	NOUN
bjos-8641360	46	7	was	be	AUX
bjos-8641360	46	8	performed	perform	VERB
bjos-8641360	46	9	using	use	VERB
bjos-8641360	46	10	a	a	DET
bjos-8641360	46	11	dental	dental	ADJ
bjos-8641360	46	12	mirror	mirror	NOUN
bjos-8641360	46	13	under	under	ADP
bjos-8641360	46	14	relative	relative	ADJ
bjos-8641360	46	15	isolation	isolation	NOUN
bjos-8641360	46	16	and	and	CCONJ
bjos-8641360	46	17	artificial	artificial	ADJ
bjos-8641360	46	18	lighting	lighting	NOUN
bjos-8641360	46	19	to	to	PART
bjos-8641360	46	20	evaluate	evaluate	VERB
bjos-8641360	46	21	the	the	DET
bjos-8641360	46	22	presence	presence	NOUN
bjos-8641360	46	23	of	of	ADP
bjos-8641360	46	24	caries	carie	NOUN
bjos-8641360	46	25	,	,	PUNCT
bjos-8641360	46	26	missing	miss	VERB
bjos-8641360	46	27	and	and	CCONJ
bjos-8641360	46	28	filled	fill	VERB
bjos-8641360	46	29	teeth	tooth	NOUN
bjos-8641360	46	30	,	,	PUNCT
bjos-8641360	46	31	and	and	CCONJ
bjos-8641360	46	32	the	the	DET
bjos-8641360	46	33	bleeding	bleeding	NOUN
bjos-8641360	46	34	index	index	NOUN
bjos-8641360	46	35	,	,	PUNCT
bjos-8641360	46	36	recorded	record	VERB
bjos-8641360	46	37	by	by	ADP
bjos-8641360	46	38	visible	visible	ADJ
bjos-8641360	46	39	bleeding	bleeding	NOUN
bjos-8641360	46	40	points	point	NOUN
bjos-8641360	46	41	within	within	ADP
bjos-8641360	46	42	15	15	NUM
bjos-8641360	46	43	s	s	NOUN
bjos-8641360	46	44	after	after	ADP
bjos-8641360	46	45	probing	probe	VERB
bjos-8641360	46	46	,	,	PUNCT
bjos-8641360	46	47	and	and	CCONJ
bjos-8641360	46	48	periodontal	periodontal	ADJ
bjos-8641360	46	49	pocket	pocket	NOUN
bjos-8641360	46	50	using	use	VERB
bjos-8641360	46	51	williams	williams	PROPN
bjos-8641360	46	52	1	1	NUM
bjos-8641360	46	53	-	-	SYM
bjos-8641360	46	54	10	10	NUM
bjos-8641360	46	55	mm	mm	PROPN
bjos-8641360	46	56	periodontal	periodontal	ADJ
bjos-8641360	46	57	probe	probe	NOUN
bjos-8641360	46	58	.	.	PUNCT
bjos-8641360	47	1	the	the	DET
bjos-8641360	47	2	probe	probe	NOUN
bjos-8641360	47	3	was	be	AUX
bjos-8641360	47	4	placed	place	VERB
bjos-8641360	47	5	on	on	ADP
bjos-8641360	47	6	the	the	DET
bjos-8641360	47	7	buccal	buccal	ADJ
bjos-8641360	47	8	and	and	CCONJ
bjos-8641360	47	9	proximal	proximal	ADJ
bjos-8641360	47	10	gingival	gingival	NOUN
bjos-8641360	47	11	margin	margin	NOUN
bjos-8641360	47	12	,	,	PUNCT
bjos-8641360	47	13	around	around	ADP
bjos-8641360	47	14	each	each	DET
bjos-8641360	47	15	tooth	tooth	NOUN
bjos-8641360	47	16	to	to	PART
bjos-8641360	47	17	measure	measure	VERB
bjos-8641360	47	18	sulcus	sulcus	NOUN
bjos-8641360	47	19	/	/	SYM
bjos-8641360	47	20	pocket	pocket	NOUN
bjos-8641360	47	21	depth	depth	NOUN
bjos-8641360	47	22	.	.	PUNCT
bjos-8641360	48	1	for	for	ADP
bjos-8641360	48	2	quantitative	quantitative	ADJ
bjos-8641360	48	3	variables	variable	NOUN
bjos-8641360	48	4	,	,	PUNCT
bjos-8641360	48	5	the	the	DET
bjos-8641360	48	6	analysis	analysis	NOUN
bjos-8641360	48	7	was	be	AUX
bjos-8641360	48	8	made	make	VERB
bjos-8641360	48	9	through	through	ADP
bjos-8641360	48	10	observation	observation	NOUN
bjos-8641360	48	11	of	of	ADP
bjos-8641360	48	12	minimum	minimum	ADJ
bjos-8641360	48	13	and	and	CCONJ
bjos-8641360	48	14	maximum	maximum	ADJ
bjos-8641360	48	15	values	value	NOUN
bjos-8641360	48	16	,	,	PUNCT
bjos-8641360	48	17	and	and	CCONJ
bjos-8641360	48	18	calculation	calculation	NOUN
bjos-8641360	48	19	of	of	ADP
bjos-8641360	48	20	means	mean	NOUN
bjos-8641360	48	21	,	,	PUNCT
bjos-8641360	48	22	standard	standard	ADJ
bjos-8641360	48	23	deviations	deviation	NOUN
bjos-8641360	48	24	and	and	CCONJ
bjos-8641360	48	25	medians	median	NOUN
bjos-8641360	48	26	.	.	PUNCT
bjos-8641360	49	1	for	for	ADP
bjos-8641360	49	2	qualitative	qualitative	ADJ
bjos-8641360	49	3	variables	variable	NOUN
bjos-8641360	49	4	,	,	PUNCT
bjos-8641360	49	5	absolute	absolute	ADJ
bjos-8641360	49	6	and	and	CCONJ
bjos-8641360	49	7	relative	relative	ADJ
bjos-8641360	49	8	frequencies	frequency	NOUN
bjos-8641360	49	9	were	be	AUX
bjos-8641360	49	10	calculated	calculate	VERB
bjos-8641360	49	11	and	and	CCONJ
bjos-8641360	49	12	the	the	DET
bjos-8641360	49	13	student	student	NOUN
bjos-8641360	49	14	’s	’s	PART
bjos-8641360	49	15	t	t	PROPN
bjos-8641360	49	16	-	-	PUNCT
bjos-8641360	49	17	test	test	NOUN
bjos-8641360	49	18	was	be	AUX
bjos-8641360	49	19	used	use	VERB
bjos-8641360	49	20	for	for	ADP
bjos-8641360	49	21	comparison	comparison	NOUN
bjos-8641360	49	22	of	of	ADP
bjos-8641360	49	23	the	the	DET
bjos-8641360	49	24	groups	group	NOUN
bjos-8641360	49	25	.	.	PUNCT
bjos-8641360	50	1	when	when	SCONJ
bjos-8641360	50	2	normality	normality	NOUN
bjos-8641360	50	3	assumption	assumption	NOUN
bjos-8641360	50	4	was	be	AUX
bjos-8641360	50	5	rejected	reject	VERB
bjos-8641360	50	6	,	,	PUNCT
bjos-8641360	50	7	the	the	DET
bjos-8641360	50	8	nonparametric	nonparametric	NOUN
bjos-8641360	50	9	mann	mann	PROPN
bjos-8641360	50	10	-	-	PUNCT
bjos-8641360	50	11	whitney	whitney	PROPN
bjos-8641360	50	12	test	test	NOUN
bjos-8641360	50	13	was	be	AUX
bjos-8641360	50	14	used	use	VERB
bjos-8641360	50	15	.	.	PUNCT
bjos-8641360	51	1	to	to	PART
bjos-8641360	51	2	test	test	VERB
bjos-8641360	51	3	the	the	DET
bjos-8641360	51	4	homogeneity	homogeneity	NOUN
bjos-8641360	51	5	between	between	ADP
bjos-8641360	51	6	the	the	DET
bjos-8641360	51	7	ratios	ratio	NOUN
bjos-8641360	51	8	,	,	PUNCT
bjos-8641360	51	9	we	we	PRON
bjos-8641360	51	10	used	use	VERB
bjos-8641360	51	11	the	the	DET
bjos-8641360	51	12	chi	chi	ADJ
bjos-8641360	51	13	-	-	PUNCT
bjos-8641360	51	14	square	square	ADJ
bjos-8641360	51	15	test	test	NOUN
bjos-8641360	51	16	or	or	CCONJ
bjos-8641360	51	17	fisher	fisher	PROPN
bjos-8641360	51	18	’s	’s	PART
bjos-8641360	51	19	exact	exact	ADJ
bjos-8641360	51	20	test	test	NOUN
bjos-8641360	51	21	(	(	PUNCT
bjos-8641360	51	22	when	when	SCONJ
bjos-8641360	51	23	we	we	PRON
bjos-8641360	51	24	had	have	VERB
bjos-8641360	51	25	frequencies	frequency	NOUN
bjos-8641360	51	26	below	below	ADP
bjos-8641360	51	27	5	5	NUM
bjos-8641360	51	28	)	)	PUNCT
bjos-8641360	51	29	.	.	PUNCT
bjos-8641360	52	1	significance	significance	NOUN
bjos-8641360	52	2	level	level	NOUN
bjos-8641360	52	3	used	use	VERB
bjos-8641360	52	4	for	for	ADP
bjos-8641360	52	5	the	the	DET
bjos-8641360	52	6	tests	test	NOUN
bjos-8641360	52	7	was	be	AUX
bjos-8641360	52	8	5	5	NUM
bjos-8641360	52	9	%	%	NOUN
bjos-8641360	52	10	.	.	PUNCT
bjos-8641360	53	1	the	the	DET
bjos-8641360	53	2	groups	group	NOUN
bjos-8641360	53	3	showed	show	VERB
bjos-8641360	53	4	no	no	DET
bjos-8641360	53	5	significant	significant	ADJ
bjos-8641360	53	6	differences	difference	NOUN
bjos-8641360	53	7	regarding	regard	VERB
bjos-8641360	53	8	gender	gender	NOUN
bjos-8641360	53	9	(	(	PUNCT
bjos-8641360	53	10	p	p	NOUN
bjos-8641360	53	11	=	=	NOUN
bjos-8641360	53	12	0.109	0.109	NUM
bjos-8641360	53	13	)	)	PUNCT
bjos-8641360	53	14	and	and	CCONJ
bjos-8641360	53	15	race	race	NOUN
bjos-8641360	53	16	(	(	PUNCT
bjos-8641360	53	17	p	p	NOUN
bjos-8641360	53	18	=	=	NOUN
bjos-8641360	53	19	1.000	1.000	NUM
bjos-8641360	53	20	)	)	PUNCT
bjos-8641360	53	21	,	,	PUNCT
bjos-8641360	53	22	but	but	CCONJ
bjos-8641360	53	23	they	they	PRON
bjos-8641360	53	24	differed	differ	VERB
bjos-8641360	53	25	significantly	significantly	ADV
bjos-8641360	53	26	353353353353353diagnosis	353353353353353diagnosis	NUM
bjos-8641360	53	27	of	of	ADP
bjos-8641360	53	28	oral	oral	ADJ
bjos-8641360	53	29	manifestations	manifestation	NOUN
bjos-8641360	53	30	in	in	ADP
bjos-8641360	53	31	hiv	hiv	PROPN
bjos-8641360	53	32	/	/	SYM
bjos-8641360	53	33	aids	aids	PROPN
bjos-8641360	53	34	patients	patient	NOUN
bjos-8641360	53	35	who	who	PRON
bjos-8641360	53	36	used	use	VERB
bjos-8641360	53	37	haart	haart	PROPN
bjos-8641360	53	38	and	and	CCONJ
bjos-8641360	53	39	developed	developed	ADJ
bjos-8641360	53	40	diabetes	diabetes	NOUN
bjos-8641360	53	41	mellitus	mellitus	NOUN
bjos-8641360	53	42	354354354354354	354354354354354	NUM
bjos-8641360	53	43	braz	braz	PROPN
bjos-8641360	53	44	j	j	PROPN
bjos-8641360	53	45	oral	oral	PROPN
bjos-8641360	53	46	sci	sci	PROPN
bjos-8641360	53	47	.	.	PUNCT
bjos-8641360	54	1	11(3):352	11(3):352	NUM
bjos-8641360	54	2	-	-	SYM
bjos-8641360	54	3	356	356	NUM
bjos-8641360	54	4	in	in	ADP
bjos-8641360	54	5	age	age	NOUN
bjos-8641360	54	6	(	(	PUNCT
bjos-8641360	54	7	p<0.05	p<0.05	NOUN
bjos-8641360	54	8	)	)	PUNCT
bjos-8641360	54	9	.	.	PUNCT
bjos-8641360	55	1	the	the	DET
bjos-8641360	55	2	hiv	hiv	PROPN
bjos-8641360	55	3	group	group	PROPN
bjos-8641360	55	4	presented	present	VERB
bjos-8641360	55	5	age	age	NOUN
bjos-8641360	55	6	(	(	PUNCT
bjos-8641360	55	7	p	p	X
bjos-8641360	55	8	<	<	NOUN
bjos-8641360	55	9	0.001	0.001	NUM
bjos-8641360	55	10	)	)	PUNCT
bjos-8641360	55	11	significantly	significantly	ADV
bjos-8641360	55	12	lower	low	ADJ
bjos-8641360	55	13	than	than	ADP
bjos-8641360	55	14	that	that	PRON
bjos-8641360	55	15	of	of	ADP
bjos-8641360	55	16	the	the	DET
bjos-8641360	55	17	control	control	NOUN
bjos-8641360	55	18	group	group	NOUN
bjos-8641360	55	19	.	.	PUNCT
bjos-8641360	56	1	regarding	regard	VERB
bjos-8641360	56	2	habit	habit	NOUN
bjos-8641360	56	3	,	,	PUNCT
bjos-8641360	56	4	the	the	DET
bjos-8641360	56	5	percentage	percentage	NOUN
bjos-8641360	56	6	of	of	ADP
bjos-8641360	56	7	patients	patient	NOUN
bjos-8641360	56	8	who	who	PRON
bjos-8641360	56	9	did	do	VERB
bjos-8641360	56	10	not	not	PART
bjos-8641360	56	11	state	state	NOUN
bjos-8641360	56	12	habits	habit	NOUN
bjos-8641360	56	13	was	be	AUX
bjos-8641360	56	14	practically	practically	ADV
bjos-8641360	56	15	the	the	DET
bjos-8641360	56	16	same	same	ADJ
bjos-8641360	56	17	in	in	ADP
bjos-8641360	56	18	both	both	DET
bjos-8641360	56	19	groups	group	NOUN
bjos-8641360	56	20	.	.	PUNCT
bjos-8641360	57	1	results	result	VERB
bjos-8641360	57	2	fifty	fifty	NUM
bjos-8641360	57	3	-	-	PUNCT
bjos-8641360	57	4	six	six	NUM
bjos-8641360	57	5	patients	patient	NOUN
bjos-8641360	57	6	between	between	ADP
bjos-8641360	57	7	27	27	NUM
bjos-8641360	57	8	and	and	CCONJ
bjos-8641360	57	9	75	75	NUM
bjos-8641360	57	10	years	year	NOUN
bjos-8641360	57	11	of	of	ADP
bjos-8641360	57	12	age	age	NOUN
bjos-8641360	57	13	(	(	PUNCT
bjos-8641360	57	14	mean	mean	INTJ
bjos-8641360	57	15	age	age	NOUN
bjos-8641360	57	16	of	of	ADP
bjos-8641360	57	17	53.96	53.96	NUM
bjos-8641360	57	18	years	year	NOUN
bjos-8641360	57	19	with	with	ADP
bjos-8641360	57	20	standard	standard	ADJ
bjos-8641360	57	21	deviation	deviation	NOUN
bjos-8641360	57	22	of	of	ADP
bjos-8641360	57	23	11.22	11.22	NUM
bjos-8641360	57	24	years	year	NOUN
bjos-8641360	57	25	and	and	CCONJ
bjos-8641360	57	26	median	median	NOUN
bjos-8641360	57	27	of	of	ADP
bjos-8641360	57	28	54	54	NUM
bjos-8641360	57	29	years	year	NOUN
bjos-8641360	57	30	)	)	PUNCT
bjos-8641360	57	31	were	be	AUX
bjos-8641360	57	32	evaluated	evaluate	VERB
bjos-8641360	57	33	.	.	PUNCT
bjos-8641360	58	1	of	of	ADP
bjos-8641360	58	2	the	the	DET
bjos-8641360	58	3	28	28	NUM
bjos-8641360	58	4	patients	patient	NOUN
bjos-8641360	58	5	examined	examine	VERB
bjos-8641360	58	6	in	in	ADP
bjos-8641360	58	7	the	the	DET
bjos-8641360	58	8	hiv	hiv	PROPN
bjos-8641360	58	9	group	group	NOUN
bjos-8641360	58	10	,	,	PUNCT
bjos-8641360	58	11	17	17	NUM
bjos-8641360	58	12	(	(	PUNCT
bjos-8641360	58	13	60.7	60.7	NUM
bjos-8641360	58	14	%	%	NOUN
bjos-8641360	58	15	)	)	PUNCT
bjos-8641360	58	16	were	be	AUX
bjos-8641360	58	17	male	male	ADJ
bjos-8641360	58	18	and	and	CCONJ
bjos-8641360	58	19	11	11	NUM
bjos-8641360	58	20	(	(	PUNCT
bjos-8641360	58	21	39.3	39.3	NUM
bjos-8641360	58	22	%	%	NOUN
bjos-8641360	58	23	)	)	PUNCT
bjos-8641360	58	24	female	female	NOUN
bjos-8641360	58	25	,	,	PUNCT
bjos-8641360	58	26	21	21	NUM
bjos-8641360	58	27	(	(	PUNCT
bjos-8641360	58	28	75.0	75.0	NUM
bjos-8641360	58	29	%	%	NOUN
bjos-8641360	58	30	)	)	PUNCT
bjos-8641360	58	31	were	be	AUX
bjos-8641360	58	32	caucasian	caucasian	ADJ
bjos-8641360	58	33	,	,	PUNCT
bjos-8641360	58	34	6	6	NUM
bjos-8641360	58	35	(	(	PUNCT
bjos-8641360	58	36	21.4	21.4	NUM
bjos-8641360	58	37	%	%	NOUN
bjos-8641360	58	38	)	)	PUNCT
bjos-8641360	58	39	african	african	ADJ
bjos-8641360	58	40	descendants	descendant	NOUN
bjos-8641360	58	41	and	and	CCONJ
bjos-8641360	58	42	1	1	NUM
bjos-8641360	58	43	(	(	PUNCT
bjos-8641360	58	44	3.6	3.6	NUM
bjos-8641360	58	45	%	%	NOUN
bjos-8641360	58	46	)	)	PUNCT
bjos-8641360	58	47	oriental	oriental	ADJ
bjos-8641360	58	48	descendants	descendant	NOUN
bjos-8641360	58	49	and	and	CCONJ
bjos-8641360	58	50	the	the	DET
bjos-8641360	58	51	mean	mean	ADJ
bjos-8641360	58	52	age	age	NOUN
bjos-8641360	58	53	was	be	AUX
bjos-8641360	58	54	47	47	NUM
bjos-8641360	58	55	years	year	NOUN
bjos-8641360	58	56	.	.	PUNCT
bjos-8641360	59	1	regarding	regard	VERB
bjos-8641360	59	2	the	the	DET
bjos-8641360	59	3	count	count	NOUN
bjos-8641360	59	4	of	of	ADP
bjos-8641360	59	5	cd4	cd4	PROPN
bjos-8641360	59	6	t	t	PROPN
bjos-8641360	59	7	lymphocytes	lymphocyte	NOUN
bjos-8641360	59	8	,	,	PUNCT
bjos-8641360	59	9	1	1	NUM
bjos-8641360	59	10	(	(	PUNCT
bjos-8641360	59	11	3.5	3.5	NUM
bjos-8641360	59	12	%	%	NOUN
bjos-8641360	59	13	)	)	PUNCT
bjos-8641360	59	14	presented	present	VERB
bjos-8641360	59	15	t	t	PROPN
bjos-8641360	59	16	-	-	PUNCT
bjos-8641360	59	17	cd4	cd4	PROPN
bjos-8641360	59	18	inferior	inferior	ADJ
bjos-8641360	59	19	to	to	ADP
bjos-8641360	59	20	199	199	NUM
bjos-8641360	59	21	cells	cell	NOUN
bjos-8641360	59	22	/	/	SYM
bjos-8641360	59	23	mm	mm	PROPN
bjos-8641360	59	24	³	³	PROPN
bjos-8641360	59	25	,	,	PUNCT
bjos-8641360	59	26	while	while	SCONJ
bjos-8641360	59	27	14	14	NUM
bjos-8641360	59	28	(	(	PUNCT
bjos-8641360	59	29	50.0	50.0	NUM
bjos-8641360	59	30	%	%	NOUN
bjos-8641360	59	31	)	)	PUNCT
bjos-8641360	59	32	had	have	VERB
bjos-8641360	59	33	t	t	PROPN
bjos-8641360	59	34	-	-	PUNCT
bjos-8641360	59	35	cd4	cd4	PROPN
bjos-8641360	59	36	between	between	ADP
bjos-8641360	59	37	200	200	NUM
bjos-8641360	59	38	to	to	PART
bjos-8641360	59	39	499	499	NUM
bjos-8641360	59	40	cells	cell	NOUN
bjos-8641360	59	41	/	/	SYM
bjos-8641360	59	42	mm	mm	PROPN
bjos-8641360	59	43	³	³	PROPN
bjos-8641360	59	44	and	and	CCONJ
bjos-8641360	59	45	13	13	NUM
bjos-8641360	59	46	(	(	PUNCT
bjos-8641360	59	47	46.5	46.5	NUM
bjos-8641360	59	48	%	%	NOUN
bjos-8641360	59	49	)	)	PUNCT
bjos-8641360	59	50	t	t	PROPN
bjos-8641360	59	51	-	-	PUNCT
bjos-8641360	59	52	cd4	cd4	PROPN
bjos-8641360	59	53	e	e	NOUN
bjos-8641360	59	54	”	"	PUNCT
bjos-8641360	59	55	500	500	NUM
bjos-8641360	59	56	cells	cell	NOUN
bjos-8641360	59	57	/	/	SYM
bjos-8641360	59	58	mm	mm	X
bjos-8641360	59	59	³.	³.	X
bjos-8641360	59	60	about	about	ADP
bjos-8641360	59	61	the	the	DET
bjos-8641360	59	62	viral	viral	ADJ
bjos-8641360	59	63	load	load	NOUN
bjos-8641360	59	64	(	(	PUNCT
bjos-8641360	59	65	vl	vl	PROPN
bjos-8641360	59	66	)	)	PUNCT
bjos-8641360	59	67	,	,	PUNCT
bjos-8641360	59	68	8	8	NUM
bjos-8641360	59	69	(	(	PUNCT
bjos-8641360	59	70	28.5	28.5	NUM
bjos-8641360	59	71	%	%	NOUN
bjos-8641360	59	72	)	)	PUNCT
bjos-8641360	59	73	had	have	VERB
bjos-8641360	59	74	less	less	ADJ
bjos-8641360	59	75	than	than	ADP
bjos-8641360	59	76	4999	4999	NUM
bjos-8641360	59	77	virus	virus	NOUN
bjos-8641360	59	78	,	,	PUNCT
bjos-8641360	59	79	2	2	NUM
bjos-8641360	59	80	(	(	PUNCT
bjos-8641360	59	81	7.2	7.2	NUM
bjos-8641360	59	82	%	%	NOUN
bjos-8641360	59	83	)	)	PUNCT
bjos-8641360	59	84	between	between	ADP
bjos-8641360	59	85	5000	5000	NUM
bjos-8641360	59	86	to	to	ADP
bjos-8641360	59	87	9999	9999	NUM
bjos-8641360	59	88	virus	virus	NOUN
bjos-8641360	59	89	,	,	PUNCT
bjos-8641360	59	90	3	3	NUM
bjos-8641360	59	91	(	(	PUNCT
bjos-8641360	59	92	10.8	10.8	NUM
bjos-8641360	59	93	%	%	NOUN
bjos-8641360	59	94	)	)	PUNCT
bjos-8641360	60	1	e	e	NOUN
bjos-8641360	60	2	”	"	PUNCT
bjos-8641360	60	3	10	10	NUM
bjos-8641360	60	4	000	000	NUM
bjos-8641360	60	5	virus	virus	NOUN
bjos-8641360	60	6	and	and	CCONJ
bjos-8641360	60	7	8	8	NUM
bjos-8641360	60	8	(	(	PUNCT
bjos-8641360	60	9	28.5	28.5	NUM
bjos-8641360	60	10	%	%	NOUN
bjos-8641360	60	11	)	)	PUNCT
bjos-8641360	60	12	undetectable	undetectable	ADJ
bjos-8641360	60	13	.	.	PUNCT
bjos-8641360	61	1	all	all	DET
bjos-8641360	61	2	patients	patient	NOUN
bjos-8641360	61	3	used	use	VERB
bjos-8641360	61	4	haart	haart	PROPN
bjos-8641360	61	5	;	;	PUNCT
bjos-8641360	61	6	of	of	ADP
bjos-8641360	61	7	these	these	PRON
bjos-8641360	61	8	,	,	PUNCT
bjos-8641360	61	9	20	20	NUM
bjos-8641360	61	10	(	(	PUNCT
bjos-8641360	61	11	71.4	71.4	NUM
bjos-8641360	61	12	%	%	NOUN
bjos-8641360	61	13	)	)	PUNCT
bjos-8641360	61	14	used	use	VERB
bjos-8641360	61	15	biovir	biovir	NOUN
bjos-8641360	61	16	,	,	PUNCT
bjos-8641360	61	17	15	15	NUM
bjos-8641360	61	18	(	(	PUNCT
bjos-8641360	61	19	53.6	53.6	NUM
bjos-8641360	61	20	%	%	NOUN
bjos-8641360	61	21	)	)	PUNCT
bjos-8641360	61	22	efavirenz	efavirenz	NOUN
bjos-8641360	61	23	,	,	PUNCT
bjos-8641360	61	24	7	7	NUM
bjos-8641360	61	25	(	(	PUNCT
bjos-8641360	61	26	25.0	25.0	NUM
bjos-8641360	61	27	%	%	NOUN
bjos-8641360	61	28	)	)	PUNCT
bjos-8641360	61	29	lamivudine	lamivudine	NOUN
bjos-8641360	61	30	,	,	PUNCT
bjos-8641360	61	31	7	7	NUM
bjos-8641360	61	32	(	(	PUNCT
bjos-8641360	61	33	25.0	25.0	NUM
bjos-8641360	61	34	%	%	NOUN
bjos-8641360	61	35	)	)	PUNCT
bjos-8641360	61	36	stavudine	stavudine	ADJ
bjos-8641360	61	37	,	,	PUNCT
bjos-8641360	61	38	5	5	NUM
bjos-8641360	61	39	(	(	PUNCT
bjos-8641360	61	40	17.9	17.9	NUM
bjos-8641360	61	41	%	%	NOUN
bjos-8641360	61	42	)	)	PUNCT
bjos-8641360	61	43	zidovudine	zidovudine	NOUN
bjos-8641360	61	44	,	,	PUNCT
bjos-8641360	61	45	2	2	NUM
bjos-8641360	61	46	(	(	PUNCT
bjos-8641360	61	47	7.1	7.1	NUM
bjos-8641360	61	48	%	%	NOUN
bjos-8641360	61	49	)	)	PUNCT
bjos-8641360	62	1	tenofovir	tenofovir	NOUN
bjos-8641360	62	2	,	,	PUNCT
bjos-8641360	62	3	2	2	NUM
bjos-8641360	62	4	(	(	PUNCT
bjos-8641360	62	5	7.1	7.1	NUM
bjos-8641360	62	6	%	%	NOUN
bjos-8641360	62	7	)	)	PUNCT
bjos-8641360	62	8	kaletra	kaletra	PROPN
bjos-8641360	62	9	,	,	PUNCT
bjos-8641360	62	10	2	2	NUM
bjos-8641360	62	11	(	(	PUNCT
bjos-8641360	62	12	7.1	7.1	NUM
bjos-8641360	62	13	%	%	NOUN
bjos-8641360	62	14	)	)	PUNCT
bjos-8641360	62	15	abacavir	abacavir	VERB
bjos-8641360	62	16	,	,	PUNCT
bjos-8641360	62	17	1	1	NUM
bjos-8641360	62	18	(	(	PUNCT
bjos-8641360	62	19	3.6	3.6	NUM
bjos-8641360	62	20	%	%	NOUN
bjos-8641360	62	21	)	)	PUNCT
bjos-8641360	63	1	atazanavir	atazanavir	PROPN
bjos-8641360	63	2	,	,	PUNCT
bjos-8641360	63	3	a	a	DET
bjos-8641360	63	4	(	(	PUNCT
bjos-8641360	63	5	3.6	3.6	NUM
bjos-8641360	63	6	%	%	NOUN
bjos-8641360	63	7	)	)	PUNCT
bjos-8641360	63	8	zalcitabine	zalcitabine	NOUN
bjos-8641360	63	9	,	,	PUNCT
bjos-8641360	63	10	1	1	NUM
bjos-8641360	63	11	(	(	PUNCT
bjos-8641360	63	12	3.6	3.6	NUM
bjos-8641360	63	13	%	%	NOUN
bjos-8641360	63	14	)	)	PUNCT
bjos-8641360	63	15	and	and	CCONJ
bjos-8641360	63	16	a	a	DET
bjos-8641360	63	17	didanosine	didanosine	NOUN
bjos-8641360	63	18	(	(	PUNCT
bjos-8641360	63	19	3.6	3.6	NUM
bjos-8641360	63	20	%	%	NOUN
bjos-8641360	63	21	)	)	PUNCT
bjos-8641360	63	22	ritonavir	ritonavir	PROPN
bjos-8641360	63	23	.	.	PUNCT
bjos-8641360	64	1	for	for	ADP
bjos-8641360	64	2	the	the	DET
bjos-8641360	64	3	variable	variable	ADJ
bjos-8641360	64	4	means	mean	NOUN
bjos-8641360	64	5	of	of	ADP
bjos-8641360	64	6	contamination	contamination	NOUN
bjos-8641360	64	7	of	of	ADP
bjos-8641360	64	8	the	the	DET
bjos-8641360	64	9	hiv	hiv	PROPN
bjos-8641360	64	10	group	group	NOUN
bjos-8641360	64	11	,	,	PUNCT
bjos-8641360	64	12	17	17	NUM
bjos-8641360	64	13	(	(	PUNCT
bjos-8641360	64	14	60.7	60.7	NUM
bjos-8641360	64	15	%	%	NOUN
bjos-8641360	64	16	)	)	PUNCT
bjos-8641360	64	17	were	be	AUX
bjos-8641360	64	18	infected	infect	VERB
bjos-8641360	64	19	through	through	ADP
bjos-8641360	64	20	heterosexual	heterosexual	ADJ
bjos-8641360	64	21	contact	contact	NOUN
bjos-8641360	64	22	,	,	PUNCT
bjos-8641360	64	23	9	9	NUM
bjos-8641360	64	24	(	(	PUNCT
bjos-8641360	64	25	32.3	32.3	NUM
bjos-8641360	64	26	%	%	NOUN
bjos-8641360	64	27	)	)	PUNCT
bjos-8641360	64	28	msm	msm	NOUN
bjos-8641360	64	29	(	(	PUNCT
bjos-8641360	64	30	homosexual	homosexual	ADJ
bjos-8641360	64	31	)	)	PUNCT
bjos-8641360	64	32	,	,	PUNCT
bjos-8641360	64	33	1	1	NUM
bjos-8641360	64	34	(	(	PUNCT
bjos-8641360	64	35	3.5	3.5	NUM
bjos-8641360	64	36	%	%	NOUN
bjos-8641360	64	37	)	)	PUNCT
bjos-8641360	64	38	bisexual	bisexual	NOUN
bjos-8641360	64	39	and	and	CCONJ
bjos-8641360	64	40	1	1	NUM
bjos-8641360	64	41	(	(	PUNCT
bjos-8641360	64	42	3.5	3.5	NUM
bjos-8641360	64	43	%	%	NOUN
bjos-8641360	64	44	)	)	PUNCT
bjos-8641360	64	45	by	by	ADP
bjos-8641360	64	46	transfusion	transfusion	NOUN
bjos-8641360	64	47	.	.	PUNCT
bjos-8641360	65	1	from	from	ADP
bjos-8641360	65	2	the	the	DET
bjos-8641360	65	3	28	28	NUM
bjos-8641360	65	4	patients	patient	NOUN
bjos-8641360	65	5	of	of	ADP
bjos-8641360	65	6	the	the	DET
bjos-8641360	65	7	control	control	NOUN
bjos-8641360	65	8	group	group	NOUN
bjos-8641360	65	9	,	,	PUNCT
bjos-8641360	65	10	11	11	NUM
bjos-8641360	65	11	(	(	PUNCT
bjos-8641360	65	12	39.3	39.3	NUM
bjos-8641360	65	13	%	%	NOUN
bjos-8641360	65	14	)	)	PUNCT
bjos-8641360	65	15	were	be	AUX
bjos-8641360	65	16	male	male	ADJ
bjos-8641360	65	17	and	and	CCONJ
bjos-8641360	65	18	17	17	NUM
bjos-8641360	65	19	(	(	PUNCT
bjos-8641360	65	20	60.7	60.7	NUM
bjos-8641360	65	21	%	%	NOUN
bjos-8641360	65	22	)	)	PUNCT
bjos-8641360	65	23	female	female	NOUN
bjos-8641360	65	24	,	,	PUNCT
bjos-8641360	65	25	21	21	NUM
bjos-8641360	65	26	(	(	PUNCT
bjos-8641360	65	27	75.0	75.0	NUM
bjos-8641360	65	28	%	%	NOUN
bjos-8641360	65	29	)	)	PUNCT
bjos-8641360	65	30	were	be	AUX
bjos-8641360	65	31	caucasian	caucasian	ADJ
bjos-8641360	65	32	,	,	PUNCT
bjos-8641360	65	33	5	5	NUM
bjos-8641360	65	34	(	(	PUNCT
bjos-8641360	65	35	17.8	17.8	NUM
bjos-8641360	65	36	%	%	NOUN
bjos-8641360	65	37	)	)	PUNCT
bjos-8641360	65	38	african	african	ADJ
bjos-8641360	65	39	descendants	descendant	NOUN
bjos-8641360	65	40	and	and	CCONJ
bjos-8641360	65	41	2	2	NUM
bjos-8641360	65	42	(	(	PUNCT
bjos-8641360	65	43	7	7	NUM
bjos-8641360	65	44	2	2	NUM
bjos-8641360	65	45	%	%	NOUN
bjos-8641360	65	46	)	)	PUNCT
bjos-8641360	65	47	oriental	oriental	ADJ
bjos-8641360	65	48	descendants	descendant	NOUN
bjos-8641360	65	49	,	,	PUNCT
bjos-8641360	65	50	and	and	CCONJ
bjos-8641360	65	51	the	the	DET
bjos-8641360	65	52	mean	mean	ADJ
bjos-8641360	65	53	age	age	NOUN
bjos-8641360	65	54	was	be	AUX
bjos-8641360	65	55	60.11	60.11	NUM
bjos-8641360	65	56	years	year	NOUN
bjos-8641360	65	57	.	.	PUNCT
bjos-8641360	66	1	initially	initially	ADV
bjos-8641360	66	2	all	all	DET
bjos-8641360	66	3	variables	variable	NOUN
bjos-8641360	66	4	were	be	AUX
bjos-8641360	66	5	analyzed	analyze	VERB
bjos-8641360	66	6	descriptively	descriptively	ADV
bjos-8641360	66	7	.	.	PUNCT
bjos-8641360	67	1	the	the	DET
bjos-8641360	67	2	most	most	ADV
bjos-8641360	67	3	prevalent	prevalent	ADJ
bjos-8641360	67	4	habits	habit	NOUN
bjos-8641360	67	5	in	in	ADP
bjos-8641360	67	6	both	both	DET
bjos-8641360	67	7	groups	group	NOUN
bjos-8641360	67	8	were	be	AUX
bjos-8641360	67	9	smoking	smoking	NOUN
bjos-8641360	67	10	and	and	CCONJ
bjos-8641360	67	11	alcohol	alcohol	NOUN
bjos-8641360	67	12	,	,	PUNCT
bjos-8641360	67	13	being	be	AUX
bjos-8641360	67	14	present	present	ADJ
bjos-8641360	67	15	in	in	ADP
bjos-8641360	67	16	64.3	64.3	NUM
bjos-8641360	67	17	%	%	NOUN
bjos-8641360	67	18	of	of	ADP
bjos-8641360	67	19	patients	patient	NOUN
bjos-8641360	67	20	in	in	ADP
bjos-8641360	67	21	the	the	DET
bjos-8641360	67	22	control	control	NOUN
bjos-8641360	67	23	group	group	NOUN
bjos-8641360	67	24	and	and	CCONJ
bjos-8641360	67	25	67.9	67.9	NUM
bjos-8641360	67	26	%	%	NOUN
bjos-8641360	67	27	of	of	ADP
bjos-8641360	67	28	patients	patient	NOUN
bjos-8641360	67	29	in	in	ADP
bjos-8641360	67	30	the	the	DET
bjos-8641360	67	31	hiv	hiv	PROPN
bjos-8641360	67	32	group	group	NOUN
bjos-8641360	67	33	.	.	PUNCT
bjos-8641360	68	1	table	table	NOUN
bjos-8641360	68	2	1	1	NUM
bjos-8641360	68	3	shows	show	VERB
bjos-8641360	68	4	the	the	DET
bjos-8641360	68	5	frequency	frequency	NOUN
bjos-8641360	68	6	distributions	distribution	NOUN
bjos-8641360	68	7	between	between	ADP
bjos-8641360	68	8	distribution	distribution	NOUN
bjos-8641360	68	9	of	of	ADP
bjos-8641360	68	10	frequencies	frequency	NOUN
bjos-8641360	68	11	of	of	ADP
bjos-8641360	68	12	the	the	DET
bjos-8641360	68	13	variable	variable	ADJ
bjos-8641360	68	14	salivary	salivary	ADJ
bjos-8641360	68	15	flow	flow	NOUN
bjos-8641360	68	16	and	and	CCONJ
bjos-8641360	68	17	buffering	buffering	NOUN
bjos-8641360	68	18	capacity	capacity	NOUN
bjos-8641360	68	19	.	.	PUNCT
bjos-8641360	69	1	table	table	NOUN
bjos-8641360	69	2	2	2	NUM
bjos-8641360	69	3	presents	present	VERB
bjos-8641360	69	4	the	the	DET
bjos-8641360	69	5	means	mean	NOUN
bjos-8641360	69	6	,	,	PUNCT
bjos-8641360	69	7	standard	standard	ADJ
bjos-8641360	69	8	deviations	deviation	NOUN
bjos-8641360	69	9	,	,	PUNCT
bjos-8641360	69	10	medians	median	NOUN
bjos-8641360	69	11	and	and	CCONJ
bjos-8641360	69	12	p	p	NOUN
bjos-8641360	69	13	values	value	NOUN
bjos-8641360	69	14	for	for	ADP
bjos-8641360	69	15	the	the	DET
bjos-8641360	69	16	variable	variable	ADJ
bjos-8641360	69	17	dmft	dmft	VERB
bjos-8641360	69	18	index	index	NOUN
bjos-8641360	69	19	,	,	PUNCT
bjos-8641360	69	20	plaque	plaque	NOUN
bjos-8641360	69	21	index	index	NOUN
bjos-8641360	69	22	and	and	CCONJ
bjos-8641360	69	23	bleeding	bleed	VERB
bjos-8641360	69	24	index	index	NOUN
bjos-8641360	69	25	.	.	PUNCT
bjos-8641360	70	1	table	table	NOUN
bjos-8641360	70	2	3	3	NUM
bjos-8641360	70	3	presents	present	VERB
bjos-8641360	70	4	the	the	DET
bjos-8641360	70	5	joint	joint	ADJ
bjos-8641360	70	6	frequency	frequency	NOUN
bjos-8641360	70	7	distribution	distribution	NOUN
bjos-8641360	70	8	for	for	ADP
bjos-8641360	70	9	the	the	DET
bjos-8641360	70	10	variable	variable	ADJ
bjos-8641360	70	11	oral	oral	ADJ
bjos-8641360	70	12	manifestations	manifestation	NOUN
bjos-8641360	70	13	.	.	PUNCT
bjos-8641360	71	1	these	these	DET
bjos-8641360	71	2	tables	table	NOUN
bjos-8641360	71	3	also	also	ADV
bjos-8641360	71	4	present	present	VERB
bjos-8641360	71	5	the	the	DET
bjos-8641360	71	6	descriptive	descriptive	ADJ
bjos-8641360	71	7	p	p	NOUN
bjos-8641360	71	8	value	value	NOUN
bjos-8641360	71	9	of	of	ADP
bjos-8641360	71	10	fisher	fisher	PROPN
bjos-8641360	71	11	’s	’s	PART
bjos-8641360	71	12	exact	exact	ADJ
bjos-8641360	71	13	test	test	NOUN
bjos-8641360	71	14	.	.	PUNCT
bjos-8641360	72	1	it	it	PRON
bjos-8641360	72	2	was	be	AUX
bjos-8641360	72	3	observed	observe	VERB
bjos-8641360	72	4	that	that	SCONJ
bjos-8641360	72	5	for	for	ADP
bjos-8641360	72	6	these	these	DET
bjos-8641360	72	7	variables	variable	NOUN
bjos-8641360	72	8	there	there	PRON
bjos-8641360	72	9	was	be	VERB
bjos-8641360	72	10	no	no	DET
bjos-8641360	72	11	significant	significant	ADJ
bjos-8641360	72	12	difference	difference	NOUN
bjos-8641360	72	13	.	.	PUNCT
bjos-8641360	73	1	the	the	DET
bjos-8641360	73	2	groups	group	NOUN
bjos-8641360	73	3	did	do	AUX
bjos-8641360	73	4	not	not	PART
bjos-8641360	73	5	differ	differ	VERB
bjos-8641360	73	6	significantly	significantly	ADV
bjos-8641360	73	7	regarding	regard	VERB
bjos-8641360	73	8	plaque	plaque	NOUN
bjos-8641360	73	9	index	index	NOUN
bjos-8641360	73	10	.	.	PUNCT
bjos-8641360	74	1	the	the	DET
bjos-8641360	74	2	most	most	ADV
bjos-8641360	74	3	prevalent	prevalent	ADJ
bjos-8641360	74	4	oral	oral	ADJ
bjos-8641360	74	5	manifestations	manifestation	NOUN
bjos-8641360	74	6	in	in	ADP
bjos-8641360	74	7	the	the	DET
bjos-8641360	74	8	hiv	hiv	PROPN
bjos-8641360	74	9	group	group	NOUN
bjos-8641360	74	10	were	be	AUX
bjos-8641360	74	11	oral	oral	ADJ
bjos-8641360	74	12	candidiasis	candidiasis	NOUN
bjos-8641360	74	13	,	,	PUNCT
bjos-8641360	74	14	herpes	herpe	NOUN
bjos-8641360	74	15	simplex	simplex	NOUN
bjos-8641360	74	16	and	and	CCONJ
bjos-8641360	74	17	periodontal	periodontal	ADJ
bjos-8641360	74	18	disease	disease	NOUN
bjos-8641360	74	19	,	,	PUNCT
bjos-8641360	74	20	and	and	CCONJ
bjos-8641360	74	21	the	the	DET
bjos-8641360	74	22	control	control	NOUN
bjos-8641360	74	23	group	group	NOUN
bjos-8641360	74	24	caries	carie	NOUN
bjos-8641360	74	25	,	,	PUNCT
bjos-8641360	74	26	bleeding	bleed	VERB
bjos-8641360	74	27	on	on	ADP
bjos-8641360	74	28	probing	probing	NOUN
bjos-8641360	74	29	and	and	CCONJ
bjos-8641360	74	30	xerostomia	xerostomia	NOUN
bjos-8641360	74	31	.	.	PUNCT
bjos-8641360	75	1	the	the	DET
bjos-8641360	75	2	percentage	percentage	NOUN
bjos-8641360	75	3	of	of	ADP
bjos-8641360	75	4	patients	patient	NOUN
bjos-8641360	75	5	who	who	PRON
bjos-8641360	75	6	had	have	VERB
bjos-8641360	75	7	no	no	DET
bjos-8641360	75	8	oral	oral	ADJ
bjos-8641360	75	9	manifestation	manifestation	NOUN
bjos-8641360	75	10	in	in	ADP
bjos-8641360	75	11	the	the	DET
bjos-8641360	75	12	hiv	hiv	PROPN
bjos-8641360	75	13	group	group	NOUN
bjos-8641360	75	14	is	be	AUX
bjos-8641360	75	15	32.1	32.1	NUM
bjos-8641360	75	16	%	%	NOUN
bjos-8641360	75	17	higher	high	ADJ
bjos-8641360	75	18	than	than	ADP
bjos-8641360	75	19	in	in	ADP
bjos-8641360	75	20	the	the	DET
bjos-8641360	75	21	control	control	NOUN
bjos-8641360	75	22	group	group	NOUN
bjos-8641360	75	23	that	that	PRON
bjos-8641360	75	24	is	be	AUX
bjos-8641360	75	25	21.4	21.4	NUM
bjos-8641360	75	26	%	%	NOUN
bjos-8641360	75	27	.	.	PUNCT
bjos-8641360	76	1	the	the	DET
bjos-8641360	76	2	groups	group	NOUN
bjos-8641360	76	3	differ	differ	VERB
bjos-8641360	76	4	in	in	ADP
bjos-8641360	76	5	relation	relation	NOUN
bjos-8641360	76	6	to	to	ADP
bjos-8641360	76	7	caries	carie	NOUN
bjos-8641360	76	8	(	(	PUNCT
bjos-8641360	76	9	p	p	X
bjos-8641360	76	10	=	=	NOUN
bjos-8641360	76	11	0.004	0.004	NUM
bjos-8641360	76	12	)	)	PUNCT
bjos-8641360	76	13	,	,	PUNCT
bjos-8641360	76	14	xerostomia	xerostomia	NOUN
bjos-8641360	77	1	(	(	PUNCT
bjos-8641360	77	2	p	p	X
bjos-8641360	77	3	=	=	NOUN
bjos-8641360	77	4	0.005	0.005	NUM
bjos-8641360	77	5	)	)	PUNCT
bjos-8641360	77	6	,	,	PUNCT
bjos-8641360	77	7	oral	oral	ADJ
bjos-8641360	77	8	candidiasis	candidiasis	NOUN
bjos-8641360	77	9	(	(	PUNCT
bjos-8641360	77	10	p	p	NOUN
bjos-8641360	77	11	=	=	NOUN
bjos-8641360	77	12	0.001	0.001	NUM
bjos-8641360	77	13	)	)	PUNCT
bjos-8641360	77	14	and	and	CCONJ
bjos-8641360	77	15	herpes	herpe	NOUN
bjos-8641360	77	16	simplex	simplex	NOUN
bjos-8641360	77	17	(	(	PUNCT
bjos-8641360	77	18	p	p	X
bjos-8641360	77	19	=	=	NOUN
bjos-8641360	77	20	0.010	0.010	NUM
bjos-8641360	77	21	)	)	PUNCT
bjos-8641360	77	22	.	.	PUNCT
bjos-8641360	78	1	the	the	DET
bjos-8641360	78	2	hiv	hiv	PROPN
bjos-8641360	78	3	group	group	PROPN
bjos-8641360	78	4	had	have	VERB
bjos-8641360	78	5	a	a	DET
bjos-8641360	78	6	higher	high	ADJ
bjos-8641360	78	7	percentage	percentage	NOUN
bjos-8641360	78	8	of	of	ADP
bjos-8641360	78	9	cases	case	NOUN
bjos-8641360	78	10	with	with	ADP
bjos-8641360	78	11	oral	oral	ADJ
bjos-8641360	78	12	candidiasis	candidiasis	NOUN
bjos-8641360	78	13	(	(	PUNCT
bjos-8641360	78	14	35.7	35.7	NUM
bjos-8641360	78	15	%	%	NOUN
bjos-8641360	78	16	)	)	PUNCT
bjos-8641360	78	17	and	and	CCONJ
bjos-8641360	78	18	herpes	herpe	NOUN
bjos-8641360	78	19	simplex	simplex	NOUN
bjos-8641360	78	20	(	(	PUNCT
bjos-8641360	78	21	25.0	25.0	NUM
bjos-8641360	78	22	%	%	NOUN
bjos-8641360	78	23	)	)	PUNCT
bjos-8641360	78	24	and	and	CCONJ
bjos-8641360	78	25	lower	low	ADJ
bjos-8641360	78	26	percentage	percentage	NOUN
bjos-8641360	78	27	of	of	ADP
bjos-8641360	78	28	cases	case	NOUN
bjos-8641360	78	29	with	with	ADP
bjos-8641360	78	30	caries	carie	NOUN
bjos-8641360	78	31	(	(	PUNCT
bjos-8641360	78	32	7.1	7.1	NUM
bjos-8641360	78	33	%	%	NOUN
bjos-8641360	78	34	)	)	PUNCT
bjos-8641360	78	35	and	and	CCONJ
bjos-8641360	78	36	xerostomia	xerostomia	NOUN
bjos-8641360	78	37	(	(	PUNCT
bjos-8641360	78	38	3.6	3.6	NUM
bjos-8641360	78	39	%	%	NOUN
bjos-8641360	78	40	)	)	PUNCT
bjos-8641360	78	41	compared	compare	VERB
bjos-8641360	78	42	to	to	ADP
bjos-8641360	78	43	control	control	PROPN
bjos-8641360	78	44	group	group	NOUN
bjos-8641360	78	45	.	.	PUNCT
bjos-8641360	79	1	the	the	DET
bjos-8641360	79	2	groups	group	NOUN
bjos-8641360	79	3	did	do	AUX
bjos-8641360	79	4	not	not	PART
bjos-8641360	79	5	show	show	VERB
bjos-8641360	79	6	significant	significant	ADJ
bjos-8641360	79	7	difference	difference	NOUN
bjos-8641360	79	8	compared	compare	VERB
bjos-8641360	79	9	with	with	ADP
bjos-8641360	79	10	other	other	ADJ
bjos-8641360	79	11	oral	oral	ADJ
bjos-8641360	79	12	manifestations	manifestation	NOUN
bjos-8641360	79	13	.	.	PUNCT
bjos-8641360	80	1	discussion	discussion	NOUN
bjos-8641360	80	2	regarding	regard	VERB
bjos-8641360	80	3	the	the	DET
bjos-8641360	80	4	oral	oral	ADJ
bjos-8641360	80	5	manifestations	manifestation	NOUN
bjos-8641360	80	6	present	present	ADJ
bjos-8641360	80	7	in	in	ADP
bjos-8641360	80	8	the	the	DET
bjos-8641360	80	9	hiv	hiv	PROPN
bjos-8641360	80	10	group	group	NOUN
bjos-8641360	80	11	,	,	PUNCT
bjos-8641360	80	12	the	the	DET
bjos-8641360	80	13	most	most	ADV
bjos-8641360	80	14	common	common	ADJ
bjos-8641360	80	15	manifestation	manifestation	NOUN
bjos-8641360	80	16	was	be	AUX
bjos-8641360	80	17	oral	oral	ADJ
bjos-8641360	80	18	candidiasis	candidiasis	NOUN
bjos-8641360	80	19	,	,	PUNCT
bjos-8641360	80	20	affecting	affect	VERB
bjos-8641360	80	21	35.7	35.7	NUM
bjos-8641360	80	22	%	%	NOUN
bjos-8641360	80	23	patients	patient	NOUN
bjos-8641360	80	24	,	,	PUNCT
bjos-8641360	80	25	which	which	PRON
bjos-8641360	80	26	is	be	AUX
bjos-8641360	80	27	in	in	ADP
bjos-8641360	80	28	accordance	accordance	NOUN
bjos-8641360	80	29	with	with	ADP
bjos-8641360	80	30	the	the	DET
bjos-8641360	80	31	literature22	literature22	NOUN
bjos-8641360	80	32	-	-	PUNCT
bjos-8641360	80	33	25,28	25,28	NUM
bjos-8641360	80	34	-	-	SYM
bjos-8641360	80	35	29	29	NUM
bjos-8641360	80	36	.	.	PUNCT
bjos-8641360	81	1	besides	besides	SCONJ
bjos-8641360	81	2	oral	oral	ADJ
bjos-8641360	81	3	candidiasis	candidiasis	NOUN
bjos-8641360	81	4	,	,	PUNCT
bjos-8641360	81	5	other	other	ADJ
bjos-8641360	81	6	oral	oral	ADJ
bjos-8641360	81	7	manifestations	manifestation	NOUN
bjos-8641360	81	8	were	be	AUX
bjos-8641360	81	9	found	find	VERB
bjos-8641360	81	10	,	,	PUNCT
bjos-8641360	81	11	such	such	ADJ
bjos-8641360	81	12	as	as	ADP
bjos-8641360	81	13	herpes	herpe	NOUN
bjos-8641360	81	14	simplex	simplex	NOUN
bjos-8641360	81	15	(	(	PUNCT
bjos-8641360	81	16	25	25	NUM
bjos-8641360	81	17	%	%	NOUN
bjos-8641360	81	18	)	)	PUNCT
bjos-8641360	81	19	,	,	PUNCT
bjos-8641360	81	20	periodontal	periodontal	ADJ
bjos-8641360	81	21	disease	disease	NOUN
bjos-8641360	81	22	(	(	PUNCT
bjos-8641360	81	23	21.4	21.4	NUM
bjos-8641360	81	24	%	%	NOUN
bjos-8641360	81	25	)	)	PUNCT
bjos-8641360	81	26	,	,	PUNCT
bjos-8641360	81	27	oral	oral	ADJ
bjos-8641360	81	28	ulcer	ulcer	NOUN
bjos-8641360	81	29	(	(	PUNCT
bjos-8641360	81	30	14.3	14.3	NUM
bjos-8641360	81	31	%	%	NOUN
bjos-8641360	81	32	)	)	PUNCT
bjos-8641360	81	33	,	,	PUNCT
bjos-8641360	81	34	hairy	hairy	ADJ
bjos-8641360	81	35	leukoplakia	leukoplakia	NOUN
bjos-8641360	81	36	(	(	PUNCT
bjos-8641360	81	37	10.7	10.7	NUM
bjos-8641360	81	38	%	%	NOUN
bjos-8641360	81	39	)	)	PUNCT
bjos-8641360	81	40	,	,	PUNCT
bjos-8641360	81	41	caries	carie	NOUN
bjos-8641360	81	42	and	and	CCONJ
bjos-8641360	81	43	kaposi	kaposi	PROPN
bjos-8641360	81	44	’s	’s	PART
bjos-8641360	81	45	sarcoma	sarcoma	NOUN
bjos-8641360	81	46	(	(	PUNCT
bjos-8641360	81	47	7.1	7.1	NUM
bjos-8641360	81	48	%	%	NOUN
bjos-8641360	81	49	)	)	PUNCT
bjos-8641360	81	50	,	,	PUNCT
bjos-8641360	81	51	xerostomia	xerostomia	NOUN
bjos-8641360	81	52	,	,	PUNCT
bjos-8641360	81	53	nicotinic	nicotinic	ADJ
bjos-8641360	81	54	stomatitis	stomatitis	NOUN
bjos-8641360	81	55	and	and	CCONJ
bjos-8641360	81	56	lichen	lichen	NOUN
bjos-8641360	81	57	planus	planus	NOUN
bjos-8641360	81	58	(	(	PUNCT
bjos-8641360	81	59	3.6	3.6	NUM
bjos-8641360	81	60	%	%	NOUN
bjos-8641360	81	61	)	)	PUNCT
bjos-8641360	81	62	.	.	PUNCT
bjos-8641360	82	1	this	this	PRON
bjos-8641360	82	2	is	be	AUX
bjos-8641360	82	3	consistent	consistent	ADJ
bjos-8641360	82	4	with	with	ADP
bjos-8641360	82	5	the	the	DET
bjos-8641360	82	6	findings	finding	NOUN
bjos-8641360	82	7	of	of	ADP
bjos-8641360	82	8	coogan	coogan	PROPN
bjos-8641360	82	9	et	et	PROPN
bjos-8641360	82	10	al	al	PROPN
bjos-8641360	82	11	.	.	PROPN
bjos-8641360	83	1	(	(	PUNCT
bjos-8641360	83	2	2005)23	2005)23	NUM
bjos-8641360	83	3	and	and	CCONJ
bjos-8641360	83	4	giovani	giovani	X
bjos-8641360	83	5	et	et	PROPN
bjos-8641360	83	6	al	al	PROPN
bjos-8641360	83	7	.	.	PROPN
bjos-8641360	84	1	(	(	PUNCT
bjos-8641360	84	2	2007	2007	NUM
bjos-8641360	84	3	)	)	PUNCT
bjos-8641360	84	4	24	24	NUM
bjos-8641360	84	5	,	,	PUNCT
bjos-8641360	84	6	who	who	PRON
bjos-8641360	84	7	reported	report	VERB
bjos-8641360	84	8	that	that	SCONJ
bjos-8641360	84	9	the	the	DET
bjos-8641360	84	10	most	most	ADV
bjos-8641360	84	11	frequent	frequent	ADJ
bjos-8641360	84	12	dmft	dmft	VERB
bjos-8641360	84	13	index	index	NOUN
bjos-8641360	84	14	plaque	plaque	NOUN
bjos-8641360	84	15	index	index	NOUN
bjos-8641360	84	16	bleeding	bleed	VERB
bjos-8641360	84	17	index	index	NOUN
bjos-8641360	84	18	group	group	NOUN
bjos-8641360	84	19	mean	mean	VERB
bjos-8641360	84	20	standard	standard	ADJ
bjos-8641360	84	21	median	median	ADJ
bjos-8641360	84	22	mean	mean	NOUN
bjos-8641360	84	23	standard	standard	ADJ
bjos-8641360	84	24	median	median	ADJ
bjos-8641360	84	25	mean	mean	NOUN
bjos-8641360	84	26	standard	standard	ADJ
bjos-8641360	84	27	median	median	ADJ
bjos-8641360	84	28	deviation	deviation	NOUN
bjos-8641360	84	29	(	(	PUNCT
bjos-8641360	84	30	min	min	NOUN
bjos-8641360	84	31	-	-	PUNCT
bjos-8641360	84	32	max	max	ADJ
bjos-8641360	84	33	)	)	PUNCT
bjos-8641360	84	34	deviation	deviation	NOUN
bjos-8641360	84	35	(	(	PUNCT
bjos-8641360	84	36	min	min	NOUN
bjos-8641360	84	37	-	-	PUNCT
bjos-8641360	84	38	max	max	ADJ
bjos-8641360	84	39	)	)	PUNCT
bjos-8641360	84	40	deviation	deviation	NOUN
bjos-8641360	84	41	(	(	PUNCT
bjos-8641360	84	42	min	min	NOUN
bjos-8641360	84	43	-	-	PUNCT
bjos-8641360	84	44	max	max	NOUN
bjos-8641360	84	45	)	)	PUNCT
bjos-8641360	84	46	control	control	NOUN
bjos-8641360	84	47	22.46	22.46	NUM
bjos-8641360	84	48	5.12	5.12	NUM
bjos-8641360	84	49	23.5(11	23.5(11	NUM
bjos-8641360	84	50	-	-	SYM
bjos-8641360	84	51	32	32	NUM
bjos-8641360	84	52	)	)	PUNCT
bjos-8641360	84	53	49.19	49.19	NUM
bjos-8641360	84	54	29.12	29.12	NUM
bjos-8641360	84	55	52.0(0	52.0(0	NUM
bjos-8641360	84	56	-	-	PUNCT
bjos-8641360	84	57	100	100	NUM
bjos-8641360	84	58	)	)	PUNCT
bjos-8641360	84	59	32.14	32.14	NUM
bjos-8641360	84	60	26.76	26.76	NUM
bjos-8641360	84	61	24.0(0	24.0(0	NUM
bjos-8641360	84	62	-	-	SYM
bjos-8641360	84	63	98	98	NUM
bjos-8641360	84	64	)	)	PUNCT
bjos-8641360	84	65	hiv	hiv	PROPN
bjos-8641360	84	66	17.54	17.54	NUM
bjos-8641360	84	67	8.11	8.11	NUM
bjos-8641360	84	68	16.0(2	16.0(2	NUM
bjos-8641360	84	69	-	-	SYM
bjos-8641360	84	70	32	32	NUM
bjos-8641360	84	71	)	)	PUNCT
bjos-8641360	84	72	54.80	54.80	NUM
bjos-8641360	84	73	24.98	24.98	NUM
bjos-8641360	84	74	52.0(17	52.0(17	NUM
bjos-8641360	84	75	-	-	SYM
bjos-8641360	84	76	100	100	NUM
bjos-8641360	84	77	)	)	PUNCT
bjos-8641360	84	78	46.53	46.53	NUM
bjos-8641360	84	79	25.21	25.21	NUM
bjos-8641360	84	80	45.0(0	45.0(0	NUM
bjos-8641360	84	81	-	-	PUNCT
bjos-8641360	84	82	100	100	NUM
bjos-8641360	84	83	)	)	PUNCT
bjos-8641360	84	84	p*=0.019	p*=0.019	NOUN
bjos-8641360	84	85	p*=0.533	p*=0.533	VERB
bjos-8641360	84	86	p*=0.017	p*=0.017	NOUN
bjos-8641360	84	87	table	table	NOUN
bjos-8641360	84	88	2	2	NUM
bjos-8641360	84	89	mean	mean	NOUN
bjos-8641360	84	90	,	,	PUNCT
bjos-8641360	84	91	standard	standard	ADJ
bjos-8641360	84	92	deviation	deviation	NOUN
bjos-8641360	84	93	,	,	PUNCT
bjos-8641360	84	94	median	median	ADJ
bjos-8641360	84	95	and	and	CCONJ
bjos-8641360	84	96	descriptive	descriptive	ADJ
bjos-8641360	84	97	p	p	NOUN
bjos-8641360	84	98	level	level	NOUN
bjos-8641360	84	99	for	for	ADP
bjos-8641360	84	100	dmft	dmft	VERB
bjos-8641360	84	101	index	index	NOUN
bjos-8641360	84	102	,	,	PUNCT
bjos-8641360	84	103	plaque	plaque	NOUN
bjos-8641360	84	104	index	index	NOUN
bjos-8641360	84	105	and	and	CCONJ
bjos-8641360	84	106	bleeding	bleed	VERB
bjos-8641360	84	107	index	index	NOUN
bjos-8641360	84	108	(	(	PUNCT
bjos-8641360	84	109	*	*	NOUN
bjos-8641360	84	110	)	)	PUNCT
bjos-8641360	84	111	descriptive	descriptive	ADJ
bjos-8641360	84	112	level	level	NOUN
bjos-8641360	84	113	of	of	ADP
bjos-8641360	84	114	probability	probability	NOUN
bjos-8641360	84	115	of	of	ADP
bjos-8641360	84	116	mann	mann	PROPN
bjos-8641360	84	117	-	-	PUNCT
bjos-8641360	84	118	whitney	whitney	PROPN
bjos-8641360	84	119	’s	’s	PART
bjos-8641360	84	120	non	non	ADJ
bjos-8641360	84	121	-	-	ADJ
bjos-8641360	84	122	parametric	parametric	ADJ
bjos-8641360	84	123	test	test	NOUN
bjos-8641360	84	124	.	.	PUNCT
bjos-8641360	85	1	(	(	PUNCT
bjos-8641360	85	2	*	*	X
bjos-8641360	85	3	)	)	PUNCT
bjos-8641360	85	4	descriptive	descriptive	ADJ
bjos-8641360	85	5	level	level	NOUN
bjos-8641360	85	6	of	of	ADP
bjos-8641360	85	7	probability	probability	NOUN
bjos-8641360	85	8	of	of	ADP
bjos-8641360	85	9	fisher	fisher	PROPN
bjos-8641360	85	10	’s	’s	PART
bjos-8641360	85	11	exact	exact	ADJ
bjos-8641360	85	12	test	test	NOUN
bjos-8641360	85	13	.	.	PUNCT
bjos-8641360	86	1	salivary	salivary	ADJ
bjos-8641360	86	2	flow	flow	NOUN
bjos-8641360	86	3	buffering	buffering	NOUN
bjos-8641360	86	4	capacity	capacity	NOUN
bjos-8641360	86	5	group	group	NOUN
bjos-8641360	86	6	low	low	ADJ
bjos-8641360	86	7	normal	normal	ADJ
bjos-8641360	86	8	total	total	ADJ
bjos-8641360	86	9	low	low	ADJ
bjos-8641360	86	10	normal	normal	ADJ
bjos-8641360	86	11	total	total	ADJ
bjos-8641360	86	12	intermediate	intermediate	ADJ
bjos-8641360	86	13	intermediate	intermediate	ADJ
bjos-8641360	86	14	control	control	NOUN
bjos-8641360	86	15	11(39.2	11(39.2	NOUN
bjos-8641360	86	16	)	)	PUNCT
bjos-8641360	86	17	2(7.14	2(7.14	NUM
bjos-8641360	86	18	)	)	PUNCT
bjos-8641360	86	19	15(53.5	15(53.5	NUM
bjos-8641360	86	20	)	)	PUNCT
bjos-8641360	86	21	28(100.0	28(100.0	NUM
bjos-8641360	86	22	)	)	PUNCT
bjos-8641360	86	23	0(0.0	0(0.0	NUM
bjos-8641360	86	24	)	)	PUNCT
bjos-8641360	86	25	11(39.3	11(39.3	NUM
bjos-8641360	86	26	)	)	PUNCT
bjos-8641360	86	27	17(60.7	17(60.7	NUM
bjos-8641360	86	28	)	)	PUNCT
bjos-8641360	86	29	28(100.0	28(100.0	NUM
bjos-8641360	86	30	)	)	PUNCT
bjos-8641360	86	31	hiv	hiv	NOUN
bjos-8641360	86	32	6(21.4	6(21.4	NUM
bjos-8641360	86	33	)	)	PUNCT
bjos-8641360	86	34	4(14.3	4(14.3	NUM
bjos-8641360	86	35	)	)	PUNCT
bjos-8641360	86	36	18(64.3	18(64.3	NUM
bjos-8641360	86	37	)	)	PUNCT
bjos-8641360	86	38	28(100.0	28(100.0	NUM
bjos-8641360	86	39	)	)	PUNCT
bjos-8641360	86	40	2(7.2	2(7.2	NUM
bjos-8641360	86	41	)	)	PUNCT
bjos-8641360	86	42	8(28.5	8(28.5	NOUN
bjos-8641360	86	43	)	)	PUNCT
bjos-8641360	86	44	18(64.3	18(64.3	NUM
bjos-8641360	86	45	)	)	PUNCT
bjos-8641360	86	46	28(100.0	28(100.0	NUM
bjos-8641360	86	47	)	)	PUNCT
bjos-8641360	86	48	total	total	ADJ
bjos-8641360	86	49	17(30.3	17(30.3	NUM
bjos-8641360	86	50	)	)	PUNCT
bjos-8641360	86	51	6(10.8	6(10.8	NOUN
bjos-8641360	86	52	)	)	PUNCT
bjos-8641360	86	53	33(58.9	33(58.9	NUM
bjos-8641360	86	54	)	)	PUNCT
bjos-8641360	86	55	56(100.0	56(100.0	NUM
bjos-8641360	86	56	)	)	PUNCT
bjos-8641360	86	57	2(3.6	2(3.6	NUM
bjos-8641360	86	58	)	)	PUNCT
bjos-8641360	86	59	20(35.7	20(35.7	NOUN
bjos-8641360	86	60	)	)	PUNCT
bjos-8641360	86	61	34(60.7	34(60.7	ADJ
bjos-8641360	86	62	)	)	PUNCT
bjos-8641360	86	63	56(100.0	56(100.0	NUM
bjos-8641360	86	64	)	)	PUNCT
bjos-8641360	86	65	p*=0.332	p*=0.332	NOUN
bjos-8641360	86	66	p*=0.413	p*=0.413	ADJ
bjos-8641360	86	67	table	table	NOUN
bjos-8641360	86	68	1distribution	1distribution	NUM
bjos-8641360	86	69	of	of	ADP
bjos-8641360	86	70	frequencies	frequency	NOUN
bjos-8641360	86	71	of	of	ADP
bjos-8641360	86	72	salivary	salivary	ADJ
bjos-8641360	86	73	flow	flow	NOUN
bjos-8641360	86	74	rate	rate	NOUN
bjos-8641360	86	75	and	and	CCONJ
bjos-8641360	86	76	buffering	buffering	NOUN
bjos-8641360	86	77	capacity	capacity	NOUN
bjos-8641360	86	78	diagnosis	diagnosis	NOUN
bjos-8641360	86	79	of	of	ADP
bjos-8641360	86	80	oral	oral	ADJ
bjos-8641360	86	81	manifestations	manifestation	NOUN
bjos-8641360	86	82	in	in	ADP
bjos-8641360	86	83	hiv	hiv	PROPN
bjos-8641360	86	84	/	/	SYM
bjos-8641360	86	85	aids	aids	PROPN
bjos-8641360	86	86	patients	patient	NOUN
bjos-8641360	86	87	who	who	PRON
bjos-8641360	86	88	used	use	VERB
bjos-8641360	86	89	haart	haart	PROPN
bjos-8641360	86	90	and	and	CCONJ
bjos-8641360	86	91	developed	developed	ADJ
bjos-8641360	86	92	diabetes	diabetes	NOUN
bjos-8641360	86	93	mellitus	mellitus	PROPN
bjos-8641360	86	94	braz	braz	PROPN
bjos-8641360	86	95	j	j	PROPN
bjos-8641360	86	96	oral	oral	PROPN
bjos-8641360	86	97	sci	sci	PROPN
bjos-8641360	86	98	.	.	PUNCT
bjos-8641360	87	1	11(3):352	11(3):352	NUM
bjos-8641360	87	2	-	-	SYM
bjos-8641360	87	3	356	356	NUM
bjos-8641360	87	4	355355355355355	355355355355355	NUM
bjos-8641360	87	5	oral	oral	ADJ
bjos-8641360	87	6	manifestations	manifestation	NOUN
bjos-8641360	87	7	in	in	ADP
bjos-8641360	87	8	hiv	hiv	PROPN
bjos-8641360	87	9	were	be	AUX
bjos-8641360	87	10	candidiasis	candidiasis	NOUN
bjos-8641360	87	11	,	,	PUNCT
bjos-8641360	87	12	gun	gun	NOUN
bjos-8641360	87	13	(	(	PUNCT
bjos-8641360	87	14	necrotizing	necrotize	VERB
bjos-8641360	87	15	ulcerative	ulcerative	ADJ
bjos-8641360	87	16	gingivitis	gingivitis	NOUN
bjos-8641360	87	17	)	)	PUNCT
bjos-8641360	87	18	,	,	PUNCT
bjos-8641360	87	19	pun	pun	VERB
bjos-8641360	87	20	(	(	PUNCT
bjos-8641360	87	21	necrotizing	necrotize	VERB
bjos-8641360	87	22	ulcerative	ulcerative	ADJ
bjos-8641360	87	23	periodontitis	periodontitis	NOUN
bjos-8641360	87	24	)	)	PUNCT
bjos-8641360	87	25	,	,	PUNCT
bjos-8641360	87	26	hairy	hairy	ADJ
bjos-8641360	87	27	leukoplakia	leukoplakia	NOUN
bjos-8641360	87	28	,	,	PUNCT
bjos-8641360	87	29	herpes	herpe	NOUN
bjos-8641360	87	30	simplex	simplex	NOUN
bjos-8641360	87	31	,	,	PUNCT
bjos-8641360	87	32	hpv	hpv	X
bjos-8641360	87	33	(	(	PUNCT
bjos-8641360	87	34	human	human	ADJ
bjos-8641360	87	35	papillomavirus	papillomavirus	NOUN
bjos-8641360	87	36	)	)	PUNCT
bjos-8641360	87	37	and	and	CCONJ
bjos-8641360	87	38	kaposi	kaposi	PROPN
bjos-8641360	87	39	’s	’s	PART
bjos-8641360	87	40	sarcoma	sarcoma	NOUN
bjos-8641360	87	41	.	.	PUNCT
bjos-8641360	88	1	in	in	ADP
bjos-8641360	88	2	the	the	DET
bjos-8641360	88	3	control	control	NOUN
bjos-8641360	88	4	group	group	NOUN
bjos-8641360	88	5	,	,	PUNCT
bjos-8641360	88	6	the	the	DET
bjos-8641360	88	7	most	most	ADV
bjos-8641360	88	8	frequent	frequent	ADJ
bjos-8641360	88	9	oral	oral	ADJ
bjos-8641360	88	10	manifestation	manifestation	NOUN
bjos-8641360	88	11	were	be	AUX
bjos-8641360	88	12	caries	carie	NOUN
bjos-8641360	88	13	(	(	PUNCT
bjos-8641360	88	14	39.3	39.3	NUM
bjos-8641360	88	15	%	%	NOUN
bjos-8641360	88	16	)	)	PUNCT
bjos-8641360	88	17	,	,	PUNCT
bjos-8641360	88	18	followed	follow	VERB
bjos-8641360	88	19	by	by	ADP
bjos-8641360	88	20	periodontal	periodontal	ADJ
bjos-8641360	88	21	disease	disease	NOUN
bjos-8641360	88	22	(	(	PUNCT
bjos-8641360	88	23	35.7	35.7	NUM
bjos-8641360	88	24	%	%	NOUN
bjos-8641360	88	25	)	)	PUNCT
bjos-8641360	88	26	,	,	PUNCT
bjos-8641360	88	27	xerostomia	xerostomia	PROPN
bjos-8641360	88	28	(	(	PUNCT
bjos-8641360	88	29	32.1	32.1	NUM
bjos-8641360	88	30	%	%	NOUN
bjos-8641360	88	31	)	)	PUNCT
bjos-8641360	88	32	and	and	CCONJ
bjos-8641360	88	33	radicular	radicular	ADJ
bjos-8641360	88	34	cyst	cyst	NOUN
bjos-8641360	88	35	(	(	PUNCT
bjos-8641360	88	36	3.6	3.6	NUM
bjos-8641360	88	37	%	%	NOUN
bjos-8641360	88	38	)	)	PUNCT
bjos-8641360	88	39	;	;	PUNCT
bjos-8641360	88	40	21.4	21.4	NUM
bjos-8641360	88	41	%	%	NOUN
bjos-8641360	88	42	did	do	AUX
bjos-8641360	88	43	not	not	PART
bjos-8641360	88	44	show	show	VERB
bjos-8641360	88	45	any	any	DET
bjos-8641360	88	46	kind	kind	NOUN
bjos-8641360	88	47	of	of	ADP
bjos-8641360	88	48	utterance	utterance	NOUN
bjos-8641360	88	49	.	.	PUNCT
bjos-8641360	89	1	thus	thus	ADV
bjos-8641360	89	2	,	,	PUNCT
bjos-8641360	89	3	the	the	DET
bjos-8641360	89	4	group	group	NOUN
bjos-8641360	89	5	hiv	hiv	PROPN
bjos-8641360	89	6	had	have	VERB
bjos-8641360	89	7	more	more	ADJ
bjos-8641360	89	8	oral	oral	ADJ
bjos-8641360	89	9	manifestations	manifestation	NOUN
bjos-8641360	89	10	than	than	ADP
bjos-8641360	89	11	the	the	DET
bjos-8641360	89	12	control	control	NOUN
bjos-8641360	89	13	group	group	NOUN
bjos-8641360	89	14	,	,	PUNCT
bjos-8641360	89	15	demonstrating	demonstrate	VERB
bjos-8641360	89	16	the	the	DET
bjos-8641360	89	17	susceptibility	susceptibility	NOUN
bjos-8641360	89	18	of	of	ADP
bjos-8641360	89	19	patients	patient	NOUN
bjos-8641360	89	20	to	to	ADP
bjos-8641360	89	21	opportunistic	opportunistic	ADJ
bjos-8641360	89	22	infections	infection	NOUN
bjos-8641360	89	23	because	because	SCONJ
bjos-8641360	89	24	of	of	ADP
bjos-8641360	89	25	the	the	DET
bjos-8641360	89	26	immunosuppression	immunosuppression	NOUN
bjos-8641360	89	27	of	of	ADP
bjos-8641360	89	28	hiv	hiv	PROPN
bjos-8641360	89	29	-	-	PUNCT
bjos-8641360	89	30	positive	positive	ADJ
bjos-8641360	89	31	individuals	individual	NOUN
bjos-8641360	89	32	.	.	PUNCT
bjos-8641360	90	1	according	accord	VERB
bjos-8641360	90	2	to	to	ADP
bjos-8641360	90	3	de	de	X
bjos-8641360	90	4	wit	wit	PROPN
bjos-8641360	90	5	et	et	PROPN
bjos-8641360	90	6	al	al	PROPN
bjos-8641360	90	7	.	.	PROPN
bjos-8641360	91	1	(	(	PUNCT
bjos-8641360	91	2	2008)6	2008)6	NUM
bjos-8641360	91	3	,	,	PUNCT
bjos-8641360	91	4	with	with	ADP
bjos-8641360	91	5	the	the	DET
bjos-8641360	91	6	use	use	NOUN
bjos-8641360	91	7	of	of	ADP
bjos-8641360	91	8	stavudine	stavudine	NOUN
bjos-8641360	91	9	,	,	PUNCT
bjos-8641360	91	10	the	the	DET
bjos-8641360	91	11	risk	risk	NOUN
bjos-8641360	91	12	of	of	ADP
bjos-8641360	91	13	developing	develop	VERB
bjos-8641360	91	14	diabetes	diabetes	NOUN
bjos-8641360	91	15	was	be	AUX
bjos-8641360	91	16	higher	high	ADJ
bjos-8641360	91	17	,	,	PUNCT
bjos-8641360	91	18	as	as	ADV
bjos-8641360	91	19	well	well	ADV
bjos-8641360	91	20	as	as	ADP
bjos-8641360	91	21	the	the	DET
bjos-8641360	91	22	use	use	NOUN
bjos-8641360	91	23	of	of	ADP
bjos-8641360	91	24	zidovudine	zidovudine	PROPN
bjos-8641360	91	25	and	and	CCONJ
bjos-8641360	91	26	didanosine	didanosine	PROPN
bjos-8641360	91	27	,	,	PUNCT
bjos-8641360	91	28	disagreeing	disagree	VERB
bjos-8641360	91	29	with	with	ADP
bjos-8641360	91	30	this	this	DET
bjos-8641360	91	31	research	research	NOUN
bjos-8641360	91	32	,	,	PUNCT
bjos-8641360	91	33	which	which	PRON
bjos-8641360	91	34	revealed	reveal	VERB
bjos-8641360	91	35	that	that	SCONJ
bjos-8641360	91	36	the	the	DET
bjos-8641360	91	37	highest	high	ADJ
bjos-8641360	91	38	risk	risk	NOUN
bjos-8641360	91	39	of	of	ADP
bjos-8641360	91	40	developing	develop	VERB
bjos-8641360	91	41	diabetes	diabetes	NOUN
bjos-8641360	91	42	comes	come	VERB
bjos-8641360	91	43	with	with	ADP
bjos-8641360	91	44	prolonged	prolonged	ADJ
bjos-8641360	91	45	use	use	NOUN
bjos-8641360	91	46	of	of	ADP
bjos-8641360	91	47	combivir	combivir	NOUN
bjos-8641360	91	48	(	(	PUNCT
bjos-8641360	91	49	71.4	71.4	NUM
bjos-8641360	91	50	%	%	NOUN
bjos-8641360	91	51	)	)	PUNCT
bjos-8641360	91	52	and	and	CCONJ
bjos-8641360	91	53	efavirenz	efavirenz	NOUN
bjos-8641360	91	54	(	(	PUNCT
bjos-8641360	91	55	53.6	53.6	NUM
bjos-8641360	91	56	%	%	NOUN
bjos-8641360	91	57	)	)	PUNCT
bjos-8641360	91	58	.	.	PUNCT
bjos-8641360	92	1	it	it	PRON
bjos-8641360	92	2	was	be	AUX
bjos-8641360	92	3	also	also	ADV
bjos-8641360	92	4	observed	observe	VERB
bjos-8641360	92	5	in	in	ADP
bjos-8641360	92	6	this	this	DET
bjos-8641360	92	7	study	study	NOUN
bjos-8641360	92	8	that	that	SCONJ
bjos-8641360	92	9	the	the	DET
bjos-8641360	92	10	use	use	NOUN
bjos-8641360	92	11	of	of	ADP
bjos-8641360	92	12	zalcitabine	zalcitabine	NOUN
bjos-8641360	92	13	(	(	PUNCT
bjos-8641360	92	14	3.6	3.6	NUM
bjos-8641360	92	15	%	%	NOUN
bjos-8641360	92	16	)	)	PUNCT
bjos-8641360	92	17	and	and	CCONJ
bjos-8641360	92	18	didanosine	didanosine	VERB
bjos-8641360	92	19	(	(	PUNCT
bjos-8641360	92	20	3.6	3.6	NUM
bjos-8641360	92	21	%	%	NOUN
bjos-8641360	92	22	)	)	PUNCT
bjos-8641360	92	23	was	be	AUX
bjos-8641360	92	24	associated	associate	VERB
bjos-8641360	92	25	with	with	ADP
bjos-8641360	92	26	low	low	ADJ
bjos-8641360	92	27	risk	risk	NOUN
bjos-8641360	92	28	for	for	ADP
bjos-8641360	92	29	developing	develop	VERB
bjos-8641360	92	30	diabetes	diabete	NOUN
bjos-8641360	92	31	.	.	PUNCT
bjos-8641360	93	1	among	among	ADP
bjos-8641360	93	2	the	the	DET
bjos-8641360	93	3	most	most	ADV
bjos-8641360	93	4	common	common	ADJ
bjos-8641360	93	5	manifestations	manifestation	NOUN
bjos-8641360	93	6	observed	observe	VERB
bjos-8641360	93	7	in	in	ADP
bjos-8641360	93	8	patients	patient	NOUN
bjos-8641360	93	9	with	with	ADP
bjos-8641360	93	10	diabetes	diabetes	NOUN
bjos-8641360	93	11	are	be	AUX
bjos-8641360	93	12	xerostomia	xerostomia	NOUN
bjos-8641360	93	13	,	,	PUNCT
bjos-8641360	93	14	caries	carie	NOUN
bjos-8641360	93	15	and	and	CCONJ
bjos-8641360	93	16	periodontal	periodontal	ADJ
bjos-8641360	93	17	disease29	disease29	NOUN
bjos-8641360	93	18	,	,	PUNCT
bjos-8641360	93	19	in	in	ADP
bjos-8641360	93	20	agreement	agreement	NOUN
bjos-8641360	93	21	with	with	ADP
bjos-8641360	93	22	our	our	PRON
bjos-8641360	93	23	research	research	NOUN
bjos-8641360	93	24	,	,	PUNCT
bjos-8641360	93	25	which	which	PRON
bjos-8641360	93	26	revealed	reveal	VERB
bjos-8641360	93	27	that	that	SCONJ
bjos-8641360	93	28	these	these	DET
bjos-8641360	93	29	diseases	disease	NOUN
bjos-8641360	93	30	were	be	AUX
bjos-8641360	93	31	most	most	ADV
bjos-8641360	93	32	prevalent	prevalent	ADJ
bjos-8641360	93	33	in	in	ADP
bjos-8641360	93	34	the	the	DET
bjos-8641360	93	35	control	control	NOUN
bjos-8641360	93	36	group	group	NOUN
bjos-8641360	93	37	(	(	PUNCT
bjos-8641360	93	38	39.3	39.3	NUM
bjos-8641360	93	39	%	%	NOUN
bjos-8641360	93	40	for	for	ADP
bjos-8641360	93	41	caries	carie	NOUN
bjos-8641360	93	42	,	,	PUNCT
bjos-8641360	93	43	35.7	35.7	NUM
bjos-8641360	93	44	%	%	NOUN
bjos-8641360	93	45	for	for	ADP
bjos-8641360	93	46	periodontal	periodontal	ADJ
bjos-8641360	93	47	disease	disease	NOUN
bjos-8641360	93	48	and	and	CCONJ
bjos-8641360	93	49	32.1	32.1	NUM
bjos-8641360	93	50	%	%	NOUN
bjos-8641360	93	51	for	for	ADP
bjos-8641360	93	52	xerostomia	xerostomia	NOUN
bjos-8641360	93	53	)	)	PUNCT
bjos-8641360	93	54	.	.	PUNCT
bjos-8641360	94	1	for	for	ADP
bjos-8641360	94	2	the	the	DET
bjos-8641360	94	3	analysis	analysis	NOUN
bjos-8641360	94	4	of	of	ADP
bjos-8641360	94	5	dmft	dmft	ADJ
bjos-8641360	94	6	index	index	NOUN
bjos-8641360	94	7	in	in	ADP
bjos-8641360	94	8	our	our	PRON
bjos-8641360	94	9	sample	sample	NOUN
bjos-8641360	94	10	,	,	PUNCT
bjos-8641360	94	11	it	it	PRON
bjos-8641360	94	12	was	be	AUX
bjos-8641360	94	13	found	find	VERB
bjos-8641360	94	14	a	a	DET
bjos-8641360	94	15	statistically	statistically	ADV
bjos-8641360	94	16	significant	significant	ADJ
bjos-8641360	94	17	difference	difference	NOUN
bjos-8641360	94	18	(	(	PUNCT
bjos-8641360	94	19	p	p	NOUN
bjos-8641360	94	20	=	=	NOUN
bjos-8641360	94	21	0.019	0.019	NUM
bjos-8641360	94	22	)	)	PUNCT
bjos-8641360	94	23	between	between	ADP
bjos-8641360	94	24	groups	group	NOUN
bjos-8641360	94	25	.	.	PUNCT
bjos-8641360	95	1	for	for	ADP
bjos-8641360	95	2	the	the	DET
bjos-8641360	95	3	control	control	NOUN
bjos-8641360	95	4	group	group	NOUN
bjos-8641360	95	5	,	,	PUNCT
bjos-8641360	95	6	the	the	DET
bjos-8641360	95	7	mean	mean	NOUN
bjos-8641360	95	8	was	be	AUX
bjos-8641360	95	9	22	22	NUM
bjos-8641360	95	10	for	for	ADP
bjos-8641360	95	11	each	each	DET
bjos-8641360	95	12	patient	patient	NOUN
bjos-8641360	95	13	and	and	CCONJ
bjos-8641360	95	14	for	for	ADP
bjos-8641360	95	15	the	the	DET
bjos-8641360	95	16	hiv	hiv	PROPN
bjos-8641360	95	17	group	group	NOUN
bjos-8641360	95	18	,	,	PUNCT
bjos-8641360	95	19	the	the	DET
bjos-8641360	95	20	mean	mean	NOUN
bjos-8641360	95	21	was	be	AUX
bjos-8641360	95	22	17	17	NUM
bjos-8641360	95	23	for	for	ADP
bjos-8641360	95	24	each	each	DET
bjos-8641360	95	25	patient	patient	NOUN
bjos-8641360	95	26	.	.	PUNCT
bjos-8641360	96	1	in	in	ADP
bjos-8641360	96	2	addition	addition	NOUN
bjos-8641360	96	3	to	to	ADP
bjos-8641360	96	4	the	the	DET
bjos-8641360	96	5	high	high	ADJ
bjos-8641360	96	6	dmft	dmft	PROPN
bjos-8641360	96	7	presented	present	VERB
bjos-8641360	96	8	index	index	NOUN
bjos-8641360	96	9	,	,	PUNCT
bjos-8641360	96	10	the	the	DET
bjos-8641360	96	11	groups	group	NOUN
bjos-8641360	96	12	also	also	ADV
bjos-8641360	96	13	had	have	VERB
bjos-8641360	96	14	high	high	ADJ
bjos-8641360	96	15	plaque	plaque	NOUN
bjos-8641360	96	16	index	index	NOUN
bjos-8641360	96	17	.	.	PUNCT
bjos-8641360	97	1	the	the	DET
bjos-8641360	97	2	control	control	PROPN
bjos-8641360	97	3	group	group	NOUN
bjos-8641360	97	4	had	have	VERB
bjos-8641360	97	5	a	a	DET
bjos-8641360	97	6	mean	mean	NOUN
bjos-8641360	97	7	of	of	ADP
bjos-8641360	97	8	49	49	NUM
bjos-8641360	97	9	%	%	NOUN
bjos-8641360	97	10	and	and	CCONJ
bjos-8641360	97	11	54	54	NUM
bjos-8641360	97	12	%	%	NOUN
bjos-8641360	97	13	hiv	hiv	PROPN
bjos-8641360	97	14	group	group	NOUN
bjos-8641360	97	15	,	,	PUNCT
bjos-8641360	97	16	which	which	PRON
bjos-8641360	97	17	indicates	indicate	VERB
bjos-8641360	97	18	that	that	SCONJ
bjos-8641360	97	19	the	the	DET
bjos-8641360	97	20	control	control	NOUN
bjos-8641360	97	21	group	group	NOUN
bjos-8641360	97	22	is	be	AUX
bjos-8641360	97	23	more	more	ADV
bjos-8641360	97	24	prone	prone	ADJ
bjos-8641360	97	25	to	to	ADP
bjos-8641360	97	26	a	a	DET
bjos-8641360	97	27	higher	high	ADJ
bjos-8641360	97	28	prevalence	prevalence	NOUN
bjos-8641360	97	29	of	of	ADP
bjos-8641360	97	30	caries	carie	NOUN
bjos-8641360	97	31	due	due	ADJ
bjos-8641360	97	32	to	to	ADP
bjos-8641360	97	33	poor	poor	ADJ
bjos-8641360	97	34	hygiene	hygiene	NOUN
bjos-8641360	97	35	,	,	PUNCT
bjos-8641360	97	36	the	the	DET
bjos-8641360	97	37	possible	possible	ADJ
bjos-8641360	97	38	intake	intake	NOUN
bjos-8641360	97	39	of	of	ADP
bjos-8641360	97	40	foods	food	NOUN
bjos-8641360	97	41	rich	rich	ADJ
bjos-8641360	97	42	in	in	ADP
bjos-8641360	97	43	sucrose	sucrose	PROPN
bjos-8641360	97	44	,	,	PUNCT
bjos-8641360	97	45	presence	presence	NOUN
bjos-8641360	97	46	of	of	ADP
bjos-8641360	97	47	cariogenic	cariogenic	ADJ
bjos-8641360	97	48	bacteria	bacteria	NOUN
bjos-8641360	97	49	and	and	CCONJ
bjos-8641360	97	50	even	even	ADV
bjos-8641360	97	51	the	the	DET
bjos-8641360	97	52	longest	long	ADJ
bjos-8641360	97	53	living	living	NOUN
bjos-8641360	97	54	with	with	ADP
bjos-8641360	97	55	the	the	DET
bjos-8641360	97	56	disease	disease	NOUN
bjos-8641360	97	57	diabetes	diabetes	NOUN
bjos-8641360	97	58	than	than	ADP
bjos-8641360	97	59	the	the	DET
bjos-8641360	97	60	patients	patient	NOUN
bjos-8641360	97	61	who	who	PRON
bjos-8641360	97	62	developed	develop	VERB
bjos-8641360	97	63	diabetes	diabetes	NOUN
bjos-8641360	97	64	due	due	ADJ
bjos-8641360	97	65	to	to	ADP
bjos-8641360	97	66	adverse	adverse	ADJ
bjos-8641360	97	67	effects	effect	NOUN
bjos-8641360	97	68	of	of	ADP
bjos-8641360	97	69	haart	haart	PROPN
bjos-8641360	97	70	.	.	PUNCT
bjos-8641360	98	1	so	so	ADV
bjos-8641360	98	2	,	,	PUNCT
bjos-8641360	98	3	patients	patient	NOUN
bjos-8641360	98	4	should	should	AUX
bjos-8641360	98	5	be	be	AUX
bjos-8641360	98	6	counseled	counsel	VERB
bjos-8641360	98	7	about	about	ADP
bjos-8641360	98	8	oral	oral	ADJ
bjos-8641360	98	9	hygiene	hygiene	NOUN
bjos-8641360	98	10	and	and	CCONJ
bjos-8641360	98	11	should	should	AUX
bjos-8641360	98	12	maintain	maintain	VERB
bjos-8641360	98	13	regularity	regularity	NOUN
bjos-8641360	98	14	in	in	ADP
bjos-8641360	98	15	the	the	DET
bjos-8641360	98	16	treatments	treatment	NOUN
bjos-8641360	98	17	and	and	CCONJ
bjos-8641360	98	18	have	have	VERB
bjos-8641360	98	19	a	a	DET
bjos-8641360	98	20	lowsucrose	lowsucrose	NOUN
bjos-8641360	98	21	diet	diet	NOUN
bjos-8641360	98	22	.	.	PUNCT
bjos-8641360	99	1	thus	thus	ADV
bjos-8641360	99	2	,	,	PUNCT
bjos-8641360	99	3	oral	oral	ADJ
bjos-8641360	99	4	pathologies	pathology	NOUN
bjos-8641360	99	5	can	can	AUX
bjos-8641360	99	6	be	be	AUX
bjos-8641360	99	7	minimized	minimize	VERB
bjos-8641360	99	8	by	by	ADP
bjos-8641360	99	9	maintaining	maintain	VERB
bjos-8641360	99	10	the	the	DET
bjos-8641360	99	11	oral	oral	ADJ
bjos-8641360	99	12	health	health	NOUN
bjos-8641360	99	13	of	of	ADP
bjos-8641360	99	14	patients	patient	NOUN
bjos-8641360	99	15	.	.	PUNCT
bjos-8641360	100	1	the	the	DET
bjos-8641360	100	2	buffering	buffering	NOUN
bjos-8641360	100	3	capacity	capacity	NOUN
bjos-8641360	100	4	was	be	AUX
bjos-8641360	100	5	also	also	ADV
bjos-8641360	100	6	evaluated	evaluate	VERB
bjos-8641360	100	7	and	and	CCONJ
bjos-8641360	100	8	represented	represent	VERB
bjos-8641360	100	9	as	as	SCONJ
bjos-8641360	100	10	follows	follow	VERB
bjos-8641360	100	11	:	:	PUNCT
bjos-8641360	100	12	low	low	ADJ
bjos-8641360	100	13	(	(	PUNCT
bjos-8641360	100	14	ph<4.5	ph<4.5	PROPN
bjos-8641360	100	15	)	)	PUNCT
bjos-8641360	100	16	,	,	PUNCT
bjos-8641360	100	17	intermediate	intermediate	ADJ
bjos-8641360	100	18	(	(	PUNCT
bjos-8641360	100	19	ph	ph	NOUN
bjos-8641360	100	20	between	between	ADP
bjos-8641360	100	21	4.5	4.5	NUM
bjos-8641360	100	22	and	and	CCONJ
bjos-8641360	100	23	5.5	5.5	NUM
bjos-8641360	100	24	)	)	PUNCT
bjos-8641360	100	25	and	and	CCONJ
bjos-8641360	100	26	normal	normal	ADJ
bjos-8641360	100	27	(	(	PUNCT
bjos-8641360	100	28	ph>5.5	ph>5.5	NOUN
bjos-8641360	100	29	)	)	PUNCT
bjos-8641360	100	30	.	.	PUNCT
bjos-8641360	101	1	in	in	ADP
bjos-8641360	101	2	the	the	DET
bjos-8641360	101	3	control	control	NOUN
bjos-8641360	101	4	group	group	NOUN
bjos-8641360	101	5	,	,	PUNCT
bjos-8641360	101	6	60.7	60.7	NUM
bjos-8641360	101	7	%	%	NOUN
bjos-8641360	101	8	patients	patient	NOUN
bjos-8641360	101	9	had	have	VERB
bjos-8641360	101	10	normal	normal	ADJ
bjos-8641360	101	11	buffering	buffering	NOUN
bjos-8641360	101	12	capacity	capacity	NOUN
bjos-8641360	101	13	,	,	PUNCT
bjos-8641360	101	14	39.3	39.3	NUM
bjos-8641360	101	15	%	%	NOUN
bjos-8641360	101	16	had	have	VERB
bjos-8641360	101	17	intermediate	intermediate	ADJ
bjos-8641360	101	18	buffering	buffering	NOUN
bjos-8641360	101	19	capacity	capacity	NOUN
bjos-8641360	101	20	and	and	CCONJ
bjos-8641360	101	21	no	no	DET
bjos-8641360	101	22	patient	patient	NOUN
bjos-8641360	101	23	had	have	VERB
bjos-8641360	101	24	low	low	ADJ
bjos-8641360	101	25	buffering	buffering	NOUN
bjos-8641360	101	26	capacity	capacity	NOUN
bjos-8641360	101	27	.	.	PUNCT
bjos-8641360	102	1	in	in	ADP
bjos-8641360	102	2	the	the	DET
bjos-8641360	102	3	hiv	hiv	PROPN
bjos-8641360	102	4	group	group	NOUN
bjos-8641360	102	5	,	,	PUNCT
bjos-8641360	102	6	64.3	64.3	NUM
bjos-8641360	102	7	%	%	NOUN
bjos-8641360	102	8	patients	patient	NOUN
bjos-8641360	102	9	had	have	VERB
bjos-8641360	102	10	normal	normal	ADJ
bjos-8641360	102	11	buffering	buffering	NOUN
bjos-8641360	102	12	capacity	capacity	NOUN
bjos-8641360	102	13	,	,	PUNCT
bjos-8641360	102	14	28.5	28.5	NUM
bjos-8641360	102	15	%	%	NOUN
bjos-8641360	102	16	intermediate	intermediate	ADJ
bjos-8641360	102	17	buffering	buffering	NOUN
bjos-8641360	102	18	capacity	capacity	NOUN
bjos-8641360	102	19	and	and	CCONJ
bjos-8641360	102	20	7.2	7.2	NUM
bjos-8641360	102	21	%	%	NOUN
bjos-8641360	102	22	low	low	ADJ
bjos-8641360	102	23	buffering	buffering	NOUN
bjos-8641360	102	24	capacity	capacity	NOUN
bjos-8641360	102	25	.	.	PUNCT
bjos-8641360	103	1	these	these	DET
bjos-8641360	103	2	results	result	NOUN
bjos-8641360	103	3	show	show	VERB
bjos-8641360	103	4	that	that	SCONJ
bjos-8641360	103	5	the	the	DET
bjos-8641360	103	6	control	control	NOUN
bjos-8641360	103	7	group	group	NOUN
bjos-8641360	103	8	had	have	VERB
bjos-8641360	103	9	better	well	ADJ
bjos-8641360	103	10	buffering	buffering	NOUN
bjos-8641360	103	11	capacity	capacity	NOUN
bjos-8641360	103	12	of	of	ADP
bjos-8641360	103	13	saliva	saliva	NOUN
bjos-8641360	103	14	than	than	ADP
bjos-8641360	103	15	the	the	DET
bjos-8641360	103	16	hiv	hiv	PROPN
bjos-8641360	103	17	group	group	NOUN
bjos-8641360	103	18	,	,	PUNCT
bjos-8641360	103	19	which	which	PRON
bjos-8641360	103	20	is	be	AUX
bjos-8641360	103	21	the	the	DET
bjos-8641360	103	22	capacity	capacity	NOUN
bjos-8641360	103	23	of	of	ADP
bjos-8641360	103	24	saliva	saliva	NOUN
bjos-8641360	103	25	to	to	PART
bjos-8641360	103	26	maintain	maintain	VERB
bjos-8641360	103	27	the	the	DET
bjos-8641360	103	28	a	a	DET
bjos-8641360	103	29	constant	constant	ADJ
bjos-8641360	103	30	ph	ph	NOUN
bjos-8641360	103	31	in	in	ADP
bjos-8641360	103	32	the	the	DET
bjos-8641360	103	33	oral	oral	ADJ
bjos-8641360	103	34	cavity	cavity	NOUN
bjos-8641360	103	35	,	,	PUNCT
bjos-8641360	103	36	thus	thus	ADV
bjos-8641360	103	37	maintaining	maintain	VERB
bjos-8641360	103	38	the	the	DET
bjos-8641360	103	39	health	health	NOUN
bjos-8641360	103	40	of	of	ADP
bjos-8641360	103	41	the	the	DET
bjos-8641360	103	42	oral	oral	ADJ
bjos-8641360	103	43	mucosa	mucosa	NOUN
bjos-8641360	103	44	and	and	CCONJ
bjos-8641360	103	45	teeth	tooth	NOUN
bjos-8641360	103	46	,	,	PUNCT
bjos-8641360	103	47	unlike	unlike	ADP
bjos-8641360	103	48	the	the	DET
bjos-8641360	103	49	two	two	NUM
bjos-8641360	103	50	patients	patient	NOUN
bjos-8641360	103	51	of	of	ADP
bjos-8641360	103	52	the	the	DET
bjos-8641360	103	53	hiv	hiv	PROPN
bjos-8641360	103	54	group	group	NOUN
bjos-8641360	103	55	who	who	PRON
bjos-8641360	103	56	had	have	VERB
bjos-8641360	103	57	low	low	ADJ
bjos-8641360	103	58	buffer	buffer	NOUN
bjos-8641360	103	59	capacity	capacity	NOUN
bjos-8641360	103	60	.	.	PUNCT
bjos-8641360	104	1	if	if	SCONJ
bjos-8641360	104	2	the	the	DET
bjos-8641360	104	3	buffering	buffering	NOUN
bjos-8641360	104	4	capacity	capacity	NOUN
bjos-8641360	104	5	is	be	AUX
bjos-8641360	104	6	low	low	ADJ
bjos-8641360	104	7	,	,	PUNCT
bjos-8641360	104	8	the	the	DET
bjos-8641360	104	9	ph	ph	NOUN
bjos-8641360	104	10	is	be	AUX
bjos-8641360	104	11	not	not	PART
bjos-8641360	104	12	constant	constant	ADJ
bjos-8641360	104	13	and	and	CCONJ
bjos-8641360	104	14	the	the	DET
bjos-8641360	104	15	action	action	NOUN
bjos-8641360	104	16	of	of	ADP
bjos-8641360	104	17	saliva	saliva	NOUN
bjos-8641360	104	18	against	against	ADP
bjos-8641360	104	19	acid	acid	NOUN
bjos-8641360	104	20	attacks	attack	NOUN
bjos-8641360	104	21	to	to	ADP
bjos-8641360	104	22	the	the	DET
bjos-8641360	104	23	oral	oral	ADJ
bjos-8641360	104	24	cavity	cavity	NOUN
bjos-8641360	104	25	becomes	become	VERB
bjos-8641360	104	26	ineffective	ineffective	ADJ
bjos-8641360	104	27	,	,	PUNCT
bjos-8641360	104	28	making	make	VERB
bjos-8641360	104	29	these	these	DET
bjos-8641360	104	30	patients	patient	NOUN
bjos-8641360	104	31	more	more	ADV
bjos-8641360	104	32	susceptible	susceptible	ADJ
bjos-8641360	104	33	to	to	ADP
bjos-8641360	104	34	oral	oral	ADJ
bjos-8641360	104	35	pathologies	pathology	NOUN
bjos-8641360	104	36	.	.	PUNCT
bjos-8641360	105	1	in	in	ADP
bjos-8641360	105	2	the	the	DET
bjos-8641360	105	3	present	present	ADJ
bjos-8641360	105	4	study	study	NOUN
bjos-8641360	105	5	,	,	PUNCT
bjos-8641360	105	6	the	the	DET
bjos-8641360	105	7	bleeding	bleed	VERB
bjos-8641360	105	8	index	index	NOUN
bjos-8641360	105	9	score	score	NOUN
bjos-8641360	105	10	was	be	AUX
bjos-8641360	105	11	determined	determine	VERB
bjos-8641360	105	12	by	by	ADP
bjos-8641360	105	13	a	a	DET
bjos-8641360	105	14	dichotomous	dichotomous	ADJ
bjos-8641360	105	15	count	count	NOUN
bjos-8641360	105	16	,	,	PUNCT
bjos-8641360	105	17	marking	mark	VERB
bjos-8641360	105	18	the	the	DET
bjos-8641360	105	19	presence	presence	NOUN
bjos-8641360	105	20	or	or	CCONJ
bjos-8641360	105	21	absence	absence	NOUN
bjos-8641360	105	22	of	of	ADP
bjos-8641360	105	23	bleeding	bleed	VERB
bjos-8641360	105	24	.	.	PUNCT
bjos-8641360	106	1	significant	significant	ADJ
bjos-8641360	106	2	differences	difference	NOUN
bjos-8641360	106	3	(	(	PUNCT
bjos-8641360	106	4	p	p	NOUN
bjos-8641360	106	5	=	=	NOUN
bjos-8641360	106	6	0.017	0.017	NUM
bjos-8641360	106	7	)	)	PUNCT
bjos-8641360	106	8	were	be	AUX
bjos-8641360	106	9	found	find	VERB
bjos-8641360	106	10	between	between	ADP
bjos-8641360	106	11	groups	group	NOUN
bjos-8641360	106	12	.	.	PUNCT
bjos-8641360	107	1	in	in	ADP
bjos-8641360	107	2	the	the	DET
bjos-8641360	107	3	control	control	NOUN
bjos-8641360	107	4	group	group	NOUN
bjos-8641360	107	5	,	,	PUNCT
bjos-8641360	107	6	the	the	DET
bjos-8641360	107	7	mean	mean	NOUN
bjos-8641360	107	8	of	of	ADP
bjos-8641360	107	9	bleeding	bleed	VERB
bjos-8641360	107	10	tooth	tooth	NOUN
bjos-8641360	107	11	surfaces	surface	NOUN
bjos-8641360	107	12	was	be	AUX
bjos-8641360	107	13	32	32	NUM
bjos-8641360	107	14	%	%	NOUN
bjos-8641360	107	15	and	and	CCONJ
bjos-8641360	107	16	46	46	NUM
bjos-8641360	107	17	%	%	NOUN
bjos-8641360	107	18	in	in	ADP
bjos-8641360	107	19	the	the	DET
bjos-8641360	107	20	control	control	NOUN
bjos-8641360	107	21	and	and	CCONJ
bjos-8641360	107	22	hiv	hiv	PROPN
bjos-8641360	107	23	group	group	NOUN
bjos-8641360	107	24	,	,	PUNCT
bjos-8641360	107	25	respectively	respectively	ADV
bjos-8641360	107	26	.	.	PUNCT
bjos-8641360	108	1	the	the	DET
bjos-8641360	108	2	hiv	hiv	PROPN
bjos-8641360	108	3	group	group	NOUN
bjos-8641360	108	4	showed	show	VERB
bjos-8641360	108	5	higher	high	ADJ
bjos-8641360	108	6	bleeding	bleeding	NOUN
bjos-8641360	108	7	index	index	NOUN
bjos-8641360	108	8	than	than	ADP
bjos-8641360	108	9	the	the	DET
bjos-8641360	108	10	control	control	NOUN
bjos-8641360	108	11	group	group	NOUN
bjos-8641360	108	12	,	,	PUNCT
bjos-8641360	108	13	and	and	CCONJ
bjos-8641360	108	14	also	also	ADV
bjos-8641360	108	15	higher	high	ADJ
bjos-8641360	108	16	prevalence	prevalence	NOUN
bjos-8641360	108	17	of	of	ADP
bjos-8641360	108	18	periodontal	periodontal	ADJ
bjos-8641360	108	19	diseases	disease	NOUN
bjos-8641360	108	20	,	,	PUNCT
bjos-8641360	108	21	with	with	ADP
bjos-8641360	108	22	the	the	DET
bjos-8641360	108	23	formation	formation	NOUN
bjos-8641360	108	24	of	of	ADP
bjos-8641360	108	25	periodontal	periodontal	ADJ
bjos-8641360	108	26	pockets	pocket	NOUN
bjos-8641360	108	27	with	with	ADP
bjos-8641360	108	28	faster	fast	ADJ
bjos-8641360	108	29	evolution	evolution	NOUN
bjos-8641360	108	30	,	,	PUNCT
bjos-8641360	108	31	which	which	PRON
bjos-8641360	108	32	may	may	AUX
bjos-8641360	108	33	be	be	AUX
bjos-8641360	108	34	caused	cause	VERB
bjos-8641360	108	35	by	by	ADP
bjos-8641360	108	36	the	the	DET
bjos-8641360	108	37	body	body	NOUN
bjos-8641360	108	38	’s	’s	PART
bjos-8641360	108	39	own	own	ADJ
bjos-8641360	108	40	immunosuppression	immunosuppression	NOUN
bjos-8641360	108	41	by	by	ADP
bjos-8641360	108	42	hiv	hiv	PROPN
bjos-8641360	108	43	or	or	CCONJ
bjos-8641360	108	44	even	even	ADV
bjos-8641360	108	45	haart	haart	PROPN
bjos-8641360	108	46	.	.	PUNCT
bjos-8641360	109	1	the	the	DET
bjos-8641360	109	2	hiv	hiv	PROPN
bjos-8641360	109	3	group	group	NOUN
bjos-8641360	109	4	and	and	CCONJ
bjos-8641360	109	5	the	the	DET
bjos-8641360	109	6	control	control	NOUN
bjos-8641360	109	7	group	group	NOUN
bjos-8641360	109	8	were	be	AUX
bjos-8641360	109	9	diagnosed	diagnose	VERB
bjos-8641360	109	10	with	with	ADP
bjos-8641360	109	11	diabetes	diabetes	NOUN
bjos-8641360	109	12	,	,	PUNCT
bjos-8641360	109	13	but	but	CCONJ
bjos-8641360	109	14	this	this	DET
bjos-8641360	109	15	condition	condition	NOUN
bjos-8641360	109	16	in	in	ADP
bjos-8641360	109	17	the	the	DET
bjos-8641360	109	18	hiv	hiv	PROPN
bjos-8641360	109	19	group	group	NOUN
bjos-8641360	109	20	presented	present	VERB
bjos-8641360	109	21	earlier	early	ADV
bjos-8641360	109	22	than	than	ADP
bjos-8641360	109	23	in	in	ADP
bjos-8641360	109	24	the	the	DET
bjos-8641360	109	25	control	control	NOUN
bjos-8641360	109	26	group	group	NOUN
bjos-8641360	109	27	,	,	PUNCT
bjos-8641360	109	28	suggesting	suggest	VERB
bjos-8641360	109	29	a	a	DET
bjos-8641360	109	30	possible	possible	ADJ
bjos-8641360	109	31	association	association	NOUN
bjos-8641360	109	32	with	with	ADP
bjos-8641360	109	33	haart	haart	PROPN
bjos-8641360	109	34	.	.	PUNCT
bjos-8641360	110	1	there	there	PRON
bjos-8641360	110	2	is	be	VERB
bjos-8641360	110	3	an	an	DET
bjos-8641360	110	4	increased	increased	ADJ
bjos-8641360	110	5	prevalence	prevalence	NOUN
bjos-8641360	110	6	of	of	ADP
bjos-8641360	110	7	oral	oral	ADJ
bjos-8641360	110	8	manifestations	manifestation	NOUN
bjos-8641360	110	9	in	in	ADP
bjos-8641360	110	10	immunocompromised	immunocompromise	VERB
bjos-8641360	110	11	patients	patient	NOUN
bjos-8641360	110	12	and	and	CCONJ
bjos-8641360	110	13	general	general	ADJ
bjos-8641360	110	14	.	.	PUNCT
bjos-8641360	111	1	the	the	DET
bjos-8641360	111	2	study	study	NOUN
bjos-8641360	111	3	showed	show	VERB
bjos-8641360	111	4	a	a	DET
bjos-8641360	111	5	correlation	correlation	NOUN
bjos-8641360	111	6	between	between	ADP
bjos-8641360	111	7	the	the	DET
bjos-8641360	111	8	administration	administration	NOUN
bjos-8641360	111	9	of	of	ADP
bjos-8641360	111	10	haart	haart	PROPN
bjos-8641360	111	11	with	with	ADP
bjos-8641360	111	12	the	the	DET
bjos-8641360	111	13	development	development	NOUN
bjos-8641360	111	14	of	of	ADP
bjos-8641360	111	15	diabetes	diabetes	NOUN
bjos-8641360	111	16	mellitus	mellitus	NOUN
bjos-8641360	111	17	,	,	PUNCT
bjos-8641360	111	18	as	as	ADV
bjos-8641360	111	19	well	well	ADV
bjos-8641360	111	20	as	as	ADP
bjos-8641360	111	21	a	a	DET
bjos-8641360	111	22	increased	increase	VERB
bjos-8641360	111	23	prevalence	prevalence	NOUN
bjos-8641360	111	24	of	of	ADP
bjos-8641360	111	25	oral	oral	ADJ
bjos-8641360	111	26	manifestations	manifestation	NOUN
bjos-8641360	111	27	,	,	PUNCT
bjos-8641360	111	28	suggesting	suggest	VERB
bjos-8641360	111	29	a	a	DET
bjos-8641360	111	30	more	more	ADV
bjos-8641360	111	31	pronounced	pronounced	ADJ
bjos-8641360	111	32	worsening	worsen	VERB
bjos-8641360	111	33	immunosuppression	immunosuppression	NOUN
bjos-8641360	111	34	in	in	ADP
bjos-8641360	111	35	these	these	DET
bjos-8641360	111	36	patients	patient	NOUN
bjos-8641360	111	37	.	.	PUNCT
bjos-8641360	112	1	table	table	NOUN
bjos-8641360	112	2	3	3	NUM
bjos-8641360	112	3	joint	joint	ADJ
bjos-8641360	112	4	frequency	frequency	NOUN
bjos-8641360	112	5	distribution	distribution	NOUN
bjos-8641360	112	6	for	for	ADP
bjos-8641360	112	7	oral	oral	ADJ
bjos-8641360	112	8	manifestations	manifestation	NOUN
bjos-8641360	112	9	(	(	PUNCT
bjos-8641360	112	10	1	1	X
bjos-8641360	112	11	)	)	PUNCT
bjos-8641360	112	12	descriptive	descriptive	ADJ
bjos-8641360	112	13	level	level	NOUN
bjos-8641360	112	14	of	of	ADP
bjos-8641360	112	15	probability	probability	NOUN
bjos-8641360	112	16	of	of	ADP
bjos-8641360	112	17	the	the	DET
bjos-8641360	112	18	chi	chi	ADJ
bjos-8641360	112	19	-	-	PUNCT
bjos-8641360	112	20	square	square	ADJ
bjos-8641360	112	21	test	test	NOUN
bjos-8641360	112	22	.	.	PUNCT
bjos-8641360	113	1	(	(	PUNCT
bjos-8641360	113	2	2	2	X
bjos-8641360	113	3	)	)	PUNCT
bjos-8641360	113	4	descriptive	descriptive	ADJ
bjos-8641360	113	5	level	level	NOUN
bjos-8641360	113	6	of	of	ADP
bjos-8641360	113	7	probability	probability	NOUN
bjos-8641360	113	8	of	of	ADP
bjos-8641360	113	9	fisher	fisher	PROPN
bjos-8641360	113	10	’s	’s	PART
bjos-8641360	113	11	exact	exact	ADJ
bjos-8641360	113	12	test	test	NOUN
bjos-8641360	113	13	.	.	PUNCT
bjos-8641360	114	1	oral	oral	ADJ
bjos-8641360	114	2	manifestations	manifestation	NOUN
bjos-8641360	114	3	control	control	NOUN
bjos-8641360	115	1	%	%	INTJ
bjos-8641360	115	2	hiv	hiv	INTJ
bjos-8641360	115	3	%	%	NOUN
bjos-8641360	116	1	p	p	NOUN
bjos-8641360	116	2	oral	oral	ADJ
bjos-8641360	116	3	candidiasis	candidiasis	NOUN
bjos-8641360	116	4	0	0	NUM
bjos-8641360	116	5	0.0	0.0	NUM
bjos-8641360	116	6	10	10	NUM
bjos-8641360	116	7	21.2	21.2	NUM
bjos-8641360	116	8	0.001(1	0.001(1	NUM
bjos-8641360	116	9	)	)	PUNCT
bjos-8641360	116	10	n	n	NOUN
bjos-8641360	116	11	o	o	NOUN
bjos-8641360	116	12	6	6	NUM
bjos-8641360	116	13	21.4	21.4	NUM
bjos-8641360	116	14	9	9	NUM
bjos-8641360	116	15	19.1	19.1	NUM
bjos-8641360	116	16	0.365(1	0.365(1	NUM
bjos-8641360	116	17	)	)	PUNCT
bjos-8641360	116	18	herpes	herpe	NOUN
bjos-8641360	116	19	simplex	simplex	NOUN
bjos-8641360	116	20	0	0	NUM
bjos-8641360	116	21	0.0	0.0	NUM
bjos-8641360	116	22	7	7	NUM
bjos-8641360	116	23	14.9	14.9	NUM
bjos-8641360	116	24	0.010(2	0.010(2	NUM
bjos-8641360	116	25	)	)	PUNCT
bjos-8641360	116	26	periodontal	periodontal	ADJ
bjos-8641360	116	27	disease	disease	NOUN
bjos-8641360	116	28	10	10	NUM
bjos-8641360	116	29	35.7	35.7	NUM
bjos-8641360	116	30	6	6	NUM
bjos-8641360	116	31	12.8	12.8	NUM
bjos-8641360	116	32	0.237(1	0.237(1	NOUN
bjos-8641360	116	33	)	)	PUNCT
bjos-8641360	116	34	oral	oral	ADJ
bjos-8641360	116	35	ulcer	ulcer	NOUN
bjos-8641360	116	36	0	0	NUM
bjos-8641360	116	37	0.0	0.0	NUM
bjos-8641360	116	38	4	4	NUM
bjos-8641360	116	39	8.6	8.6	NUM
bjos-8641360	116	40	0.111(2	0.111(2	NUM
bjos-8641360	116	41	)	)	PUNCT
bjos-8641360	116	42	hairy	hairy	ADJ
bjos-8641360	116	43	leukoplakia	leukoplakia	NOUN
bjos-8641360	116	44	0	0	NUM
bjos-8641360	116	45	0.0	0.0	NUM
bjos-8641360	116	46	3	3	NUM
bjos-8641360	116	47	6.4	6.4	NUM
bjos-8641360	116	48	0.236(1	0.236(1	NUM
bjos-8641360	116	49	)	)	PUNCT
bjos-8641360	116	50	kaposi‘s	kaposi‘	NOUN
bjos-8641360	116	51	sarcoma	sarcoma	NOUN
bjos-8641360	116	52	0	0	NUM
bjos-8641360	116	53	0.0	0.0	NUM
bjos-8641360	116	54	2	2	NUM
bjos-8641360	116	55	4.3	4.3	NUM
bjos-8641360	116	56	0.491(2	0.491(2	NUM
bjos-8641360	116	57	)	)	PUNCT
bjos-8641360	116	58	caries	carie	VERB
bjos-8641360	116	59	11	11	NUM
bjos-8641360	116	60	39.3	39.3	NUM
bjos-8641360	116	61	2	2	NUM
bjos-8641360	116	62	4.3	4.3	NUM
bjos-8641360	116	63	0.004(1	0.004(1	NUM
bjos-8641360	116	64	)	)	PUNCT
bjos-8641360	116	65	xerostomia	xerostomia	NOUN
bjos-8641360	116	66	9	9	NUM
bjos-8641360	116	67	32.1	32.1	NUM
bjos-8641360	116	68	1	1	NUM
bjos-8641360	116	69	2.1	2.1	NUM
bjos-8641360	116	70	0.005(1	0.005(1	NUM
bjos-8641360	116	71	)	)	PUNCT
bjos-8641360	116	72	nicotinic	nicotinic	ADJ
bjos-8641360	116	73	stomatitis	stomatitis	NOUN
bjos-8641360	116	74	0	0	NUM
bjos-8641360	116	75	0.0	0.0	NUM
bjos-8641360	116	76	1	1	NUM
bjos-8641360	116	77	2.1	2.1	NUM
bjos-8641360	116	78	1.000(2	1.000(2	NUM
bjos-8641360	116	79	)	)	PUNCT
bjos-8641360	116	80	sinus	sinus	NOUN
bjos-8641360	116	81	oral	oral	ADJ
bjos-8641360	116	82	communication	communication	NOUN
bjos-8641360	116	83	0	0	NUM
bjos-8641360	116	84	0.0	0.0	NUM
bjos-8641360	116	85	1	1	NUM
bjos-8641360	116	86	2.1	2.1	NUM
bjos-8641360	116	87	1.000(2	1.000(2	NUM
bjos-8641360	116	88	)	)	PUNCT
bjos-8641360	117	1	lichen	lichen	NOUN
bjos-8641360	117	2	planus	planus	NOUN
bjos-8641360	117	3	0	0	NUM
bjos-8641360	117	4	0.0	0.0	NUM
bjos-8641360	117	5	1	1	NUM
bjos-8641360	117	6	2.1	2.1	NUM
bjos-8641360	117	7	1.000(2	1.000(2	NUM
bjos-8641360	117	8	)	)	PUNCT
bjos-8641360	117	9	radicular	radicular	ADJ
bjos-8641360	117	10	cyst	cyst	NOUN
bjos-8641360	117	11	1	1	NUM
bjos-8641360	117	12	3.6	3.6	NUM
bjos-8641360	117	13	0	0	NUM
bjos-8641360	117	14	0.0	0.0	NUM
bjos-8641360	117	15	1.000(2	1.000(2	NUM
bjos-8641360	117	16	)	)	PUNCT
bjos-8641360	117	17	diagnosis	diagnosis	NOUN
bjos-8641360	117	18	of	of	ADP
bjos-8641360	117	19	oral	oral	ADJ
bjos-8641360	117	20	manifestations	manifestation	NOUN
bjos-8641360	117	21	in	in	ADP
bjos-8641360	117	22	hiv	hiv	PROPN
bjos-8641360	117	23	/	/	SYM
bjos-8641360	117	24	aids	aids	PROPN
bjos-8641360	117	25	patients	patient	NOUN
bjos-8641360	117	26	who	who	PRON
bjos-8641360	117	27	used	use	VERB
bjos-8641360	117	28	haart	haart	PROPN
bjos-8641360	117	29	and	and	CCONJ
bjos-8641360	117	30	developed	developed	ADJ
bjos-8641360	117	31	diabetes	diabetes	NOUN
bjos-8641360	117	32	mellitus	mellitus	PROPN
bjos-8641360	117	33	braz	braz	PROPN
bjos-8641360	117	34	j	j	PROPN
bjos-8641360	117	35	oral	oral	PROPN
bjos-8641360	117	36	sci	sci	PROPN
bjos-8641360	117	37	.	.	PUNCT
bjos-8641360	118	1	11(3):352	11(3):352	NUM
bjos-8641360	118	2	-	-	SYM
bjos-8641360	118	3	356	356	NUM
bjos-8641360	118	4	356356356356356	356356356356356	NUM
bjos-8641360	118	5	references	reference	NOUN
bjos-8641360	118	6	1	1	NUM
bjos-8641360	118	7	.	.	PUNCT
bjos-8641360	118	8	rinkman	rinkman	PROPN
bjos-8641360	118	9	k	k	PROPN
bjos-8641360	118	10	,	,	PUNCT
bjos-8641360	118	11	smeitink	smeitink	PROPN
bjos-8641360	118	12	ja	ja	PROPN
bjos-8641360	118	13	,	,	PUNCT
bjos-8641360	118	14	romijn	romijn	PROPN
bjos-8641360	118	15	ja	ja	PROPN
bjos-8641360	118	16	,	,	PUNCT
bjos-8641360	118	17	reiss	reiss	PROPN
bjos-8641360	118	18	p.	p.	NOUN
bjos-8641360	118	19	mitochondrial	mitochondrial	ADJ
bjos-8641360	118	20	toxicity	toxicity	NOUN
bjos-8641360	118	21	induced	induce	VERB
bjos-8641360	118	22	by	by	ADP
bjos-8641360	118	23	nucleoside	nucleoside	NOUN
bjos-8641360	118	24	-	-	PUNCT
bjos-8641360	118	25	analogue	analogue	NOUN
bjos-8641360	118	26	reverse	reverse	NOUN
bjos-8641360	118	27	-	-	PUNCT
bjos-8641360	118	28	transcriptase	transcriptase	NOUN
bjos-8641360	118	29	inhibitors	inhibitor	NOUN
bjos-8641360	118	30	is	be	AUX
bjos-8641360	118	31	a	a	DET
bjos-8641360	118	32	key	key	ADJ
bjos-8641360	118	33	factor	factor	NOUN
bjos-8641360	118	34	in	in	ADP
bjos-8641360	118	35	the	the	DET
bjos-8641360	118	36	pathogenesis	pathogenesis	NOUN
bjos-8641360	118	37	of	of	ADP
bjos-8641360	118	38	antiretroviral	antiretroviral	ADJ
bjos-8641360	118	39	-	-	PUNCT
bjos-8641360	118	40	therapy	therapy	NOUN
bjos-8641360	118	41	-	-	PUNCT
bjos-8641360	118	42	related	relate	VERB
bjos-8641360	118	43	lipodystrophy	lipodystrophy	NOUN
bjos-8641360	118	44	.	.	PUNCT
bjos-8641360	119	1	lancet	lancet	PROPN
bjos-8641360	119	2	.	.	PUNCT
bjos-8641360	120	1	1999	1999	NUM
bjos-8641360	120	2	;	;	PUNCT
bjos-8641360	120	3	354	354	NUM
bjos-8641360	120	4	:	:	PUNCT
bjos-8641360	120	5	1112	1112	NUM
bjos-8641360	120	6	-	-	SYM
bjos-8641360	120	7	5	5	NUM
bjos-8641360	120	8	.	.	NOUN
bjos-8641360	121	1	2	2	NUM
bjos-8641360	121	2	.	.	X
bjos-8641360	121	3	boubaker	boubaker	PROPN
bjos-8641360	121	4	k	k	PROPN
bjos-8641360	121	5	,	,	PUNCT
bjos-8641360	121	6	flepp	flepp	ADJ
bjos-8641360	121	7	m	m	PROPN
bjos-8641360	121	8	,	,	PUNCT
bjos-8641360	121	9	sudre	sudre	NOUN
bjos-8641360	121	10	p	p	NOUN
bjos-8641360	121	11	,	,	PUNCT
bjos-8641360	121	12	furrer	furrer	NOUN
bjos-8641360	121	13	h	h	NOUN
bjos-8641360	121	14	,	,	PUNCT
bjos-8641360	121	15	haensel	haensel	ADV
bjos-8641360	121	16	a	a	X
bjos-8641360	121	17	,	,	PUNCT
bjos-8641360	121	18	hirschel	hirschel	PROPN
bjos-8641360	121	19	b	b	PROPN
bjos-8641360	121	20	et	et	PROPN
bjos-8641360	121	21	al	al	PROPN
bjos-8641360	121	22	.	.	PUNCT
bjos-8641360	122	1	hyperlactatemia	hyperlactatemia	PROPN
bjos-8641360	122	2	and	and	CCONJ
bjos-8641360	122	3	antiretroviral	antiretroviral	ADJ
bjos-8641360	122	4	therapy	therapy	NOUN
bjos-8641360	122	5	:	:	PUNCT
bjos-8641360	122	6	the	the	DET
bjos-8641360	122	7	swiss	swiss	ADJ
bjos-8641360	122	8	hiv	hiv	PROPN
bjos-8641360	122	9	cohort	cohort	PROPN
bjos-8641360	122	10	study	study	NOUN
bjos-8641360	122	11	.	.	PUNCT
bjos-8641360	123	1	clinic	clinic	NOUN
bjos-8641360	123	2	infect	infect	PROPN
bjos-8641360	123	3	dis	dis	PROPN
bjos-8641360	123	4	.	.	PUNCT
bjos-8641360	124	1	2001	2001	NUM
bjos-8641360	124	2	;	;	PUNCT
bjos-8641360	124	3	33	33	NUM
bjos-8641360	124	4	:	:	SYM
bjos-8641360	124	5	1931	1931	NUM
bjos-8641360	124	6	-	-	SYM
bjos-8641360	124	7	7	7	NUM
bjos-8641360	124	8	.	.	NOUN
bjos-8641360	125	1	3	3	NUM
bjos-8641360	125	2	.	.	X
bjos-8641360	125	3	drechsler	drechsler	PROPN
bjos-8641360	125	4	h	h	PROPN
bjos-8641360	125	5	,	,	PUNCT
bjos-8641360	125	6	powderly	powderly	ADV
bjos-8641360	125	7	wg	wg	PRON
bjos-8641360	125	8	.	.	PUNCT
bjos-8641360	126	1	switching	switch	VERB
bjos-8641360	126	2	effective	effective	ADJ
bjos-8641360	126	3	antiretroviral	antiretroviral	ADJ
bjos-8641360	126	4	therapy	therapy	NOUN
bjos-8641360	126	5	:	:	PUNCT
bjos-8641360	126	6	a	a	DET
bjos-8641360	126	7	review.clinic	review.clinic	ADJ
bjos-8641360	126	8	infect	infect	ADJ
bjos-8641360	126	9	dis	dis	PROPN
bjos-8641360	126	10	.	.	PUNCT
bjos-8641360	127	1	2002	2002	NUM
bjos-8641360	127	2	;	;	PUNCT
bjos-8641360	127	3	35	35	NUM
bjos-8641360	127	4	:	:	SYM
bjos-8641360	127	5	1219	1219	NUM
bjos-8641360	127	6	-	-	SYM
bjos-8641360	127	7	30	30	NUM
bjos-8641360	127	8	.	.	PUNCT
bjos-8641360	128	1	4	4	NUM
bjos-8641360	128	2	.	.	X
bjos-8641360	128	3	calza	calza	PROPN
bjos-8641360	128	4	l	l	PROPN
bjos-8641360	128	5	,	,	PUNCT
bjos-8641360	128	6	manfredi	manfredi	PROPN
bjos-8641360	128	7	r	r	PROPN
bjos-8641360	128	8	,	,	PUNCT
bjos-8641360	128	9	chiodo	chiodo	PROPN
bjos-8641360	128	10	f.	f.	PROPN
bjos-8641360	128	11	insulin	insulin	PROPN
bjos-8641360	128	12	resistance	resistance	NOUN
bjos-8641360	128	13	and	and	CCONJ
bjos-8641360	128	14	diabetes	diabetes	NOUN
bjos-8641360	128	15	mellitus	mellitus	NOUN
bjos-8641360	128	16	in	in	ADP
bjos-8641360	128	17	hiv	hiv	PROPN
bjos-8641360	128	18	infected	infect	VERB
bjos-8641360	128	19	patients	patient	NOUN
bjos-8641360	128	20	receiving	receive	VERB
bjos-8641360	128	21	antiretroviral	antiretroviral	ADJ
bjos-8641360	128	22	therapy	therapy	NOUN
bjos-8641360	128	23	.	.	PUNCT
bjos-8641360	129	1	metab	metab	ADJ
bjos-8641360	129	2	syndr	syndr	PROPN
bjos-8641360	129	3	relat	relat	PROPN
bjos-8641360	129	4	disord	disord	NOUN
bjos-8641360	129	5	.	.	PUNCT
bjos-8641360	130	1	2004	2004	NUM
bjos-8641360	130	2	;	;	PUNCT
bjos-8641360	130	3	2	2	NUM
bjos-8641360	130	4	:	:	PUNCT
bjos-8641360	130	5	241	241	NUM
bjos-8641360	130	6	-	-	SYM
bjos-8641360	130	7	50	50	NUM
bjos-8641360	130	8	.	.	PUNCT
bjos-8641360	131	1	5	5	NUM
bjos-8641360	131	2	.	.	X
bjos-8641360	131	3	aboud	aboud	PROPN
bjos-8641360	131	4	m	m	PROPN
bjos-8641360	131	5	,	,	PUNCT
bjos-8641360	131	6	elgalib	elgalib	PROPN
bjos-8641360	131	7	a	a	PRON
bjos-8641360	131	8	,	,	PUNCT
bjos-8641360	131	9	kulasegaram	kulasegaram	NOUN
bjos-8641360	131	10	r	r	PROPN
bjos-8641360	131	11	,	,	PUNCT
bjos-8641360	131	12	peters	peters	PROPN
bjos-8641360	131	13	b.	b.	PROPN
bjos-8641360	131	14	insulin	insulin	PROPN
bjos-8641360	131	15	resistance	resistance	NOUN
bjos-8641360	131	16	and	and	CCONJ
bjos-8641360	131	17	hiv	hiv	PROPN
bjos-8641360	131	18	infection	infection	NOUN
bjos-8641360	131	19	:	:	PUNCT
bjos-8641360	131	20	a	a	DET
bjos-8641360	131	21	review	review	NOUN
bjos-8641360	131	22	.	.	PUNCT
bjos-8641360	132	1	int	int	PROPN
bjos-8641360	133	1	j	j	PROPN
bjos-8641360	133	2	clin	clin	PROPN
bjos-8641360	133	3	pract	pract	PROPN
bjos-8641360	133	4	.	.	PUNCT
bjos-8641360	134	1	2007	2007	NUM
bjos-8641360	134	2	;	;	PUNCT
bjos-8641360	134	3	61	61	NUM
bjos-8641360	134	4	:	:	SYM
bjos-8641360	134	5	463	463	NUM
bjos-8641360	134	6	-	-	SYM
bjos-8641360	134	7	72	72	NUM
bjos-8641360	134	8	.	.	NOUN
bjos-8641360	135	1	6	6	NUM
bjos-8641360	135	2	.	.	X
bjos-8641360	135	3	de	de	PROPN
bjos-8641360	135	4	wit	wit	PROPN
bjos-8641360	135	5	s	s	PROPN
bjos-8641360	135	6	,	,	PUNCT
bjos-8641360	135	7	sabin	sabin	PROPN
bjos-8641360	135	8	ca	ca	PROPN
bjos-8641360	135	9	,	,	PUNCT
bjos-8641360	135	10	weber	weber	PROPN
bjos-8641360	135	11	r	r	PROPN
bjos-8641360	135	12	,	,	PUNCT
bjos-8641360	135	13	worm	worm	NOUN
bjos-8641360	135	14	sw	sw	PROPN
bjos-8641360	135	15	,	,	PUNCT
bjos-8641360	135	16	reiss	reiss	PROPN
bjos-8641360	135	17	p	p	NOUN
bjos-8641360	135	18	,	,	PUNCT
bjos-8641360	135	19	cazanave	cazanave	NOUN
bjos-8641360	135	20	c	c	NOUN
bjos-8641360	135	21	,	,	PUNCT
bjos-8641360	135	22	et	et	PROPN
bjos-8641360	135	23	al	al	PROPN
bjos-8641360	135	24	.	.	PROPN
bjos-8641360	135	25	incidence	incidence	NOUN
bjos-8641360	135	26	and	and	CCONJ
bjos-8641360	135	27	risk	risk	NOUN
bjos-8641360	135	28	factors	factor	NOUN
bjos-8641360	135	29	for	for	ADP
bjos-8641360	135	30	new	new	ADJ
bjos-8641360	135	31	-	-	PUNCT
bjos-8641360	135	32	onset	onset	NOUN
bjos-8641360	135	33	diabetes	diabetes	NOUN
bjos-8641360	135	34	in	in	ADP
bjos-8641360	135	35	hiv	hiv	PROPN
bjos-8641360	135	36	-	-	PUNCT
bjos-8641360	135	37	infected	infect	VERB
bjos-8641360	135	38	patients	patient	NOUN
bjos-8641360	135	39	the	the	DET
bjos-8641360	135	40	data	data	NOUN
bjos-8641360	135	41	collection	collection	NOUN
bjos-8641360	135	42	on	on	ADP
bjos-8641360	135	43	adverse	adverse	ADJ
bjos-8641360	135	44	events	event	NOUN
bjos-8641360	135	45	of	of	ADP
bjos-8641360	135	46	anti	anti	ADJ
bjos-8641360	135	47	-	-	ADJ
bjos-8641360	135	48	hiv	hiv	ADJ
bjos-8641360	135	49	drugs	drug	NOUN
bjos-8641360	135	50	(	(	PUNCT
bjos-8641360	135	51	d	d	NOUN
bjos-8641360	135	52	:	:	PUNCT
bjos-8641360	135	53	a	a	DET
bjos-8641360	135	54	:	:	PUNCT
bjos-8641360	135	55	d	d	ADJ
bjos-8641360	135	56	)	)	PUNCT
bjos-8641360	135	57	study	study	NOUN
bjos-8641360	135	58	.	.	PUNCT
bjos-8641360	136	1	diabetes	diabetes	NOUN
bjos-8641360	136	2	care	care	VERB
bjos-8641360	136	3	2008	2008	NUM
bjos-8641360	136	4	;	;	PUNCT
bjos-8641360	136	5	31	31	NUM
bjos-8641360	136	6	:	:	PUNCT
bjos-8641360	136	7	1224	1224	NUM
bjos-8641360	136	8	-	-	SYM
bjos-8641360	136	9	9	9	NUM
bjos-8641360	136	10	.	.	NOUN
bjos-8641360	136	11	7	7	NUM
bjos-8641360	136	12	.	.	X
bjos-8641360	136	13	samaras	samaras	PROPN
bjos-8641360	136	14	k.	k.	PROPN
bjos-8641360	136	15	metabolic	metabolic	PROPN
bjos-8641360	136	16	consequences	consequence	NOUN
bjos-8641360	136	17	and	and	CCONJ
bjos-8641360	136	18	therapeutic	therapeutic	ADJ
bjos-8641360	136	19	options	option	NOUN
bjos-8641360	136	20	in	in	ADP
bjos-8641360	136	21	highly	highly	ADV
bjos-8641360	136	22	active	active	ADJ
bjos-8641360	136	23	antiretroviral	antiretroviral	ADJ
bjos-8641360	136	24	therapy	therapy	NOUN
bjos-8641360	136	25	in	in	ADP
bjos-8641360	136	26	human	human	ADJ
bjos-8641360	136	27	immunodeficiency	immunodeficiency	NOUN
bjos-8641360	136	28	virus-1	virus-1	ADP
bjos-8641360	136	29	infection	infection	NOUN
bjos-8641360	136	30	.	.	PUNCT
bjos-8641360	137	1	j	j	PROPN
bjos-8641360	137	2	antimicrob	antimicrob	PROPN
bjos-8641360	137	3	chemother	chemother	PROPN
bjos-8641360	137	4	.	.	PUNCT
bjos-8641360	138	1	2008	2008	NUM
bjos-8641360	138	2	;	;	PUNCT
bjos-8641360	138	3	61	61	NUM
bjos-8641360	138	4	:	:	SYM
bjos-8641360	138	5	238	238	NUM
bjos-8641360	138	6	-	-	SYM
bjos-8641360	138	7	45	45	NUM
bjos-8641360	138	8	.	.	NOUN
bjos-8641360	138	9	8	8	NUM
bjos-8641360	138	10	.	.	NUM
bjos-8641360	139	1	alves	alves	PROPN
bjos-8641360	139	2	c	c	X
bjos-8641360	139	3	,	,	PUNCT
bjos-8641360	139	4	oliveira	oliveira	PROPN
bjos-8641360	139	5	ac	ac	PROPN
bjos-8641360	139	6	,	,	PUNCT
bjos-8641360	139	7	brites	brites	PROPN
bjos-8641360	139	8	c.	c.	PROPN
bjos-8641360	139	9	lipodystrophic	lipodystrophic	PROPN
bjos-8641360	139	10	syndrome	syndrome	NOUN
bjos-8641360	139	11	in	in	ADP
bjos-8641360	139	12	children	child	NOUN
bjos-8641360	139	13	and	and	CCONJ
bjos-8641360	139	14	adolescents	adolescent	NOUN
bjos-8641360	139	15	infected	infect	VERB
bjos-8641360	139	16	with	with	ADP
bjos-8641360	139	17	the	the	DET
bjos-8641360	139	18	human	human	ADJ
bjos-8641360	139	19	immunodeficiency	immunodeficiency	NOUN
bjos-8641360	139	20	virus	virus	NOUN
bjos-8641360	139	21	.	.	PUNCT
bjos-8641360	140	1	braz	braz	PROPN
bjos-8641360	140	2	j	j	PROPN
bjos-8641360	140	3	infect	infect	PROPN
bjos-8641360	140	4	dis	dis	PROPN
bjos-8641360	140	5	.	.	PUNCT
bjos-8641360	140	6	2008	2008	NUM
bjos-8641360	140	7	;	;	PUNCT
bjos-8641360	140	8	12	12	NUM
bjos-8641360	140	9	:	:	PUNCT
bjos-8641360	140	10	342	342	NUM
bjos-8641360	140	11	-	-	SYM
bjos-8641360	140	12	8	8	NUM
bjos-8641360	140	13	.	.	NOUN
bjos-8641360	140	14	9	9	NUM
bjos-8641360	140	15	.	.	X
bjos-8641360	140	16	saint	saint	PROPN
bjos-8641360	140	17	-	-	PUNCT
bjos-8641360	140	18	marc	marc	PROPN
bjos-8641360	140	19	t	t	PROPN
bjos-8641360	140	20	,	,	PUNCT
bjos-8641360	140	21	touraine	touraine	PROPN
bjos-8641360	140	22	jl	jl	PROPN
bjos-8641360	140	23	.	.	PUNCT
bjos-8641360	140	24	effects	effect	NOUN
bjos-8641360	140	25	of	of	ADP
bjos-8641360	140	26	metformin	metformin	NOUN
bjos-8641360	140	27	on	on	ADP
bjos-8641360	140	28	insulin	insulin	NOUN
bjos-8641360	140	29	resistance	resistance	NOUN
bjos-8641360	140	30	and	and	CCONJ
bjos-8641360	140	31	central	central	ADJ
bjos-8641360	140	32	adiposity	adiposity	NOUN
bjos-8641360	140	33	in	in	ADP
bjos-8641360	140	34	patients	patient	NOUN
bjos-8641360	140	35	receiving	receive	VERB
bjos-8641360	140	36	effective	effective	ADJ
bjos-8641360	140	37	protease	protease	NOUN
bjos-8641360	140	38	inhibitor	inhibitor	NOUN
bjos-8641360	140	39	therapy	therapy	NOUN
bjos-8641360	140	40	.	.	PUNCT
bjos-8641360	141	1	aids	aids	PROPN
bjos-8641360	141	2	.	.	PUNCT
bjos-8641360	142	1	1999	1999	NUM
bjos-8641360	142	2	;	;	PUNCT
bjos-8641360	142	3	13	13	NUM
bjos-8641360	142	4	:	:	SYM
bjos-8641360	142	5	1000	1000	NUM
bjos-8641360	142	6	-	-	SYM
bjos-8641360	142	7	2	2	NUM
bjos-8641360	142	8	.	.	NOUN
bjos-8641360	142	9	10	10	NUM
bjos-8641360	142	10	.	.	PUNCT
bjos-8641360	143	1	murata	murata	PROPN
bjos-8641360	143	2	h	h	PROPN
bjos-8641360	143	3	,	,	PUNCT
bjos-8641360	143	4	hruz	hruz	PROPN
bjos-8641360	143	5	pw	pw	PROPN
bjos-8641360	143	6	,	,	PUNCT
bjos-8641360	143	7	mueckler	mueckler	PROPN
bjos-8641360	143	8	m.	m.	NOUN
bjos-8641360	143	9	the	the	DET
bjos-8641360	143	10	mechanism	mechanism	NOUN
bjos-8641360	143	11	of	of	ADP
bjos-8641360	143	12	insulin	insulin	NOUN
bjos-8641360	143	13	resistance	resistance	NOUN
bjos-8641360	143	14	caused	cause	VERB
bjos-8641360	143	15	by	by	ADP
bjos-8641360	143	16	hiv	hiv	PROPN
bjos-8641360	143	17	protease	protease	NOUN
bjos-8641360	143	18	inhibitor	inhibitor	NOUN
bjos-8641360	143	19	therapy	therapy	NOUN
bjos-8641360	143	20	.	.	PUNCT
bjos-8641360	144	1	j	j	PROPN
bjos-8641360	144	2	biol	biol	PROPN
bjos-8641360	144	3	chem	chem	NOUN
bjos-8641360	144	4	.	.	PUNCT
bjos-8641360	145	1	2000	2000	NUM
bjos-8641360	145	2	;	;	PUNCT
bjos-8641360	145	3	275	275	NUM
bjos-8641360	145	4	:	:	SYM
bjos-8641360	145	5	20251	20251	NUM
bjos-8641360	145	6	-	-	SYM
bjos-8641360	145	7	4	4	NUM
bjos-8641360	145	8	.	.	NOUN
bjos-8641360	145	9	11	11	NUM
bjos-8641360	145	10	.	.	X
bjos-8641360	145	11	schambelan	schambelan	PROPN
bjos-8641360	145	12	m	m	PROPN
bjos-8641360	145	13	,	,	PUNCT
bjos-8641360	145	14	benson	benson	PROPN
bjos-8641360	145	15	ca	ca	PROPN
bjos-8641360	145	16	,	,	PUNCT
bjos-8641360	145	17	carr	carr	PROPN
bjos-8641360	145	18	a.	a.	NOUN
bjos-8641360	145	19	management	management	PROPN
bjos-8641360	145	20	of	of	ADP
bjos-8641360	145	21	metabolic	metabolic	NOUN
bjos-8641360	145	22	complications	complication	NOUN
bjos-8641360	145	23	associated	associate	VERB
bjos-8641360	145	24	with	with	ADP
bjos-8641360	145	25	antiretroviral	antiretroviral	ADJ
bjos-8641360	145	26	therapy	therapy	NOUN
bjos-8641360	145	27	for	for	ADP
bjos-8641360	145	28	hiv-1	hiv-1	ADJ
bjos-8641360	145	29	infection	infection	NOUN
bjos-8641360	145	30	:	:	PUNCT
bjos-8641360	145	31	recommendations	recommendation	NOUN
bjos-8641360	145	32	of	of	ADP
bjos-8641360	145	33	an	an	DET
bjos-8641360	145	34	international	international	ADJ
bjos-8641360	145	35	aids	aids	PROPN
bjos-8641360	145	36	society	society	PROPN
bjos-8641360	145	37	-	-	PUNCT
bjos-8641360	145	38	usa	usa	PROPN
bjos-8641360	145	39	panel	panel	NOUN
bjos-8641360	145	40	.	.	PUNCT
bjos-8641360	146	1	j	j	PROPN
bjos-8641360	146	2	acquir	acquir	PROPN
bjos-8641360	146	3	immune	immune	VERB
bjos-8641360	146	4	defic	defic	ADJ
bjos-8641360	146	5	syndr	syndr	NOUN
bjos-8641360	146	6	.	.	PUNCT
bjos-8641360	147	1	2002	2002	NUM
bjos-8641360	147	2	;	;	PUNCT
bjos-8641360	147	3	31	31	NUM
bjos-8641360	147	4	:	:	PUNCT
bjos-8641360	147	5	257	257	NUM
bjos-8641360	147	6	-	-	SYM
bjos-8641360	147	7	75	75	NUM
bjos-8641360	147	8	.	.	PUNCT
bjos-8641360	148	1	12	12	NUM
bjos-8641360	148	2	.	.	PUNCT
bjos-8641360	149	1	palella	palella	PROPN
bjos-8641360	149	2	jr	jr	PROPN
bjos-8641360	149	3	fj	fj	PROPN
bjos-8641360	149	4	,	,	PUNCT
bjos-8641360	149	5	chmiel	chmiel	PROPN
bjos-8641360	149	6	js	js	PROPN
bjos-8641360	149	7	,	,	PUNCT
bjos-8641360	149	8	riddler	riddler	PROPN
bjos-8641360	149	9	sa	sa	PROPN
bjos-8641360	149	10	.	.	PUNCT
bjos-8641360	150	1	a	a	DET
bjos-8641360	150	2	novel	novel	ADJ
bjos-8641360	150	3	pattern	pattern	NOUN
bjos-8641360	150	4	of	of	ADP
bjos-8641360	150	5	lipoaccumulation	lipoaccumulation	NOUN
bjos-8641360	150	6	in	in	ADP
bjos-8641360	150	7	hivinfected	hivinfected	ADJ
bjos-8641360	150	8	men	man	NOUN
bjos-8641360	150	9	.	.	PUNCT
bjos-8641360	151	1	jama	jama	PROPN
bjos-8641360	151	2	.	.	PUNCT
bjos-8641360	152	1	2006	2006	NUM
bjos-8641360	152	2	;	;	PUNCT
bjos-8641360	152	3	296	296	NUM
bjos-8641360	152	4	:	:	PUNCT
bjos-8641360	152	5	766	766	NUM
bjos-8641360	152	6	-	-	SYM
bjos-8641360	152	7	8	8	NUM
bjos-8641360	152	8	.	.	NOUN
bjos-8641360	152	9	13	13	NUM
bjos-8641360	152	10	.	.	PUNCT
bjos-8641360	153	1	mulligan	mulligan	PROPN
bjos-8641360	153	2	k	k	PROPN
bjos-8641360	153	3	,	,	PUNCT
bjos-8641360	153	4	grunfeld	grunfeld	PROPN
bjos-8641360	153	5	c	c	PROPN
bjos-8641360	153	6	,	,	PUNCT
bjos-8641360	153	7	tai	tai	PROPN
bjos-8641360	153	8	vw	vw	PROPN
bjos-8641360	153	9	,	,	PUNCT
bjos-8641360	153	10	algren	algren	PROPN
bjos-8641360	153	11	h	h	PROPN
bjos-8641360	153	12	,	,	PUNCT
bjos-8641360	153	13	pang	pang	NOUN
bjos-8641360	153	14	m	m	PRON
bjos-8641360	153	15	,	,	PUNCT
bjos-8641360	153	16	chernoff	chernoff	PROPN
bjos-8641360	153	17	dn	dn	PROPN
bjos-8641360	153	18	et	et	PROPN
bjos-8641360	153	19	al	al	PROPN
bjos-8641360	153	20	.	.	PROPN
bjos-8641360	153	21	hyperlipidemia	hyperlipidemia	NOUN
bjos-8641360	153	22	and	and	CCONJ
bjos-8641360	153	23	insulin	insulin	NOUN
bjos-8641360	153	24	resistance	resistance	NOUN
bjos-8641360	153	25	are	be	AUX
bjos-8641360	153	26	induced	induce	VERB
bjos-8641360	153	27	by	by	ADP
bjos-8641360	153	28	protease	protease	NOUN
bjos-8641360	153	29	inhibitors	inhibitor	NOUN
bjos-8641360	153	30	independent	independent	ADJ
bjos-8641360	153	31	of	of	ADP
bjos-8641360	153	32	changes	change	NOUN
bjos-8641360	153	33	in	in	ADP
bjos-8641360	153	34	body	body	NOUN
bjos-8641360	153	35	composition	composition	NOUN
bjos-8641360	153	36	in	in	ADP
bjos-8641360	153	37	patients	patient	NOUN
bjos-8641360	153	38	with	with	ADP
bjos-8641360	153	39	hiv	hiv	PROPN
bjos-8641360	153	40	infection	infection	NOUN
bjos-8641360	153	41	.	.	PUNCT
bjos-8641360	154	1	j	j	PROPN
bjos-8641360	154	2	acquir	acquir	VERB
bjos-8641360	154	3	defic	defic	ADJ
bjos-8641360	154	4	syndr	syndr	NOUN
bjos-8641360	154	5	.	.	PUNCT
bjos-8641360	155	1	2000	2000	NUM
bjos-8641360	155	2	;	;	PUNCT
bjos-8641360	155	3	22	22	NUM
bjos-8641360	155	4	:	:	SYM
bjos-8641360	155	5	35	35	NUM
bjos-8641360	155	6	-	-	SYM
bjos-8641360	155	7	43	43	NUM
bjos-8641360	155	8	.	.	PUNCT
bjos-8641360	156	1	14	14	NUM
bjos-8641360	156	2	.	.	PUNCT
bjos-8641360	157	1	noor	noor	PROPN
bjos-8641360	157	2	ma	ma	PROPN
bjos-8641360	157	3	,	,	PUNCT
bjos-8641360	157	4	lo	lo	PROPN
bjos-8641360	157	5	jc	jc	PROPN
bjos-8641360	157	6	,	,	PUNCT
bjos-8641360	157	7	mulligan	mulligan	PROPN
bjos-8641360	157	8	k.	k.	PROPN
bjos-8641360	157	9	metabolic	metabolic	PROPN
bjos-8641360	157	10	effects	effect	NOUN
bjos-8641360	157	11	of	of	ADP
bjos-8641360	157	12	indinavir	indinavir	NOUN
bjos-8641360	157	13	in	in	ADP
bjos-8641360	157	14	healthy	healthy	ADJ
bjos-8641360	157	15	hiv	hiv	PROPN
bjos-8641360	157	16	seronegative	seronegative	ADJ
bjos-8641360	157	17	men	man	NOUN
bjos-8641360	157	18	.	.	PUNCT
bjos-8641360	158	1	aids	aids	PROPN
bjos-8641360	158	2	.	.	PUNCT
bjos-8641360	159	1	2001	2001	NUM
bjos-8641360	159	2	;	;	PUNCT
bjos-8641360	159	3	15	15	NUM
bjos-8641360	159	4	:	:	SYM
bjos-8641360	159	5	11	11	NUM
bjos-8641360	159	6	-	-	SYM
bjos-8641360	159	7	8	8	NUM
bjos-8641360	159	8	.	.	NOUN
bjos-8641360	159	9	15	15	NUM
bjos-8641360	159	10	.	.	X
bjos-8641360	160	1	mulligan	mulligan	PROPN
bjos-8641360	160	2	,	,	PUNCT
bjos-8641360	160	3	k.	k.	PROPN
bjos-8641360	160	4	metabolic	metabolic	PROPN
bjos-8641360	160	5	abnormalities	abnormality	NOUN
bjos-8641360	160	6	in	in	ADP
bjos-8641360	160	7	patients	patient	NOUN
bjos-8641360	160	8	with	with	ADP
bjos-8641360	160	9	hiv	hiv	PROPN
bjos-8641360	160	10	infection	infection	NOUN
bjos-8641360	160	11	.	.	PUNCT
bjos-8641360	161	1	j	j	PROPN
bjos-8641360	161	2	int	int	PROPN
bjos-8641360	161	3	assoc	assoc	PROPN
bjos-8641360	161	4	physicians	physicians	PROPN
bjos-8641360	161	5	aids	aids	PROPN
bjos-8641360	161	6	care	care	PROPN
bjos-8641360	161	7	.	.	PUNCT
bjos-8641360	162	1	2003	2003	NUM
bjos-8641360	162	2	;	;	PUNCT
bjos-8641360	162	3	2	2	NUM
bjos-8641360	162	4	:	:	PUNCT
bjos-8641360	162	5	66	66	NUM
bjos-8641360	162	6	-	-	SYM
bjos-8641360	162	7	74	74	NUM
bjos-8641360	162	8	.	.	PUNCT
bjos-8641360	163	1	16	16	NUM
bjos-8641360	163	2	.	.	PUNCT
bjos-8641360	163	3	brown	brown	PROPN
bjos-8641360	163	4	tt	tt	PROPN
bjos-8641360	163	5	,	,	PUNCT
bjos-8641360	163	6	cole	cole	PROPN
bjos-8641360	163	7	sr	sr	PROPN
bjos-8641360	163	8	,	,	PUNCT
bjos-8641360	163	9	li	li	PROPN
bjos-8641360	163	10	x	x	PROPN
bjos-8641360	163	11	,	,	PUNCT
bjos-8641360	163	12	kingsley	kingsley	PROPN
bjos-8641360	163	13	la	la	PROPN
bjos-8641360	163	14	,	,	PUNCT
bjos-8641360	163	15	palella	palella	PROPN
bjos-8641360	163	16	fj	fj	PROPN
bjos-8641360	163	17	,	,	PUNCT
bjos-8641360	163	18	riddler	riddler	PROPN
bjos-8641360	163	19	sa	sa	PROPN
bjos-8641360	163	20	,	,	PUNCT
bjos-8641360	163	21	et	et	PROPN
bjos-8641360	163	22	al	al	PROPN
bjos-8641360	163	23	.	.	PROPN
bjos-8641360	163	24	antiretroviral	antiretroviral	ADJ
bjos-8641360	163	25	therapy	therapy	NOUN
bjos-8641360	163	26	and	and	CCONJ
bjos-8641360	163	27	the	the	DET
bjos-8641360	163	28	prevalence	prevalence	NOUN
bjos-8641360	163	29	and	and	CCONJ
bjos-8641360	163	30	incidence	incidence	NOUN
bjos-8641360	163	31	of	of	ADP
bjos-8641360	163	32	diabetes	diabetes	NOUN
bjos-8641360	163	33	mellitus	mellitus	NOUN
bjos-8641360	163	34	in	in	ADP
bjos-8641360	163	35	the	the	DET
bjos-8641360	163	36	multicenter	multicenter	ADJ
bjos-8641360	163	37	aids	aid	NOUN
bjos-8641360	163	38	cohort	cohort	NOUN
bjos-8641360	163	39	study	study	NOUN
bjos-8641360	163	40	.	.	PUNCT
bjos-8641360	164	1	arch	arch	ADJ
bjos-8641360	164	2	intern	intern	PROPN
bjos-8641360	164	3	med	med	PROPN
bjos-8641360	164	4	.	.	PUNCT
bjos-8641360	165	1	2005	2005	NUM
bjos-8641360	165	2	;	;	PUNCT
bjos-8641360	165	3	165	165	NUM
bjos-8641360	165	4	:	:	SYM
bjos-8641360	165	5	1179	1179	NUM
bjos-8641360	165	6	-	-	SYM
bjos-8641360	165	7	84	84	NUM
bjos-8641360	165	8	.	.	PUNCT
bjos-8641360	166	1	17	17	NUM
bjos-8641360	166	2	.	.	PUNCT
bjos-8641360	167	1	american	american	ADJ
bjos-8641360	167	2	diabetes	diabetes	PROPN
bjos-8641360	167	3	association	association	PROPN
bjos-8641360	167	4	.	.	PUNCT
bjos-8641360	168	1	new	new	ADJ
bjos-8641360	168	2	american	american	PROPN
bjos-8641360	168	3	diabetes	diabetes	PROPN
bjos-8641360	168	4	association	association	NOUN
bjos-8641360	168	5	survey	survey	NOUN
bjos-8641360	168	6	sheds	shed	VERB
bjos-8641360	168	7	light	light	NOUN
bjos-8641360	168	8	on	on	ADP
bjos-8641360	168	9	the	the	DET
bjos-8641360	168	10	need	need	NOUN
bjos-8641360	168	11	to	to	PART
bjos-8641360	168	12	care	care	VERB
bjos-8641360	168	13	about	about	ADP
bjos-8641360	168	14	diabetes	diabetes	NOUN
bjos-8641360	168	15	and	and	CCONJ
bjos-8641360	168	16	its	its	PRON
bjos-8641360	168	17	serious	serious	ADJ
bjos-8641360	168	18	complications	complication	NOUN
bjos-8641360	168	19	during	during	ADP
bjos-8641360	168	20	ame	ame	PROPN
bjos-8641360	168	21	;	;	PUNCT
bjos-8641360	168	22	2008	2008	NUM
bjos-8641360	168	23	.	.	PUNCT
bjos-8641360	169	1	18	18	NUM
bjos-8641360	169	2	.	.	PUNCT
bjos-8641360	170	1	zimmet	zimmet	NOUN
bjos-8641360	170	2	p.	p.	NOUN
bjos-8641360	170	3	epidemiology	epidemiology	NOUN
bjos-8641360	170	4	of	of	ADP
bjos-8641360	170	5	diabetes	diabetes	NOUN
bjos-8641360	170	6	mellitus	mellitus	NOUN
bjos-8641360	170	7	and	and	CCONJ
bjos-8641360	170	8	associated	associate	VERB
bjos-8641360	170	9	cardiovascular	cardiovascular	ADJ
bjos-8641360	170	10	risk	risk	NOUN
bjos-8641360	170	11	factors	factor	NOUN
bjos-8641360	170	12	:	:	PUNCT
bjos-8641360	170	13	focus	focus	VERB
bjos-8641360	170	14	on	on	ADP
bjos-8641360	170	15	human	human	ADJ
bjos-8641360	170	16	immunodeficiency	immunodeficiency	NOUN
bjos-8641360	170	17	virus	virus	NOUN
bjos-8641360	170	18	and	and	CCONJ
bjos-8641360	170	19	psychiatric	psychiatric	ADJ
bjos-8641360	170	20	disorders	disorder	NOUN
bjos-8641360	170	21	.	.	PUNCT
bjos-8641360	171	1	am	be	AUX
bjos-8641360	171	2	j	j	PROPN
bjos-8641360	171	3	med	med	PROPN
bjos-8641360	171	4	.	.	PUNCT
bjos-8641360	172	1	2005	2005	NUM
bjos-8641360	172	2	;	;	PUNCT
bjos-8641360	173	1	118	118	NUM
bjos-8641360	173	2	(	(	PUNCT
bjos-8641360	173	3	suppl	suppl	NOUN
bjos-8641360	173	4	2	2	NUM
bjos-8641360	173	5	):	):	PUNCT
bjos-8641360	173	6	3	3	NUM
bjos-8641360	173	7	-	-	SYM
bjos-8641360	173	8	8	8	NUM
bjos-8641360	173	9	.	.	NOUN
bjos-8641360	173	10	19	19	NUM
bjos-8641360	173	11	.	.	PUNCT
bjos-8641360	173	12	samarasinghe	samarasinghe	PROPN
bjos-8641360	174	1	y	y	PROPN
bjos-8641360	174	2	p.	p.	PROPN
bjos-8641360	174	3	hiv	hiv	PROPN
bjos-8641360	174	4	and	and	CCONJ
bjos-8641360	174	5	diabetes	diabetes	NOUN
bjos-8641360	174	6	.	.	PUNCT
bjos-8641360	175	1	prim	prim	ADJ
bjos-8641360	175	2	care	care	NOUN
bjos-8641360	175	3	diabetes	diabetes	NOUN
bjos-8641360	175	4	.	.	PUNCT
bjos-8641360	176	1	2007	2007	NUM
bjos-8641360	176	2	;	;	PUNCT
bjos-8641360	176	3	1	1	NUM
bjos-8641360	176	4	:	:	SYM
bjos-8641360	176	5	99	99	NUM
bjos-8641360	176	6	-	-	SYM
bjos-8641360	176	7	101	101	NUM
bjos-8641360	176	8	.	.	PUNCT
bjos-8641360	177	1	20	20	NUM
bjos-8641360	177	2	.	.	PUNCT
bjos-8641360	178	1	ledergerber	ledergerber	PROPN
bjos-8641360	178	2	b	b	PROPN
bjos-8641360	178	3	,	,	PUNCT
bjos-8641360	178	4	furrer	furrer	NOUN
bjos-8641360	178	5	h	h	NOUN
bjos-8641360	178	6	,	,	PUNCT
bjos-8641360	178	7	rickenbach	rickenbach	NOUN
bjos-8641360	178	8	m.	m.	NOUN
bjos-8641360	178	9	factors	factor	NOUN
bjos-8641360	178	10	associated	associate	VERB
bjos-8641360	178	11	with	with	ADP
bjos-8641360	178	12	the	the	DET
bjos-8641360	178	13	incidence	incidence	NOUN
bjos-8641360	178	14	of	of	ADP
bjos-8641360	178	15	type	type	NOUN
bjos-8641360	178	16	2	2	NUM
bjos-8641360	178	17	diabetes	diabetes	NOUN
bjos-8641360	178	18	mellitus	mellitus	NOUN
bjos-8641360	178	19	in	in	ADP
bjos-8641360	178	20	hiv	hiv	PROPN
bjos-8641360	178	21	-	-	PUNCT
bjos-8641360	178	22	infected	infect	VERB
bjos-8641360	178	23	participants	participant	NOUN
bjos-8641360	178	24	in	in	ADP
bjos-8641360	178	25	the	the	DET
bjos-8641360	178	26	swiss	swiss	ADJ
bjos-8641360	178	27	hiv	hiv	PROPN
bjos-8641360	178	28	cohort	cohort	PROPN
bjos-8641360	178	29	study	study	NOUN
bjos-8641360	178	30	.	.	PUNCT
bjos-8641360	179	1	clinic	clinic	NOUN
bjos-8641360	179	2	infect	infect	PROPN
bjos-8641360	179	3	dis	dis	PROPN
bjos-8641360	179	4	.	.	PUNCT
bjos-8641360	180	1	2007	2007	NUM
bjos-8641360	180	2	;	;	PUNCT
bjos-8641360	180	3	45	45	NUM
bjos-8641360	180	4	:	:	SYM
bjos-8641360	180	5	111	111	NUM
bjos-8641360	180	6	-	-	SYM
bjos-8641360	180	7	9	9	NUM
bjos-8641360	180	8	.	.	NOUN
bjos-8641360	180	9	21	21	NUM
bjos-8641360	180	10	.	.	PUNCT
bjos-8641360	181	1	gkrania	gkrania	NOUN
bjos-8641360	181	2	-	-	PUNCT
bjos-8641360	181	3	klotsas	klotsa	NOUN
bjos-8641360	181	4	e	e	NOUN
bjos-8641360	181	5	,	,	PUNCT
bjos-8641360	181	6	klotsas	klotsas	PROPN
bjos-8641360	181	7	ae	ae	PROPN
bjos-8641360	181	8	.	.	PUNCT
bjos-8641360	182	1	hiv	hiv	PROPN
bjos-8641360	182	2	and	and	CCONJ
bjos-8641360	182	3	hiv	hiv	PROPN
bjos-8641360	182	4	treatment	treatment	NOUN
bjos-8641360	182	5	:	:	PUNCT
bjos-8641360	182	6	effects	effect	NOUN
bjos-8641360	182	7	on	on	ADP
bjos-8641360	182	8	fats	fat	NOUN
bjos-8641360	182	9	,	,	PUNCT
bjos-8641360	182	10	glucose	glucose	NOUN
bjos-8641360	182	11	and	and	CCONJ
bjos-8641360	182	12	lipids	lipid	NOUN
bjos-8641360	182	13	.	.	PUNCT
bjos-8641360	183	1	br	br	PROPN
bjos-8641360	183	2	med	med	ADJ
bjos-8641360	183	3	bull	bull	NOUN
bjos-8641360	183	4	.	.	PUNCT
bjos-8641360	184	1	2007	2007	NUM
bjos-8641360	184	2	;	;	PUNCT
bjos-8641360	184	3	84	84	NUM
bjos-8641360	184	4	:	:	SYM
bjos-8641360	184	5	49	49	NUM
bjos-8641360	184	6	-	-	SYM
bjos-8641360	184	7	68	68	NUM
bjos-8641360	184	8	.	.	PUNCT
bjos-8641360	185	1	22	22	NUM
bjos-8641360	185	2	.	.	PUNCT
bjos-8641360	186	1	greenspan	greenspan	PROPN
bjos-8641360	186	2	d	d	PROPN
bjos-8641360	186	3	,	,	PUNCT
bjos-8641360	186	4	canchola	canchola	PROPN
bjos-8641360	186	5	aj	aj	PROPN
bjos-8641360	186	6	,	,	PUNCT
bjos-8641360	186	7	macphail	macphail	PROPN
bjos-8641360	186	8	la	la	PROPN
bjos-8641360	186	9	,	,	PUNCT
bjos-8641360	186	10	cheikh	cheikh	PROPN
bjos-8641360	186	11	b	b	PROPN
bjos-8641360	186	12	,	,	PUNCT
bjos-8641360	186	13	greenspan	greenspan	PROPN
bjos-8641360	186	14	js	js	PROPN
bjos-8641360	186	15	.	.	PUNCT
bjos-8641360	187	1	effect	effect	NOUN
bjos-8641360	187	2	of	of	ADP
bjos-8641360	187	3	highly	highly	ADV
bjos-8641360	187	4	antiretroviral	antiretroviral	ADJ
bjos-8641360	187	5	therapy	therapy	NOUN
bjos-8641360	187	6	on	on	ADP
bjos-8641360	187	7	frequency	frequency	NOUN
bjos-8641360	187	8	of	of	ADP
bjos-8641360	187	9	oral	oral	ADJ
bjos-8641360	187	10	warts	wart	NOUN
bjos-8641360	187	11	.	.	PUNCT
bjos-8641360	188	1	lancet	lancet	PROPN
bjos-8641360	188	2	.	.	PUNCT
bjos-8641360	189	1	2001	2001	NUM
bjos-8641360	189	2	;	;	PUNCT
bjos-8641360	189	3	357	357	NUM
bjos-8641360	189	4	:	:	PUNCT
bjos-8641360	189	5	1411	1411	NUM
bjos-8641360	189	6	-	-	SYM
bjos-8641360	189	7	2	2	NUM
bjos-8641360	189	8	.	.	NOUN
bjos-8641360	189	9	23	23	NUM
bjos-8641360	189	10	.	.	PUNCT
bjos-8641360	190	1	coogan	coogan	PROPN
bjos-8641360	190	2	mm	mm	PROPN
bjos-8641360	190	3	,	,	PUNCT
bjos-8641360	190	4	greenspan	greenspan	PROPN
bjos-8641360	190	5	j	j	PROPN
bjos-8641360	190	6	,	,	PUNCT
bjos-8641360	190	7	challacombe	challacombe	ADJ
bjos-8641360	190	8	sj	sj	NOUN
bjos-8641360	190	9	.	.	PUNCT
bjos-8641360	190	10	oral	oral	ADJ
bjos-8641360	190	11	lesions	lesion	NOUN
bjos-8641360	190	12	in	in	ADP
bjos-8641360	190	13	infection	infection	NOUN
bjos-8641360	190	14	with	with	ADP
bjos-8641360	190	15	human	human	ADJ
bjos-8641360	190	16	immunodeficiency	immunodeficiency	NOUN
bjos-8641360	190	17	virus	virus	NOUN
bjos-8641360	190	18	.	.	PUNCT
bjos-8641360	191	1	bull	bull	PROPN
bjos-8641360	191	2	world	world	PROPN
bjos-8641360	191	3	health	health	NOUN
bjos-8641360	191	4	organ	organ	NOUN
bjos-8641360	191	5	.	.	PUNCT
bjos-8641360	192	1	2005	2005	NUM
bjos-8641360	192	2	;	;	PUNCT
bjos-8641360	192	3	83	83	NUM
bjos-8641360	192	4	:	:	SYM
bjos-8641360	192	5	700	700	NUM
bjos-8641360	192	6	-	-	SYM
bjos-8641360	192	7	6	6	NUM
bjos-8641360	192	8	.	.	NOUN
bjos-8641360	192	9	24	24	NUM
bjos-8641360	192	10	.	.	PUNCT
bjos-8641360	193	1	giovani	giovani	PROPN
bjos-8641360	193	2	em	em	PRON
bjos-8641360	193	3	,	,	PUNCT
bjos-8641360	193	4	baptista	baptista	PROPN
bjos-8641360	193	5	rb	rb	PROPN
bjos-8641360	193	6	,	,	PUNCT
bjos-8641360	193	7	melo	melo	PROPN
bjos-8641360	193	8	ja	ja	PROPN
bjos-8641360	193	9	,	,	PUNCT
bjos-8641360	193	10	tortamano	tortamano	PROPN
bjos-8641360	193	11	n.	n.	PROPN
bjos-8641360	193	12	use	use	NOUN
bjos-8641360	193	13	of	of	ADP
bjos-8641360	193	14	gaalas	gaala	NOUN
bjos-8641360	193	15	in	in	ADP
bjos-8641360	193	16	the	the	DET
bjos-8641360	193	17	treatment	treatment	NOUN
bjos-8641360	193	18	of	of	ADP
bjos-8641360	193	19	necrotizing	necrotize	VERB
bjos-8641360	193	20	ulcerative	ulcerative	ADJ
bjos-8641360	193	21	periodontitis	periodontitis	NOUN
bjos-8641360	193	22	in	in	ADP
bjos-8641360	193	23	patients	patient	NOUN
bjos-8641360	193	24	seropositive	seropositive	ADJ
bjos-8641360	193	25	for	for	ADP
bjos-8641360	193	26	hiv	hiv	PROPN
bjos-8641360	193	27	/	/	SYM
bjos-8641360	193	28	aids	aids	PROPN
bjos-8641360	193	29	.	.	PUNCT
bjos-8641360	194	1	j	j	PROPN
bjos-8641360	194	2	oral	oral	ADJ
bjos-8641360	194	3	laser	laser	NOUN
bjos-8641360	194	4	applic	applic	NOUN
bjos-8641360	194	5	.	.	PUNCT
bjos-8641360	195	1	2007	2007	NUM
bjos-8641360	195	2	;	;	PUNCT
bjos-8641360	195	3	7	7	NUM
bjos-8641360	195	4	:	:	SYM
bjos-8641360	195	5	55	55	NUM
bjos-8641360	195	6	-	-	SYM
bjos-8641360	195	7	64	64	NUM
bjos-8641360	195	8	.	.	PUNCT
bjos-8641360	196	1	25	25	NUM
bjos-8641360	196	2	.	.	PUNCT
bjos-8641360	197	1	bajpai	bajpai	PROPN
bjos-8641360	197	2	s	s	PROPN
bjos-8641360	197	3	,	,	PUNCT
bjos-8641360	197	4	pazare	pazare	PROPN
bjos-8641360	197	5	ar	ar	PROPN
bjos-8641360	197	6	.	.	PROPN
bjos-8641360	197	7	oral	oral	ADJ
bjos-8641360	197	8	manifestations	manifestation	NOUN
bjos-8641360	197	9	of	of	ADP
bjos-8641360	197	10	hiv	hiv	PROPN
bjos-8641360	197	11	.	.	PUNCT
bjos-8641360	198	1	contemp	contemp	PROPN
bjos-8641360	198	2	clin	clin	PROPN
bjos-8641360	198	3	dent	dent	PROPN
bjos-8641360	198	4	.	.	PUNCT
bjos-8641360	199	1	2010	2010	NUM
bjos-8641360	199	2	;	;	PUNCT
bjos-8641360	199	3	1	1	NUM
bjos-8641360	199	4	:	:	SYM
bjos-8641360	199	5	1	1	NUM
bjos-8641360	199	6	-	-	SYM
bjos-8641360	199	7	5	5	NUM
bjos-8641360	199	8	.	.	NOUN
bjos-8641360	199	9	26	26	NUM
bjos-8641360	199	10	.	.	PUNCT
bjos-8641360	200	1	jané	jané	PROPN
bjos-8641360	200	2	-	-	PUNCT
bjos-8641360	200	3	salas	salas	PROPN
bjos-8641360	200	4	e	e	PROPN
bjos-8641360	200	5	,	,	PUNCT
bjos-8641360	200	6	chimenos	chimenos	NOUN
bjos-8641360	200	7	-	-	PUNCT
bjos-8641360	200	8	küstner	küstner	NOUN
bjos-8641360	200	9	e	e	NOUN
bjos-8641360	200	10	,	,	PUNCT
bjos-8641360	200	11	lópez	lópez	NOUN
bjos-8641360	200	12	-	-	PUNCT
bjos-8641360	200	13	lópez	lópez	PROPN
bjos-8641360	200	14	j	j	PROPN
bjos-8641360	200	15	,	,	PUNCT
bjos-8641360	200	16	roselló	roselló	ADJ
bjos-8641360	200	17	-	-	PUNCT
bjos-8641360	200	18	llabrés	llabrés	ADJ
bjos-8641360	200	19	x.	x.	NOUN
bjos-8641360	200	20	effect	effect	NOUN
bjos-8641360	200	21	of	of	ADP
bjos-8641360	200	22	antiretroviral	antiretroviral	ADJ
bjos-8641360	200	23	therapies	therapy	NOUN
bjos-8641360	200	24	em	em	PRON
bjos-8641360	200	25	oral	oral	ADJ
bjos-8641360	200	26	manifestations	manifestation	NOUN
bjos-8641360	200	27	of	of	ADP
bjos-8641360	200	28	hiv	hiv	PROPN
bjos-8641360	200	29	+	+	CCONJ
bjos-8641360	200	30	patients	patient	NOUN
bjos-8641360	200	31	.	.	PUNCT
bjos-8641360	201	1	av	av	PROPN
bjos-8641360	201	2	odontoestomatol	odontoestomatol	PROPN
bjos-8641360	201	3	.	.	PUNCT
bjos-8641360	202	1	2006	2006	NUM
bjos-8641360	202	2	;	;	PUNCT
bjos-8641360	202	3	22	22	NUM
bjos-8641360	202	4	:	:	SYM
bjos-8641360	202	5	315	315	NUM
bjos-8641360	202	6	-	-	SYM
bjos-8641360	202	7	26	26	NUM
bjos-8641360	202	8	.	.	PUNCT
bjos-8641360	203	1	27	27	NUM
bjos-8641360	203	2	.	.	PUNCT
bjos-8641360	204	1	hodgson	hodgson	PROPN
bjos-8641360	204	2	ta	ta	PROPN
bjos-8641360	204	3	,	,	PUNCT
bjos-8641360	204	4	greespan	greespan	NOUN
bjos-8641360	204	5	d	d	PROPN
bjos-8641360	204	6	,	,	PUNCT
bjos-8641360	204	7	greespan	greespan	PROPN
bjos-8641360	204	8	js	js	PROPN
bjos-8641360	204	9	.	.	PUNCT
bjos-8641360	205	1	oral	oral	ADJ
bjos-8641360	205	2	lesions	lesion	NOUN
bjos-8641360	205	3	of	of	ADP
bjos-8641360	205	4	hiv	hiv	PROPN
bjos-8641360	205	5	disease	disease	NOUN
bjos-8641360	205	6	and	and	CCONJ
bjos-8641360	205	7	haart	haart	PROPN
bjos-8641360	205	8	in	in	ADP
bjos-8641360	205	9	industrialized	industrialized	ADJ
bjos-8641360	205	10	countries	country	NOUN
bjos-8641360	205	11	.	.	PUNCT
bjos-8641360	206	1	adv	adv	PROPN
bjos-8641360	206	2	dent	dent	NOUN
bjos-8641360	206	3	res	re	NOUN
bjos-8641360	206	4	.	.	PUNCT
bjos-8641360	207	1	2006	2006	NUM
bjos-8641360	207	2	;	;	PUNCT
bjos-8641360	207	3	19	19	NUM
bjos-8641360	207	4	:	:	SYM
bjos-8641360	207	5	57	57	NUM
bjos-8641360	207	6	-	-	SYM
bjos-8641360	207	7	62	62	NUM
bjos-8641360	207	8	.	.	PUNCT
bjos-8641360	208	1	28	28	NUM
bjos-8641360	208	2	.	.	PUNCT
bjos-8641360	209	1	sen	sen	PROPN
bjos-8641360	209	2	s	s	PROPN
bjos-8641360	209	3	,	,	PUNCT
bjos-8641360	209	4	mandal	mandal	PROPN
bjos-8641360	209	5	s	s	PROPN
bjos-8641360	209	6	,	,	PUNCT
bjos-8641360	209	7	bhattacharya	bhattacharya	PROPN
bjos-8641360	209	8	s	s	PROPN
bjos-8641360	209	9	,	,	PUNCT
bjos-8641360	209	10	halder	halder	PROPN
bjos-8641360	209	11	s	s	PROPN
bjos-8641360	209	12	,	,	PUNCT
bjos-8641360	209	13	bhaumik	bhaumik	ADJ
bjos-8641360	209	14	p.	p.	PROPN
bjos-8641360	209	15	oral	oral	ADJ
bjos-8641360	209	16	manifestations	manifestation	NOUN
bjos-8641360	209	17	inhuman	inhuman	ADJ
bjos-8641360	209	18	immunodeficiency	immunodeficiency	NOUN
bjos-8641360	209	19	virus	virus	NOUN
bjos-8641360	209	20	infected	infect	VERB
bjos-8641360	209	21	patients	patient	NOUN
bjos-8641360	209	22	.	.	PUNCT
bjos-8641360	210	1	ind	ind	NOUN
bjos-8641360	210	2	j	j	PROPN
bjos-8641360	210	3	dermatol	dermatol	NOUN
bjos-8641360	210	4	.	.	PUNCT
bjos-8641360	211	1	2010	2010	NUM
bjos-8641360	211	2	;	;	PUNCT
bjos-8641360	212	1	55	55	NUM
bjos-8641360	212	2	:	:	SYM
bjos-8641360	212	3	116	116	NUM
bjos-8641360	212	4	-	-	SYM
bjos-8641360	212	5	8	8	NUM
bjos-8641360	212	6	.	.	NOUN
bjos-8641360	212	7	29	29	NUM
bjos-8641360	212	8	.	.	PUNCT
bjos-8641360	213	1	lemos	lemos	PROPN
bjos-8641360	213	2	s	s	PROPN
bjos-8641360	213	3	,	,	PUNCT
bjos-8641360	213	4	oliveira	oliveira	PROPN
bjos-8641360	213	5	f	f	PROPN
bjos-8641360	213	6	a	a	PROPN
bjos-8641360	213	7	,	,	PUNCT
bjos-8641360	213	8	vencio	vencio	PROPN
bjos-8641360	213	9	ef	ef	PROPN
bjos-8641360	213	10	.	.	PROPN
bjos-8641360	213	11	periodontal	periodontal	ADJ
bjos-8641360	213	12	disease	disease	NOUN
bjos-8641360	213	13	and	and	CCONJ
bjos-8641360	213	14	oral	oral	ADJ
bjos-8641360	213	15	hygiene	hygiene	NOUN
bjos-8641360	213	16	benefits	benefit	NOUN
bjos-8641360	213	17	in	in	ADP
bjos-8641360	213	18	hiv	hiv	PROPN
bjos-8641360	213	19	seropositive	seropositive	ADJ
bjos-8641360	213	20	and	and	CCONJ
bjos-8641360	213	21	aids	aid	NOUN
bjos-8641360	213	22	patients	patient	NOUN
bjos-8641360	213	23	.	.	PUNCT
bjos-8641360	214	1	med	med	ADJ
bjos-8641360	214	2	oral	oral	ADJ
bjos-8641360	214	3	patol	patol	NOUN
bjos-8641360	214	4	oral	oral	ADJ
bjos-8641360	214	5	cir	cir	NOUN
bjos-8641360	214	6	bucal	bucal	NOUN
bjos-8641360	214	7	.	.	PUNCT
bjos-8641360	215	1	2010	2010	NUM
bjos-8641360	215	2	;	;	PUNCT
bjos-8641360	215	3	1	1	NUM
bjos-8641360	215	4	:	:	PUNCT
bjos-8641360	215	5	417	417	NUM
bjos-8641360	215	6	-	-	SYM
bjos-8641360	215	7	21	21	NUM
bjos-8641360	215	8	.	.	PUNCT
bjos-8641360	216	1	30	30	NUM
bjos-8641360	216	2	.	.	PUNCT
bjos-8641360	217	1	maehler	maehler	PROPN
bjos-8641360	217	2	m	m	PROPN
bjos-8641360	217	3	,	,	PUNCT
bjos-8641360	217	4	deliberador	deliberador	PROPN
bjos-8641360	217	5	tm	tm	PROPN
bjos-8641360	217	6	,	,	PUNCT
bjos-8641360	217	7	soares	soares	PROPN
bjos-8641360	217	8	gms	gms	PROPN
bjos-8641360	217	9	,	,	PUNCT
bjos-8641360	217	10	grein	grein	PROPN
bjos-8641360	217	11	rl	rl	PROPN
bjos-8641360	217	12	,	,	PUNCT
bjos-8641360	217	13	nau	nau	PROPN
bjos-8641360	217	14	gv	gv	PROPN
bjos-8641360	217	15	.	.	PUNCT
bjos-8641360	218	1	periodontal	periodontal	ADJ
bjos-8641360	218	2	disease	disease	NOUN
bjos-8641360	218	3	and	and	CCONJ
bjos-8641360	218	4	its	its	PRON
bjos-8641360	218	5	influence	influence	NOUN
bjos-8641360	218	6	on	on	ADP
bjos-8641360	218	7	the	the	DET
bjos-8641360	218	8	metabolic	metabolic	NOUN
bjos-8641360	218	9	control	control	NOUN
bjos-8641360	218	10	of	of	ADP
bjos-8641360	218	11	diabetes	diabetes	NOUN
bjos-8641360	218	12	rsbo	rsbo	NOUN
bjos-8641360	218	13	.	.	PUNCT
bjos-8641360	219	1	2011	2011	NUM
bjos-8641360	219	2	;	;	PUNCT
bjos-8641360	219	3	8	8	NUM
bjos-8641360	219	4	:	:	SYM
bjos-8641360	219	5	211	211	NUM
bjos-8641360	219	6	-	-	SYM
bjos-8641360	219	7	8	8	NUM
bjos-8641360	219	8	.	.	PUNCT
bjos-8641360	219	9	31	31	NUM
bjos-8641360	219	10	.	.	PUNCT
bjos-8641360	220	1	ainamo	ainamo	PROPN
bjos-8641360	220	2	j	j	PROPN
bjos-8641360	220	3	,	,	PUNCT
bjos-8641360	220	4	bay	bay	PROPN
bjos-8641360	220	5	i.	i.	PROPN
bjos-8641360	220	6	problems	problem	NOUN
bjos-8641360	220	7	and	and	CCONJ
bjos-8641360	220	8	proposals	proposal	NOUN
bjos-8641360	220	9	for	for	ADP
bjos-8641360	220	10	recording	record	VERB
bjos-8641360	220	11	gingivitis	gingivitis	NOUN
bjos-8641360	220	12	and	and	CCONJ
bjos-8641360	220	13	plaque	plaque	NOUN
bjos-8641360	220	14	.	.	PUNCT
bjos-8641360	221	1	int	int	PROPN
bjos-8641360	221	2	dent	dent	NOUN
bjos-8641360	221	3	j.	j.	PROPN
bjos-8641360	221	4	1975	1975	NUM
bjos-8641360	221	5	;	;	PUNCT
bjos-8641360	221	6	25	25	NUM
bjos-8641360	221	7	:	:	SYM
bjos-8641360	221	8	229	229	NUM
bjos-8641360	221	9	-	-	SYM
bjos-8641360	221	10	35	35	NUM
bjos-8641360	221	11	.	.	PUNCT
bjos-8641360	222	1	diagnosis	diagnosis	NOUN
bjos-8641360	222	2	of	of	ADP
bjos-8641360	222	3	oral	oral	ADJ
bjos-8641360	222	4	manifestations	manifestation	NOUN
bjos-8641360	222	5	in	in	ADP
bjos-8641360	222	6	hiv	hiv	PROPN
bjos-8641360	222	7	/	/	SYM
bjos-8641360	222	8	aids	aids	PROPN
bjos-8641360	222	9	patients	patient	NOUN
bjos-8641360	222	10	who	who	PRON
bjos-8641360	222	11	used	use	VERB
bjos-8641360	222	12	haart	haart	PROPN
bjos-8641360	222	13	and	and	CCONJ
bjos-8641360	222	14	developed	developed	ADJ
bjos-8641360	222	15	diabetes	diabetes	NOUN
bjos-8641360	222	16	mellitus	mellitus	NOUN